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Despite the known visual and pathological implications of hyperopia, there has been inertia to 
address the modulation of refractive error in these individuals. 
 
Imposing relative peripheral hyperopic defocus using centre-near multifocal contact 
lenses accelerates axial growth in isohyperopic children.  
Axial growth and refractive error did not change during the 6 months prior to intervention in the 
intervention or control group. Axial growth across the 2-year period of intervention was 0.17 
mm in the intervention group versus 0.06 mm in the control group. Refractive error change 
across the same period was -0.26 D in the intervention group and +0.01 D in the control group. 
Axial growth and refractive error during the final 6 months without intervention did not change 
in either group. The overall difference in axial growth between groups was significant whereas 
the change in refractive error was not. 
 
Imposing relative peripheral hyperopic defocus using centre-near multifocal contact 
lenses does not accelerate axial growth nor reduce refractive error in anisohyperopic 
children.  
In this paired eye study, axial growth and refractive error did not change during the 6 months 
prior to intervention in either eye. Axial growth across the 2-year period of intervention was 
0.11 mm in the intervention eye versus 0.15 mm in the control eye. Refractive error change 
across the same period was -0.23 D in the intervention eye and -0.27 D in the fellow eye. Axial 
growth and refractive error during the final 6 months without intervention did not change in 
either group. The overall change in axial growth was greater in the control eye than the 
intervention eye, whereas the reduction in refractive error was comparable. 
 
Axial length measures are comparable and repeatable under pre- and post-cycloplegic 
conditions. 
 
Refractive error measures are comparable and repeatable at discrete time intervals after 
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1.0 Literature review  
 
1.1 Introduction 
Hyperopia is a known risk factor for the development of strabismus and amblyopia (Colburn et 
al., 2010). In addition to visual consequences, there is a growing body of evidence that 
uncorrected hyperopia (Williams et al., 2005) and anisohyperopia (Narayanasamy et al., 2014) 
may have a negative impact upon educational attainment and visuocognitive and visuomotor 
skills (Atkinson et al., 2007). Hyperopia occurs as a consequence of insufficient ocular growth 
and a failure to emmetropise in childhood with the majority of hyperopic refractive errors 
resulting from an eye that is too short for its refractive power (Strang et al., 1998).  
 
Currently hyperopia receives far less attention from research than myopia, even though the 
impact of moderate to high levels of hyperopia, especially in one eye, can lead to amblyopia if 
not corrected fully at a young age (Kulp et al., 2014). Although myopia has public health 
implications in an adult population (Flitcroft, 2012; Ohno-Matsui et al., 2021), within a paediatric 
population, hyperopia and anisometropia create the greatest ocular morbidity (Flitcroft, 2014).  
 
To understand the potential to modulate refractive error in hyperopes, it is important to explore 
the general literature. As such, this chapter will review human emmetropisation and how its 
failure leads to hyperopia. The optical approaches taken to control myopia progression will 
also be considered to hypothesise how these principles could be applied in the context of 
hyperopia. 
 
1.2 Human emmetropisation 
 
1.2.1 Background 
Emmetropisation describes a developmental process that matches optical power to axial 
length (AL) such that the unaccommodated eye is focused at distance (Troilo et al., 2019). 
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Human refraction differs from many other biological variables, such as height, which typically 
follow a normal distribution (Limpert et al., 2001). In fact, beyond 3 months of age, human 
refraction has a leptokurtic distribution, that is to say, a high peak and a distribution clustered 
around the mean, which is also negatively skewed (Flitcroft, 2014). Intriguingly, the ocular 
parameters that contribute to final refraction, namely corneal curvature (CC), anterior chamber 
depth (ACD), lens thickness and AL are distributed in a more typically Gaussian distribution 
(Flitcroft, 2014). The high prevalence of emmetropic and low hyperopic refractive errors in the 
human population has led to the hypothesis that there must be a mechanism in place to 
minimise refractive errors by regulation of eye growth; this is supported by the literature which 
shows that such a mechanism exists in human infants (Ehrlich et al., 1997; Mutti et al., 2005). 
Indeed, the mechanism responsible for aligning the optical and structural development of the 
eye to permit successful emmetropisation appears to be visually driven (Mutti et al., 2009). 
 
1.2.2 Phases of emmetropisation 
Half a century ago, the work of Sorsby and colleagues established that around 50% of 
postnatal eye growth in normal eyes occurs within the first 12 to 16 months of life, followed by 
a decade of decelerated axial elongation before stopping no later than the age of 13 years 
(Sorsby et al., 1961; Sorsby and Leary, 1970). On the basis of these observations, it is 
considered that emmetropisation can be broadly split into two distinct phases: a rapid infantile 
phase and a slow juvenile phase. 
 
The initial, rapid infantile phase of emmetropisation, is defined as the period from birth up to 3 
years of age (Sorsby and Leary (1970) where the components of the eye need to make 
significant adjustments to keep pace with axial elongation. During the first 12 months of life, 
the power of the eye drops markedly from 90 Dioptres (D) at birth to 75 D (Wood et al., 1996). 
The Gaussian distribution of refractive error observed at 3 months becomes leptokurtic by 9 
months of age (Mutti et al., 2005).  
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Neonates present with a wide refractive range, which decreases within the first year of life due 
to changes to CC (Inagaki, 1986; Mutti et al., 2005), AL (Fledelius and Christensen, 1996; 
Mutti et al., 2005; Fledelius et al., 2014), and crystalline lens power (Gordon and Donzis, 1985; 
Mutti et al., 2005). The reduction in hyperopia that occurs between the ages of 3 months and 
around 3 years of age is greater than which can be attributed to a passive process of 
emmetropisation, that is to say, through normal eye growth; therefore, an active feedback 
process to modulate axial growth must also play a part (Flitcroft, 2014).  
 
The slower juvenile phase of emmetropisation is considered to take place from the age of 3 
years up to the beginning of the teenage years. Between 3 and 6 years of age, 
emmetropisation continues but at a slower pace and the distribution remains leptokurtic but 
positively skewed at this stage of life (Flitcroft, 2014). After the age of 6 years, refraction starts 
to display divergence based upon geographical location. For instance, in Australia the 
distribution becomes more leptokurtic due to low levels of myopia and hyperopia (French et 
al., 2012) whereas in most populations, especially in the East, leptokurtosis reduces and the 
distribution becomes negatively skewed due to a higher prevalence of myopia (French et al., 
2012; Watanabe et al., 1999). In the Far East, and other parts of the world, including the UK 
(Logan et al., 2011; McCullough et al., 2016), myopia may present as early as 6 years of age 
(Matsumara and Hirai, 1999; Lin et al., 2004).  
 
1.2.3 Ocular structure changes during emmetropisation 
 
1.2.3.1 Cornea 
There is a rapid change in corneal power during the first 2 to 4 weeks of life with a reduction 
of 3 D reported, followed by a slowing of this trend after 8 weeks as measured using an adapted 
automated keratometer (Inagaki, 1986). Nevertheless, keratophakometry shows that the 
power of the cornea continues to reduce between the ages of 3 and 9 months, by 
approximately 1 D (Mutti et al., 2005). Despite this rapid pace of change in early life, which 
I.G.Beasley, PhD Thesis, Aston University 2021 
 
25 
sees average corneal power reduce from 47 to 48 D at infancy to 43 to 44 D by 9 months of 
age, it remains largely stable throughout childhood with little reduction in power seen thereafter 
(Zadnik et al., 2003; Mutti et al., 2005; Jones et al., 2005). 
 
1.2.3.2 ACD  
Assessment using A-scan ultrasonography has shown that ACD increases by 0.26 mm 
between 3 and 9 months of age (Mutti et al., 2005). The rapid growth phase sees ACD 
increasing by 0.9 to 1 mm from birth to 18 months of age, followed by modest growth of 0.3 to 
0.4 mm by age 7 years (Larsen, 1971a). From here, there is a slow phase, with growth of less 
than 0.1 mm between 8 and 13 years of age (Larsen, 1971a; Zadnik et al., 2003). 
 
1.2.3.3 Lens 
Normal development of the crystalline lens throughout childhood, as measured using A-sacn 
ultrasonography, is characterised by thinning, flattening and a decrease in power in order to 
achieve emmetropia by maintaining a balance with increasing AL (Mutti et al., 2012). A thinning 
of the crystalline lens occurs between 3 and 9 months of age with a flattening of both the 
anterior and posterior radii along with a small increase in equivalent refractive index leading to 
a net decrease in lens power of just over 3.5 D (Mutti et al., 2005). This decrease in crystalline 
lens power is around 3 times greater than the reduction in corneal power over this period. The 
mean thickness of the crystalline lens appears to decrease by approximately 0.3 mm during 
the first year of life and then by around 0.2 mm by the age of 8 to 10 years, whereupon this 
flattening process appears to stop or slow almost to the point of stopping (Larsen, 1971b). 
 
Between the ages of 6 and 14 years, ultrasound (Larsen, 1971b;) and videophakometry 
(Zadnik et al., 2003) show that thinning and flattening of the crystalline lens continues. Overall, 
the flattening of radii of curvature of the crystalline lens contributes towards an overall loss in 
equivalent power of about 18 to 19 D by 14 years of age. The curvature changes are 
accompanied by a decrease in equivalent refractive index from 1.45 in early infancy to about 
I.G.Beasley, PhD Thesis, Aston University 2021 
 
26 
1.42 by 10 years of age; this decrease in refractive index is responsible for almost half of the 
reduction in equivalent crystalline lens power (Mutti et al., 2005; Jones et al., 2005).  
 
1.2.3.4 AL 
A-scan ultrasonography demonstrates a rapid growth phase to AL in early life (Mutti et al., 
2005) with an increase of 3.7 to 3.8 mm from birth to 18 months, followed by 1.1 to 1.2 mm of 
elongation by 5 years of age and finally a further 1.3 to 1.4 mm by the age of 13 years (Larsen, 
1971c). An increase in vitreous chamber depth (VCD) is primarily responsible for this axial 
elongation. From birth to 18 months of age, VCD increases by 3 mm followed by slower growth 
of 1.3 mm up to the age of 7 years and then a further 1.1 mm during the early teenage years 
and beyond (Larsen, 1971d).  
 
1.2.3.5 Summary  
Despite the reduction in corneal and crystalline lens power during infancy, these adjustments 
do not correlate with the change in refractive error. However, AL changes are correlated with 
refractive error reduction with increases in axial elongation aligned to a decrease in hyperopia. 
In other words, the modulation of axial growth with respect to the initial level of refractive error 
appears to be more influential in the emmetropisation process than changes to other ocular 
components, namely the cornea and crystalline lens. Hence, the guidance of ocular growth 
towards reaching emmetropia appears to be an active rather than a passive mechanism (Mutti 
et al., 2005). 
 
1.2.4 Failures of emmetropisation 
 
1.2.4.1 Background 
The majority of emmetropisation occurs early on in life and is mostly complete by 6 years of 
age (Flitcroft, 2014). If a significant degree of refractive error persists beyond this age, then 
this is due to: an initial refractive error that is too high to be corrected by the emmetropisation 
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process; a failure of the emmetropisation process itself; or a combination of the two. So, 
refractive errors present at the age of 6 years are considered to be primary failures in the 
process of emmetropisation (Flitcroft, 2013). The standard deviation of refractive error is lowest 
at this age as is the proportion of those with significant ametropia. With this in mind, it seems 
that the aetiology of refractive errors is not dominated by a primary failure in emmetropisation 
(Flitcroft, 2014).  
 
At 6 years of age, the distribution of refractive error is positively skewed demonstrating the 
different courses of myopia and hyperopia. In other words, hyperopia is predominantly due to 
a primary failure of emmetropisation whereas the onset of myopia typically occurs beyond the 
age of 6 years in those who have successfully achieved emmetropia earlier on in childhood 
and is considered to be a secondary failure of emmetropisation (Flitcroft, 2014). 
 
1.2.4.2 Hyperopia 
The eye appears to be able to direct its growth in response to the underlying level of ametropia, 
guided by feedback from visual input (Saunders et al., 1995; Mutti et al., 2005). The extent of 
exposure to hyperopic defocus could provide the visual cue required to allow the eye to detect 
the magnitude of refractive error and increase AL accordingly to reduce its level of hyperopia 
in early childhood (Mutti et al., 2009). Naturally, this exposure to hyperopic defocus in 
hyperopic infants is a function of both the magnitude of refractive error and the accommodative 
response.  
 
The accommodative response in early infancy is variable (Candy and Bharadwaj, 2007) 
although dynamic capability seems to be present at 2 months of age (Tondel and Candy, 
2007). Despite initial immaturities in the accommodative response, infants appear capable of 
maintaining accurate average levels of accommodation across a moderate range of hyperopic 
refractive errors as early as 3 months of age (Mutti et al., 2009) reaching adults levels as soon 
as 5 months of age (Brookman, 1983; Sokol et al., 1983). The variability in infant 
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accommodation and resultant hyperopic defocus signals may form the basis for 
emmetropisation. It follows, that if an infant is exposed to a higher level of hyperopic defocus 
then it may be expected that a greater refractive change would occur during emmetropisation 
(Mutti et al., 2009). However, the evidence shows that infants with high levels of hyperopia are 
less likely to achieve an emmetropisation outcome by 18 months of age (Mutti et al., 2009). 
The findings by Mutti et al., 2009 show that deficiencies in emmetropisation at higher levels of 
hyperopia are related to poorer accommodation and higher levels of defocus; this is contrary 
to the expectation that emmetropisation would be more likely in the presence of greater levels 
of hyperopic defocus exposure. Although the pace of growth is related to the initial level of 
refractive error (Mutti et al., 2005), the likelihood of emmetropisation reduces if the magnitude 
exceeds its operating range (see Figure 1.1). Others have found that during infancy, 
emmetropisation occurs more rapidly in those with ‘high’ refractive errors, although these 
measures were obtained without cycloplegia and limited to an upper range of +4.25 D 
(Saunders et al., 1995). 
 
 
Figure 1.1 The probability of reaching +2.00 D by 18 months of age as a function of cycloplegic 
refractive error at 3 months of age. Adapted from Mutti et al., 2009 
 
Evidence that similar amounts of defocus exists across moderate levels of hyperopia does not 
point to a simple model of emmetropisation that is guided by hyperopic defocus (Mutti et al., 
2009). It has been postulated that other emmetropisation models driven by defocus may be at 
play. For instance, the possibility that a consistent level of defocus above a particular threshold 
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may trigger a rapid growth phase that reduces hyperopia (Mutti et al., 2009). This fast phase 
of growth may then switch to a slower growth phase once emmetropia is achieved and defocus 
falls below the threshold level. In this model, the duration of rapid growth would be dictated by 
the magnitude of the initial refractive error and limited by a ‘stop’ signal such as the presence 
of minimal distance defocus (Norton et al., 2006). Another possible model for emmetropisation 
is that the rate of axial growth is related to the level of accommodative effort. In this scenario, 
the level of hyperopia could be the driver for a dose-dependent signal for emmetropisation by 
providing the stimulus to accommodation rather than through defocus. This latter model is 
supported by the fact that similar levels of defocus are present across a modest range of 
refractive errors where emmetropisation occurs indicating that an accurate accommodative 
response is a factor in this success (Mutti et al., 2009). Further, the failure of emmetropisation 
at higher levels of hyperopia may be the result of a lack of effort to accommodate to 
compensate for the refractive error as seen in animal work (Smith and Hung, 1999). 
 
The probability of emmetropisation during infancy also appears to be linked to the level of 
visual acuity (VA) (Mutti et al., 2009). Emmetropisation in hyperopic infants is more likely if VA 
is above a certain level whereas poorer or unmeasurable vision seems to impair this process 
(see Figure 1.2). Of course, acuity is also linked to the underlying level of refractive error. 
 
 
Figure 1.2 The probability of reaching +2.00 D by 18 months of age as a function of the level 
of visual acuity group and Mohindra retinoscopy results at 3 months of age. Adapted from Mutti 
et al., 2009 




While the process of emmetropisation does not appear to have altered in recent decades, the 
distribution of refractive error in adults has changed dramatically due to an increase in myopia 
prevalence and its geographical variation over time (Flitcroft, 2014). The typical onset of 
myopia beyond the age of 6 years arises after several years of relatively stable refraction 
(Thorn et al., 2004). The initial phase of myopia progression adopts a linear path (Goss and 
Winkler, 1983) before slowing, although continuing to increase, throughout childhood and well 
into adulthood (Dirani et al., 2008). It is clear that increasing AL is the primary driver of myopia 
progression (Chung et al., 2002; Gwiazda et al., 2003; Chua et al., 2006). 
 
Despite extensive literature in the field, the triggers for the accelerated phase of myopia 
progression at onset and the mechanisms for the slowing of this process are still not fully 
understood (Flitcroft, 2014). 
 
1.2.4.4 Anisometropia 
Stochastic factors also appear to play a part in the aetiology of refractive errors as inferred by 
the existence of anisometropia. In anisometropes, despite sharing the same genome and 
environmental exposure, each eye emerges with a different refractive error. Anisometropia can 
be present early on in life with subsequent ocular development complicated by amblyopia 
(Flitcroft, 2014; Flitcroft et al., 2020). However, anisometropia often develops later, in both 
hyperopes and myopes (Abrahamsson et al., 1990, Deng and Gwiazda, 2012). Anisometropia 
is also linked to the magnitude of the refractive error, that is to say, higher levels of myopia, 
hyperopia, and astigmatism, are associated with an increasing frequency of anisometropia 
(Qin et al., 2005; Deng and Gwiazda, 2012). So, it seems that the regulated pattern of growth 
at around the age of 6 years exhibits increasing variability between individuals and between 
the two eyes of a single subject (Flitcroft, 2014). 
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The relationship between amblyopia and emmetropisation is still not clearly understood 
(Flitcroft, 2014). It has been shown in monkeys that induced amblyopia leads to hyperopia in 
the amblyopic eye (Kiorpes and Wallman, 1995) and that the development of amblyopia leads 
to a failure in compensatory growth to imposed defocus (Smith et al., 1999). The situation is 
less clear cut in humans, although some studies suggest that anisometropia may be a 
consequence of amblyopia as much as a cause (Lepard, 1975; Nastri et al., 1984). It has also 
been demonstrated that patterns of vitreous chamber growth are different between an 
amblyopic eye and its fellow eye (Burtolo et al., 2002). 
 
1.2.4.5 Summary 
The model of human emmetropisation in early life is in keeping with an optically guided model 
as predicted by animal work (Flitcroft, 2014). Rates of emmetropisation appear to be correlated 
with the magnitude of the initial refractive error, at least up to a moderate range (Saunders et 
al., 1995). Hyperopes with higher levels of refractive error appear to fall victim to a primary 
failure of emmetropisation, while later in childhood, secondary failures of emmetropisation are 
characterised by a rapid refractive acceleration in the direction of myopia.  
 
1.3 Childhood refractive error 
 
1.3.1 Prevalence 
The distribution of refractive error has changed in recent decades and continues to do so as a 
result of an alarming increase in the worldwide prevalence of myopia, which is already at 
epidemic levels in some countries (Holden et al., 2016; Sankaridurg et al., 2021). By 2050, it 
is estimated that around half of the population will be myopic with ~ 10% having levels of 5.00 
D or more (Holden et al., 2016). Despite the broad myopic shift in refractive error, there still 
represents a significant burden that results from other types of ametropia, namely hyperopia 
(Kleinstein et al., 2003; Logan et al., 2011; McCullough et al., 2016) and anisometropia (Deng 
and Gwiazda, 2012; O’Donoghue et al., 2013). 
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1.3.1.1 Hyperopia and myopia 
Given the geographical variance in the prevalence of myopia, location-specific differences in 
hyperopia also exist (Hashemi et al., 2018). While different cut off points are used in the 
literature to define hyperopia, the typical criterion is a post-cycloplegic mean spherical 
equivalent (MSE) refractive error of ≥ +2.00 D and ≥ +0.50 D for non-cycloplegic refraction 
(Hashemi et al., 2018). A meta-analysis of 45 studies identified an overall estimate of post-
cycloplegic childhood hyperopia prevalence of 4.6%, where under 20 years of age was used 
to define ‘children’. A breakdown of hyperopia prevalence by WHO region cited in the review 
is summarised in Table 1.1 (Hashemi et al., 2018).  
 
WHO region Estimated hyperopia prevalence (%) (95% CI) 
Africa 3.0 (1.8-4.3) 
Americas 14.3 (13.4-15.2) 
Southeast Asia 2.2 (1.2-3.3) 
Europe 9.0 (4.3-13.7) 
Eastern Mediterranean 6.8 (4.9-8.6) 
Western Pacific 3.1 (1.9-4.3) 
All 4.6 (3.9-5.2) 
Table 1.1 Estimates of hyperopia (post-cycloplegic MSE of ≥ +2.00 D) prevalence by World 
Health Organization (WHO) region (95% confidence intervals (CI)). Adapted from Hashemi et 
al., 2018 
 
A UK study in 2005 showed that the prevalence of (non-cycloplegic) hyperopia in an 
undergraduate university cohort was similar between the two predominant ethnic groups at 
18.8% and 17.3% for white and British Asian participants, respectively (Logan et al., 2005). In 
the same study, levels of myopia at that time were cited as 50% for white participants and 
53.4% for British Asians. The literature shows from studies in children that the distribution of 
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refractive errors in the UK is changing (Logan et al., 2011; McCullough et al., 2016), while at 
the same time demonstrating ethnic differences (Logan et al., 2011).  
The Aston Eye Study revealed that the overall prevalence of hyperopia (mean post-cycloplegic 
MSE ≥ +2.00 D in either/both eyes) in a mixed ethnic cohort was 12.3% for children aged 6 to 
7 years versus 5.4% for those aged 12 to 13 years (Logan et al., 2011). In white European 
children, the hyperopia prevalence was 22.9% at 6 to 7 years compared to 10.3% in South 
Asian children. At 12 to 13 years, the rates of hyperopia decreased to 10.4% versus 2.6% in 
white European and South Asian children, respectively. In contrast, the prevalence of myopia 
(mean post-cycloplegic MSE ≤ -0.50 D in either/both eyes) was 9.4% for those aged 6 to 7 
years compared to 29.4% for those aged 12 to 13 years. In the older group, the prevalence of 
myopia was 36.8% for South Asian children compared to 18.6% for white Europeans.  
 
The Northern Ireland Childhood Errors of Refraction (NICER) study reports longitudinal 
refractive data for white UK children over a 6-year period for 2 cohorts aged 6 to 7 years and 
12 to 13 years at baseline (McCullough et al., 2016). For the younger participants, the 
prevalence of hyperopia (mean post-cycloplegic MSE ≥ +2.00 D) at baseline was 21.7% 
(21.0% in males; 22.4% in females) and decreased to 14.2% (13.3% in males; 15.0% in 
females) after 6 years. In the older age group, the proportion of hyperopes at baseline was 
15.0% (17.4% in males; 13.3% in females) and 17.7% (19.4% in males; 16.4% in females) at 
the 6-year timepoint. The average annual rate of change in MSE refractive error was -0.09 D 
and +0.02 D in the younger and older participants, respectively. The proportion of myopes 
(mean post-cycloplegic MSE ≤ -0.50 D) at baseline in the younger group was 1.9%, rising to 
14.6% over the course of the 6-year study. In the older participants, myopia prevalence was 
16.4% at baseline and 18.6% after 6 years. There were no significant differences between 
gender in the annual rate of MSE refractive change for myopes in either age group.   
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Intriguingly, comparison of data from the NICER study with children in Australia shows 
differences in rates of hyperopia and myopia at two timepoints in childhood (French et al., 
2012). In 6- to 7-year-old children in Sydney, rates of hyperopia were lower in children in 
Sydney (12.0%) than children in Northern Ireland (22.3%). Similarly, the prevalence at age 12 
to 13 years was also lower in the Australian cohort compared to Northern Ireland at 4.4% and 
11.8%, respectively, although the MSE refractive error was higher at +0.83 D in Australian 
children compared to +0.66 D in the UK-based cohort. 
 
Elsewhere in the world, findings from the Collaborative Longitudinal Evaluation of Ethnicity and 
Refractive Error (CLEERE) study (Kleinstein et al., 2003) in the US, mirrors the higher rates of 
myopia seen in UK-based Asian children compared to those from other ethnic backgrounds. 
Overall rates of myopia were 9.2%, but specifically, the data showed that in children aged 5 to 
17 years, Asians had the highest prevalence of myopia (18.5%) followed by Hispanics (13.2%), 
while children of European ancestry had the lowest prevalence (4.4%), which was similar to 
African Americans (6.6%). Data for hyperopes (mean post-cycloplegic refraction in each 
principal meridian ≥ +1.25 D) from the same study showed an overall prevalence of 12.8% 
with highest rates seen in whites (19.3%), followed by Hispanics (12.7%), African Americans 
(6.4%) and Asians (6.3%). 
 
1.3.1.2 Anisometropia  
During the first year of life, the prevalence of anisometropia decreases (Wood et al., 1995; 
Mayer et al., 2001) but remains relatively stable throughout early (Abrahamsson et al., 1990; 
Borchert et al., 2010; de Vries, 1985) and late childhood (de Vries, 1985; Dobson et al., 2008), 
although higher rates are associated with childhood hyperopia (Deng and Gwiazda, 2012) and 
myopia (Tong et al., 2006; Deng and Gwiazda, 2012). The stable rates of anisometropia are 
maintained as a consequence of as many children losing as those developing this refractive 
status (Abrahamsson and Sjöstrand, 1996). 
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Although there does not appear to be a standard definition of anisometropia, an interocular 
MSE difference of ≥ 1.00 D appears to be a common criterion (Qin et al., 2005; Huynh et al., 
2006; Dobson et al., 2008; O’Donoghue et al., 2013). Others highlight that in strict terms, any 
difference in interocular refractive error could be classified as anisometropia but as a result of 
test-retest variability in measurement, a difference of ≥ 0.75 D should be reserved for a 
clinically significant definition (Barrett et al., 2013). 
 
Insight from the NICER study provides useful data on the prevalence of anisometropia at 2 
key timepoints during childhood (O’Donoghue et al., 2013). At age 6 to 7 years, the proportion 
of anisometropes (post-cycloplegic MSE ≥ 1.00 D) among white children in the UK was 8.5% 
and similar to levels in the 12 to 13 age group at 9.4%. In the older children, the results also 
highlighted that anisometropia is more common in those with moderate hyperopia (8 times the 
odds compared to myopia), but it remains unclear if this relationship is causal. In those with 
low levels of hyperopia, the odds of anisometropia was 80% lower than children with myopia. 
In the younger age group, there was no difference in the prevalence of anisometropia across 
refractive groups. 
 
The prevalence of anisometropia elsewhere in the world varies by location (O’Donoghue et al., 
2013). For instance, in Australia the prevalence is reported as 1.6% in 6-year-old children 
(Huynh et al., 2006), 6.7% in 4- to 13-year-old American Indians (Dobson et al., 2008) and 
9.9% in 7- to 18-year-old Taiwanese children (Shih et al., 2005). 
 
1.3.2 The burden of refractive error  
Concerns over the spiraling rates of myopia around the world are not centred on the 
inconvenience of refractive error but due to its association with a range of ocular comorbidities 
including glaucoma, cataract, myopic maculopathy and retinal detachment (Flitcroft, 2012). 
Nevertheless, myopia is not the only refractive error type that carries a burden of ocular 
disease and visual impairment. Indeed, both hyperopia and anisometropia have visual 
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implications in the early stages of life and elevated risk of ocular disease more latterly (Flitcroft, 
2012). 
 
1.3.2.1 Clinical implications of hyperopia 
While hyperopia appears to have a protective effect for certain types of cataract (Lim et al., 
1999), having a short AL, the predominant feature in hyperopia (Strang et al., 1998), 
predisposes the individual to other ocular conditions. 
 
Clinicians are alert to the fact that hyperopia carries a risk of angle closure glaucoma (Lowe, 
1970; Xu et al., 2008). It is also postulated that the link between hyperopia and angle closure 
glaucoma is greater for Caucasians than those of Asian origin (Congdon et al., 1997). Further, 
it has been shown that AL itself, rather than just a shallow anterior chamber, is important in 
terms of angle closure risk with an odds ratio of 2.04 per mm reduction in the length of the eye 
(Casson et al., 2009). Despite the association between AL, refractive error itself does not 
appear to be correlated with risk of angle closure (Casson et al., 2009; Senthil et al., 2010). 
 
Hyperopes also appear to be prone to certain retinal conditions (Flitcroft, 2012). For instance, 
eyes with a shorter AL and VCD appear to be anatomically predisposed to both central and 
branch retinal vein occlusion (Szigeti et al., 2015) although findings appear equivocal (Bandello 
et al., 1998; Kir et al., 1998). Nevertheless, the more recent work in this area by Szigeti et al., 
2015 utilised more accurate imaging techniques whereas the outcomes from earlier studies 
may be obscured by the resolution limitations of applanation ultrasound. Refractive error and 
AL also seem to have an association with the risk of diabetic retinopathy when considering a 
broad population-based sample from hyperopia to high myopia (Lim et al., 2010). In particular, 
myopic eyes appear less likely to have diabetic retinopathy, particularly at more severe stages 
of the disease. In terms of AMD, a meta-analysis showed that in comparison to emmetropes, 
hyperopes had a 13% higher risk of early disease whereas myopes had a 25% lower risk. 
Furthermore, each mm increase in AL was associated with a 21% reduction in odds and per-
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dioptre move towards hyperopia was linked to a 10% increase in early AMD prevalence (Li et 
al., 2014). In addition to the predisposition to retinal disease, hyperopes also present a greater 
surgical challenge for routine procedures such as cataract extraction due to the typical shallow 
nature of the anterior chamber in these patients (Gogate and Wood, 2008). In these eyes, it is 
more difficult for the surgeon to perform intraocular manipulations and introduce instruments 
in and out of the eye, which increases the risk of iatrogenic complications. 
 
Of course, outside of its association with the range of ocular comorbidities above, hyperopia 
is a well-recognised risk factor for the development of amblyopia and strabismus, particularly 
at moderate to high levels (Ingram, 1977; Ip et al., 2008; Klimek et al., 2004; Kulp et al., 2014). 
The literature shows that for post-cycloplegic refractive error >+3.25 D, the proportion of 3- to 
5-year-old children with amblyopia was 34.5% versus 2.8% in those ‘without’ hyperopia 
(defined as +3.25 D or less in the most positive meridian). Using the same criteria, strabismus 
was present in 17.7% of children with hyperopia >+3.25 D compared to just 2.2% in those with 
a refractive error below this threshold (Kulp et al., 2014). For those with +5.00 D of hyperopia 
or more, levels of amblyopia reached 51.5% compared to 13.2% in children with ametropia 
between +3.50 D and +4.75 D. Similarly, a greater proportion of strabismus was seen in the 
higher refractive group (32.9%) than at moderate levels of hyperopia (8.4%) (Kulp et al., 2014). 
Others have outlined the association between hyperopia and esotropia in children aged 6 
months to 6 years (Cotter et al., 2011; Tarczy-Hornoch et al., 2011). Compared with refractive 
errors between plano and +0.75 D, the odds ratios for esotropia are 23 for hyperopia between 
+3.00 D and +3.75 D, 59.8 for +4.00 D to +4.75 D and 122 for +5.00 D or more (Cotter et al., 
2011), which places these children at lifelong risk of unilateral and bilateral reduction in VA 
(Tarczy-Hornoch et al., 2011). Even in the absence of strabismus and amblyopia, impaired 
visual function at both distance and near is associated with increasing levels of hyperopia in 
pre-school children (Ciner et al., 2021). Furthermore, deficits in measures of attention, visual-
motor integration and visual perception are associated with moderate levels (3 D to 6 D) of 
uncorrected hyperopia in young children (Kulp et al., 2017). 
I.G.Beasley, PhD Thesis, Aston University 2021 
 
38 
1.3.2.2 Clinical implications of anisometropia 
While most refractive errors in humans are classified as isoametropic, a minority present with 
significant interocular differences, which can be deleterious to visual development (Barrett et 
al., 2013; O’Donoghue et al., 2013; Flitcroft et al., 2020). Anisometropia occurs despite both 
eyes being exposed to similar environmental influences throughout visual development. 
Anisometropia and amblyopia are often discovered at the same timepoint through vision 
screening programmes but it is widely proposed that the former is a precursor and the cause 
of the latter (Barrett et al., 2013). As anisometropia and amblyopia can exist without obvious 
signs and symptoms, these children typically p establish whether axial eye growth and 
refractive error could be modified in an isohyperopic cohort by imposing relative hyperopic 
defocus using MF CLs.resent to clinic some 3 years later than those with strabismus (Ingram, 
1977; Shaw et al., 1988; Woodruff et al., 1994)  
 
Most studies concur that anisometropia exists in around half of all cases of amblyopia in a 
human population (Robaei et al., 2006; Friedman et al., 2009; Chia et al., 2010; Pai et al., 
2012). A series of studies have highlighted that a greater proportion of anisometropic 
amblyopes are anisohyperopes than anisomyopes (Tanlamai and Goss, 1979; Rutstein and 
Corliss, 1999).  
 
Data from the NICER study reveals that significant differences in VA arise as a consequence 
of anisometropia with interocular differences in the logarithm of the minimum angle of 
resolution (LogMAR) acuity of 0.15 for 6- to 7-year-old children and 0.14 at 12 to 13 years of 
age; this compares to 0.04 and 0.03 for isometropes in the younger and older age groups, 
respectively (O’Donoghue et al., 2013). One study reported that the chance of finding a 
difference in VA of 2 lines or more was 4.5 times higher in those with 1 D to <2 D of 
anisometropia compared to children with 0 to <1 D of interocular refractive difference (Tarczy-
Hornoch et al., 2011). The same authors highlighted a strong linear relationship between the 
magnitude of anisometropia and prevalence of reduced VA. 




Anisometropia coexists with strabismus in around 10% of cases (Friedman et al., 2009); some 
cite figures of 19% (Robaei et al., 2006) while others report a link in as many as 28% of cases 
(Flom and Neumaier, 1966; Flom and Bedell, 1985). Data from the NICER study characterised 
a cohort of 6- to 7-year-old anisometropes by prevalence of binocular vision status as follows: 
92.8% orthophoria; 2.1% esotropia; 1.0% exotropia; and 4.1% heterophoria. In 12- to 13-year-
old children, the prevalence rates were similar at 92.2% orthophoria; 2.4% esotropia; 0.8% 
exotropia; and 4.1% heterophoria (O’Donoghue et al., 2013).  
 
A recent study suggests that even small levels of anisometropia can be a marker for impaired 
regulation of eye growth and subsequent emmetropisation (Flitcroft et al., 2020). Data taken 
from the NICER study for non-amblyopic 6- to 7-year-old children revealed that 71% were 
isometropes with a MSE interocular difference in refraction of <0.50 D. For those categorised 
as anisometropes, 29% had a MSE difference of ≥0.50 D, with 6.9% exhibiting an interocular 
difference of ≥1.00 D and 2.5% with ≥1.50 D. Intriguingly, the refractive error profiles varied 
between the two groups with the isometropes showing a close to Gaussian distribution 
whereas anisometropes did not display a normal distribution with a positive skew due to the 
influence of more hyperopes in this group. Further, among anisometropes, refraction was 
significantly correlated with CC which was not the case in isometropes. The poor correlation 
between refraction and CC seen in older children is a marker for emmetropisation; this is due 
to the fact that CC does not change greatly beyond 2 years of age and as a result achieving 
emmetropia relies upon the regulation of AL growth to match the optics of the eye. As such, 
these changes result in a poor correlation between refraction and CC but a strong correlation 
between corneal radius and AL (Flitcroft et al., 2020). 
 
1.3.3 Management of hyperopia 
While myopes have a growing armamentarium of options to not only correct, but also to 
influence, or ‘treat’, progression of refractive error, hyperopes are not afforded an equivalent 
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range of options. Indeed, the management of iso- and anisohyperopic refractive error is 
typically confined to correction with standard optical appliances, namely spectacles and 
contact lenses (CLs).  
 
The approach to managing hyperopia, that is to say, the magnitude of correction provided 
relative to the manifest refractive error, or whether a correction should be given at all, is open 
to conjecture (Mutti, 2007; Cotter, 2007) with scant evidence from randomised studies in 
humans (Cotter, 2007; Leat, 2011). Correcting hyperopia ≥4.5 D has been suggested due to 
the increased risk of amblyopia and strabismus at this level of refractive error (Klimek et al., 
2004). However, some advocate that outside of those with strabismus/amblyopia risk, 
correcting hyperopia with spectacles may interfere with the emmetropisation process and 
result in persistence of refractive error (Donahue, 2007); the counter view suggests that 
correction of the refractive error improves VA and accommodative accuracy and that an optical 
appliance is unlikely to impede the rapid emmetropisation process that occurs early on in life 
(Mutti, 2007; Cotter, 2007). Adding to the debate, some report that consistently correcting 
hyperopia up to the age of about 3 and a half years impedes emmetropisation (Ingram et al., 
2000); others have shown that by the age of 3 years, there is no difference between those 
partially corrected or not (Atkinson et al., 2000; Atkinson et al., 2007). Unsurprisingly, the 
likelihood of achieving emmetropisation decreases in those with a higher level of hyperopia 
(Mutti et al., 2009). In hyperopic children under the age of 12 years, it has been shown that 
undercorrection of hyperopia results in a more rapid reduction in refractive error than those 
with full correction (Yang et al., 2014). A recent review considered the effect of prescribing 
spectacles compared to no intervention for preventing strabismus in infants and children with 
hyperopia (Jones-Jordan et al., 2020). The review concluded that the effect of spectacle 
correction for prevention of strabismus remains unclear. 
 
The summary of guidelines from the Royal College of Ophthalmologists for the management 
of amblyopia recommends that ‘significant refractive errors should be corrected’. The guidance 
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also outlines that consideration should be given to prescribing for degrees of refractive error 
which have the potential to induce amblyopia even in the presence of normal VA, specifically 
≥4.50 of isohyperopia (Royal College of Ophthalmologists, 2006). 
   
Conflicting evidence in the management of hyperopia presents a dilemma for the clinician. 
Nevertheless, age-dependent guidance on the level of refractive error to correct is available 
(Leat et al., 2011). Furthermore, it is argued that as uncorrected hyperopia in childhood has a 
negative impact on VA and accommodative accuracy, the reluctance by some to correct 
hyperopia is unwarranted; this is especially when taking into account that as the course of 
emmetropisation is largely complete early on in life, the immediate benefits of visual correction 
may outweigh any concerns regarding interference with this process (Mutti, 2007). 
 
For anisohyperopia specifically, while the mainstay of management is typically refractive 
correction with spectacles, the benefits of CLs should not be overlooked in these individuals. 
Using CLs to correct anisohyperopia reduces aniseikonia compared with spectacle lenses and, 
therefore, maximises the potential for normal binocular vision (Winn et al., 1986; Romano and 
von Noorden, 1999); this is the case for both refractive and axial anisometropes (Winn et al., 
1988). Further, CLs to correct high levels of anisometropia in children can deliver 
improvements in VA even after standard amblyopia treatment with spectacles and occlusion 
therapy has been tried (Roberts and Adams, 2002). 
 
In general, the level of refractive correction for anisohyperopes should aim to fully address any 
imbalance between the two eyes although, in the absence of accommodative strabismus, a 
symmetric reduction of up to 1.50 D in spherical correction may be applied (Pediatric Eye 
Disease Investigator Group, 2002; Repka et al., 2003; Holmes et al., 2003). The Royal College 
of Ophthalmologists’ guidance suggests that due to the risk of amblyopia, ≥1.50 D of 
anisohyperopia should be considered for correction (Royal College of Ophthalmologists, 
2006). 
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1.4 Experimental models of refractive error modulation 
 
1.4.1 Background 
Much of the evidence about the theories of emmetropisation and refractive error has developed 
from animal models (Trolio et al., 2019; Chakraborty et al., 2020). This body of research spans 
several decades and explores the optical, environmental and biochemical mechanisms in 
animal models, which has furthered our understanding of the factors that influence eye growth 
in humans. We know from this extensive work in animals, that visual experience plays a crucial 
role in guiding ocular growth along a path either towards emmetropisation or refractive error. 
An overview of the key optical aspects of this work is provided below. 
 
1.4.2 Form deprivation  
Experimental models of form deprivation were first described in the seventies where the lids 
of neonatal monkeys were sutured, which resulted in enlargement of the globe and 
development of myopia (Wiesel and Raviola, 1977). This work was quickly followed by other 
form-deprivation experiments using lid suturing method in other species, including tree shrews 
(Sherman et al., 1977), cats (Wilson and Sherman, 1977) and chicks (Wallman et al., 1978). 
Other methods of imposing form deprivation outlined in the literature include opacifying the 
cornea in newborn macaque monkeys (Wiesel and Raviola, 1979), use of translucent diffusers 
(Smith, 1998; Smith and Hung, 1999), glue (Wallman et al., 1978) and Velcro (Howlett and 
McFadden, 2006; Ashby et al., 2009). Regardless of the method of depriving form, the 
outcomes from these studies have shown consistently that a sharp retinal image at high 
contrast is required to permit normal eye growth, otherwise axial myopia will result 
(Chakraborty et al., 2020). Form-deprivation myopia is described as an ‘open-loop’ condition 
where an absence of visual feedback and a defined refractive endpoint results in an abnormal 
growth rate of the eye. The magnitude of refractive error, resulting mainly from elongation of 
the vitreous chamber (Gottlieb et al., 1987; Wallman et al., 1995; Wildsoet and Wallman, 1995; 
Troilo et al., 2000; Howlett and McFadden, 2006), varies among species. For instance, in 
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primates, depriving form for 17 weeks results in 5-6 D of myopia (Smith et al., 1994; Smith et 
al., 2002), whereas in chicks the rate is much faster with up to 17 D of myopia developing after 
just 10 days under these conditions (Wallman et al., 1995). Despite these varied growth rates 
between different species, the results unequivocally point towards a common mechanism of 
ocular growth (Chakraborty et al., 2020). 
 
Importantly, the degree of myopia induced by form deprivation is positively correlated to the 
extent of image degradation with even mild disruption to retinal image quality having the 
potential to induce a degree myopia (Siegwart and Norton, 1998; Howlett and McFadden, 
2006). Across a range of animals, the response to form deprivation decreases with age 
(Wallman et al., 1995; Siegwart and Norton, 1998; Smith et al., 1999; Troilo et al., 2000;) 
although a level of plasticity exists even at the end of the initial phase of emmetropisation, at 
least in chicks (Wallman and Adams, 1987; Papastergiou et al., 1998) and monkeys (Smith et 
al., 1999). 
 
Constant exposure to darkness is also sufficient to disrupt normal ocular growth resulting in 
axial elongation, along with corneal flattening in both chicks (Gottlieb et al., 1987; Trolio and 
Wallman, 1991) and monkeys (Guyton et al., 1998). This flattening of the cornea and 
subsequent loss of corneal power in young animals leads to a more hyperopic refraction.  
 
Common to all animals is the recovery from induced myopia upon cessation of form deprivation 
(Wallman and Adams, 1987; Wallman et al., 1995; Wildsoet and Wallman, 1995; Qiao-Grider 
et al., 2004; Howlett and McFadden, 2006), although the rate varies between species, with 
recovery within 2 weeks for chicks (Wallman and Adams, 1987) compared with around 8 days 
for guinea pigs (Howlett and McFadden, 2006) and up to 1366 days for rhesus monkeys (Qiao-
Grider et al., 2004). A rapid deceleration in eye growth occurs once the period of deprivation 
has ended, led chiefly by changes to the vitreous chamber and choroid (Wallman et al., 1995; 
Wildsoet and Wallman, 1995). The recovery response to form deprivation is dependent upon 
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the magnitude of myopia and the age at which the penalisation is ended (Qiao-Grider et al., 
2004). 
 
Intriguingly, visual deprivation in humans, as a result of conditions such as ptosis (O’Leary and 
Millodot, 1979), corneal opacity (Gee and Tabbara, 1988) or cataract (von Noorden and Lewis, 
1987), is also associated with the development of myopia and is presumed to be due to a 
similar mechanism observed in animals. 
 
1.4.3 Lens-induced ametropia 
Animal studies have shown that the eye is able to compensate for imposed defocus. In other 
words, ocular growth of the eye adapts in response to a change in focal plane to decrease or 
eliminate the refractive error; this occurs with both myopic and hyperopic defocus (Schaeffel 
et al., 1988; Trolio et al., 2019). When hyperopic defocus is introduced using negative lenses, 
the eye elongates as the choroid thins which moves the retina backwards resulting in a myopic 
shift. In the case of myopic defocus, imposed with positive lenses, the opposite response 
occurs where the choroid thickens, bringing the retina forward, leading to a hyperopic shift in 
refraction. In both scenarios, the changes are largely due to changes in the vitreous chamber 
(Wildsoet and Wallman, 1995). 
 
Defocus created using lenses is considered to be a ‘closed-loop’ condition, where changes to 
eye growth stop once the imposed refractive error has been compensated for (Morgan et al., 
2013). As with form deprivation, the changes in response to lens-induced ametropia are 
observed across a wide range of species including chicks (Irving et al., 1992; Wallman et al., 
1995; Wildsoet and Wallman, 1995), tree shews (Norton et al., 2006), monkeys (Hung et al., 
1995; Smith and Hung, 1999), marmosets (Graham and Judge, 1999) and mice (Tkatchenko 
et al., 2010). Although the broad response is shared across different species, the range of 
compensatory response varies. For instance, chick eyes are able to compensate for defocus 
extending from -10 to 20 D (Irving et al., 1992), whereas monkeys have a more confined range 
I.G.Beasley, PhD Thesis, Aston University 2021 
 
45 
of -5 to 8 D (Smith and Hung, 1999; Trolio et al., 2009). Interestingly, if the degree of imposed 
defocus falls outside the operating limits of lens compensation then this results in little to no 
change in refractive error (Irving et al., 1995; Smith and Hung, 1999; Tkatchenko et al., 2010). 
As seen in form deprivation work, when the experimental lens is removed, there is a fast 
reversal of choroidal thickness, and consequently, AL, to re-establish normal vision (Wallman 
et al., 1995; Wildsoet and Wallman, 1995). It is noteworthy that, in keeping with animal models, 
imposition of hyperopic and myopic defocus for one to two hours results in bidirectional 
changes in choroidal thickness and AL in young adult humans (Moderiano et al., 2019; 
Chakraborty et al., 2012; Chakraborty et al., 2013). 
 
Naturally, as the visual environment changes over time, so too does the dose, magnitude, 
frequency and sign of defocus. It follows, therefore, that the eye growth response is reliant 
upon the temporal integration of visual input (Trolio et al., 2019; Zhu, 2013). The regulation of 
ocular growth in response to visual signals over time does not appear to follow a linear path. 
For example, work in chicks has shown that exposing the eye to alternating periods of 
hyperopic and myopic defocus over equal blocks of time results in reduced axial growth and 
subsequent development of hyperopia (Zhu et al., 2003; Winawer et al., 2005). Other studies 
in chicks have shown that the response to myopic defocus has greater influence on refractive 
outcome than hyperopic defocus; this implies that different mechanisms may exist to drive the 
ocular response to hyperopic and myopic defocus (Zhu et al., 2005; Zhu, 2013;). The 
frequency and duration of exposure, rather than total time, seems important with regards to 
invoking a response. For instance, multiple periods of brief exposure to defocus across a single 
day leads to a greater response than a single dose over an equivalent time period, at least in 
chicks (Winawer and Wallman, 2002). Time of day in relation to exposure also appears to be 
important, not only in chicks (Nickla et al., 2017), but also humans, with work indicating that 
the eye may be more responsive to a hyperopic defocus, or ‘go’ signal in the morning, and a 
myopic defocus or ‘stop’ signal later in the day (Moderiano et al., 2019). 
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Current optical approaches for myopia management in contemporary clinical practice include 
multifocal (MF) CL and orthokeratology (OK), which impose competing hyperopic and myopic 
defocus signals across large parts of the retina simultaneously (Chakraborty et al., 2020). Work 
in guinea pigs reveals that exposure to dual-focus lenses with alternating power zones 
produces a response that is equivalent to the mean of the two powers (McFadden et al., 2014). 
In other species (Tse et al., 2007; Benavente-Pérez et al., 2012a), the response to a dual-
focus stimulus seems to have a greater affinity for the positive component of the lens resulting 
in a hyperopic shift in refraction. 
 
Although form deprivation and hyperopic defocus both lead to axial myopia, the underlying 
mechanisms may be different. This is highlighted in work where blocking the parasympathetic 
innervation to the chick eye inhibits form-deprivation myopia but does not impact upon the 
expected response from lens-induced defocus (Schmid and Wildsoet, 1996). Furthermore, 
undertaking optic nerve section in chicks, which eliminates active accommodation, results in a 
50% greater change in AL driven by form derivation compared to an equivalent level of spatial 
blur imposed by defocus (Choh et al., 2006). 
 
Environmental light levels also appear to impact the response to both form deprivation and 
lens-induced defocus. Rearing chicks in bright light inhibits myopia development from form 
deprivation entirely but only has a modest effect on compensation to hyperopic defocus (Ashby 
and Schaeffel, 2010); a similar outcome is observed in macaques (Smith et al., 2012).  
 
The literature on lens-induced ametropia in animals has provided a firm foundation for the 
development of optical interventions to modulate refractive error in humans, although to date, 
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1.4.4 Peripheral defocus 
Key findings in chicks have highlighted that eye growth can be guided selectively in areas 
locally subjected to retinal deprivation (Hodos and Kuenzel, 1984; Wallman et al., 1987); a 
similar response has also been shown to exist in monkeys (Smith et al., 2005; Smith et al., 
2009). In addition to form deprivation, a selective retinal response to localised defocus also 
occurs in chicks and non-human primates (Diether and Schaeffel, 1997; Morgan and 
Ambadeniya, 2006; Liu and Wildsoet, 2011; Benavente-Pérez et al., 2014) where hemifield 
exposure to negative and positive defocus results in the local development of myopia and 
hyperopia, respectively (Diether and Schaeffel, 1997; Smith et al., 2010). Peripheral defocus 
also appears to influence eye growth (Liu and Wildsoet, 2011; Benavente-Pérez A et al., 2012; 
Liu and Wildsoet, 2012; Benavente-Pérez et al., 2014). Intriguingly, the response to hyperopic 
peripheral defocus is less than full field exposure, whereas compensation to myopic peripheral 
defocus is the same (Morgan and Ambadeniya, 2006), if not greater (Liu and Wildsoet, 2011; 
Benavente-Pérez et al., 2014), than a full field approach. Animal work has shown that to slow 
eye growth with peripheral myopic defocus, treatment zones need to relatively large (Morgan 
and Ambadeniya, 2006; Liu and Wildsoet, 2011; Benavente-Pérez et al., 2014) compared to 
the smaller zones of peripheral hyperopic defocus that are required to trigger axial elongation 
(Smith et al., 2009; Benavente-Pérez A et al., 2012; Benavente-Pérez et al., 2014;). In 
contrast, some have shown that providing peripheral defocus using lenses with a central hole 
does not appear to impact central refraction in chicks, implying that peripheral defocus does 
not necessarily influence refraction measured centrally (Schippert and Schaeffel, 2006). 
 
Historically, it was thought that high foveal sensitivity was particularly important for detecting 
defocus and subsequent emmetropisation (Chakraborty et al., 2020). However, we now 
understand from work with non-foveated species, such as fish (Shen et al., 2005), or those 
without the ability to process at high spatial resolution (Sherman et al., 1977; Wallman et al., 
1995; Howlett and McFadden, 2006) that foveal input may not be critical. Work with rhesus 
monkeys supports this hypothesis, where despite having undergone foveal ablation, normal 
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emmetropisation was achieved along with compensation for form deprivation (Smith et al., 
2007). Also, it seems that foveal input is not essential for compensation to defocus, as chicks 
(Wildsoet and Schmid, 2000) and monkeys (Smith et al., 2005) are able to recover from 
induced refractions in the absence of a central signal. The fact that the eye responds at a local 
and regional retinal level, rather than being reliant upon a central, neural mechanism, has 
paved the way for refractive modulation approaches in humans.  
 
As peripheral defocus has the ability to influence refraction, it follows that this would be 
expected to be accompanied by corresponding eye growth. In humans, the characteristics of 
peripheral refraction are linked to central refraction. Specifically, myopes have a tendency to 
be relatively hyperopic along the horizontal axis, whereas hyperopes tend to exhibit relative 
peripheral myopia (Millodot, 1981; Mutti et al., 2000). There is conjecture as to whether these 
respective peripheral profiles are the cause or the result of central refractive development 
(Seidemann et al., 2002). We have learnt from work with monkeys that exposure to form 
deprivation leads to relative peripheral hyperopia (RPH) which increases with the magnitude 
of central myopia (Huang et al., 2009). The extent of peripheral refraction asymmetry varies 
with eccentricity in marmosets as does the strength of the relationship between central and 
peripheral refraction (Totonellly et al., 2006; Benavente-Pérez et al., 2012b; Benavente-Pérez 
et al., 2014). In addition to the shift towards relative hyperopia as the eye grows, in marmosets 
it appears that there is a move towards relative peripheral myopia during periods of slower 
growth during emmetropisation (Benavente-Pérez et al., 2016).  
 
The temporal aspects of visually driven eye growth and its interaction with peripheral refraction 
have also been considered in marmosets (Benavente-Pérez et al., 2016). This work has shown 
that baseline measures of peripheral refraction can only predict the compensatory changes to 
negative defocus in combination with central refraction, or once the eyes have started to 
compensate for the imposed status (Benavente-Pérez et al., 2016). The collective evidence in 
this area provides an understanding of the relationship between peripheral refractive 
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asymmetry and the visual experience of the central retina (Benavente-Pérez et al., 2012a; 
Benavente-Pérez et al., 2012b; Benavente-Pérez et al., 2014;). The fact that peripheral 
refraction appears to be both a cause and an effect of eye growth, points towards its role in 
the progression of myopia, and perhaps most significantly, opportunities to develop 
interventions to control it (Chakraborty et al., 2020). 
 
1.4.5 Ocular shape 
Ocular shape in humans varies according to refractive subtype with myopic eyes typically 
having a steeper, or relatively prolate, profile whereas emmetropes and hyperopes have a 
flatter, or oblate, retinal shape (; Atchison et al., 2005; Gilmartin et al., 2005; Charman and 
Radhakrishnan, 2010; Atchison and Charman, 2011; Schmid, 2011; Verkicharla et al., 2012). 
Techniques such as magnetic resonance imaging (MRI) have been used to show the link 
between ocular shape and peripheral refraction with the relatively more prolate myopic eye 
exhibiting RPH (see Figure 1.3). Conversely, the oblate profiles seen in emmetropes and 
hyperopes are associated with a relatively myopic peripheral refraction (Atchison et al., 2005; 
Gilmartin et al., 2005; Charman and Radhakrishnan, 2010; Atchison and Charman, 2011; 
Schmid, 2011; Verkicharla et al., 2012) (see Figure 1.4).  
 
Figure 1.3 Relatively prolate ocular shape in myopia with corresponding retinal image shell, 
indicated by the green dashed line, demonstrating RPH 
 




Figure 1.4 Relatively oblate ocular shape in hyperopia with corresponding retinal image shell, 
indicated by the red dashed line, demonstrating relative peripheral myopia  
 
MRI studies in infant rhesus monkeys (Huang et al., 2009; Smith et al., 2013) and marmosets 
(Totonelly and Trolio, 2008) with specific parts of the visual field targeted by form deprivation 
or defocus reveal that changes in peripheral refraction correspond to vitreous chamber shape 
changes. A limited number of human studies have explored peripheral refraction and retinal 
shape in combination and where these have been undertaken, the emphasis has been in 
relation to myopia. It has been shown, using partial coherence interferometry (PCI), that 
peripheral refraction, peripheral AL and retinal profile are affected by race, meridian and 
refraction (Verkicharla et al., 2016; Verkicharla et al., 2017). East Asians have a more prolate 
retinal shape and exhibit a greater degree of RPH than Caucasians with a steeper profile along 
the horizontal meridian compared to the vertical meridian.  
 
Although many contemporary clinical approaches to arrest myopia progression centre on 
manipulation of peripheral hyperopic defocus, the role of retinal shape in the pathogenesis of 
myopia is yet to be fully established (Chakraborty et al., 2020). Indeed, there is evidence 
among both Caucasian and Chinese cohorts which show that peripheral hyperopic defocus 
may not predict the development, nor the progression of myopia (Sng et al., 2011a; Sng et al., 
2011b; Mutti et al., 2011; Lee and Cho, 2013; Atchison et al., 2015; Atchison and Rosén, 2016; 
Rotolo et al., 2017; Mutti et al., 2019). The findings from this body of work highlight that the 
interaction between peripheral refraction and myopia is far from straightforward and that a 
number of optical factors are at play. Nevertheless, as retinal shape is related to peripheral 
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Given that accommodation is driven by various cues, including retinal defocus, chromatic 
aberration and optical vergence (Kruger et al., 1993; Del Aguila-Carrasco et al., 2017), it has 
been identified as a potential factor in the development of myopia. Although animal work 
indicates that emmetropisation is guided by retinal defocus, it is unclear whether 
accommodation-related defocus has a part to play in this process (Chakraborty et al., 2020). 
Evidence drawn from chicks (Schaeffel et al., 1988; Ostrin et al., 2011), marmosets (Clarke et 
al., 1985) and rhesus monkeys (Croft et al., 1998; Ostrin and Glasser, 2010) has demonstrated 
the presence of active accommodation and explored its influence with regard to ocular growth. 
As in humans, accommodation in primates is driven by the crystalline lens, whereas in chicks 
the cornea is also involved in the process (Troilo and Wallman, 1991; Glasser et al., 1994; 
Glasser et al., 1995). Accommodative lag (Mutti et al., 2006), accommodative microfluctuations 
(Day et al., 2009), tonic accommodation (McBrien and Millodot, 1987; Gwiazda et al., 1995) 
and interpretation of blur (Gwiazda et al., 1993) have all been implicated in the process of 
emmetropisation and myopia development. Early work suggested that the accommodative 
response to induced hyperopic defocus using negative lenses provided a signal for eye growth 
(Schaeffel et al., 1988). Use of atropine, a muscarinic antagonist has shown a protective effect 
for myopia progression in animal models and was thought at the time to relate to the 
cycloplegic effect on the ciliary muscle (Young, 1965). However, subsequent work has shown 
that the mechanism of atropine in the context of myopia control is not attributable to 
accommodation.  
 
The cues to accommodation begin at a retinal level with afferent signals transmitted by the 
optic nerve for higher level processing. The efferent signals pass from the Edinger-Westphal 
nucleus en route to the ciliary ganglion and then to the ciliary muscle via the ciliary nerves 
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(Crawford et al., 1989). Signals arising from the Edinger-Westphal nucleus, situated in the 
midbrain, kickstarts a binocular and consensual accommodative response. It has been 
discovered from animal work that disruption of the afferent or efferent components of the 
pathway does not stop the development of myopia in response to lens-induced defocus 
(Schaeffel et al., 1990). It seems that ocular growth proceeds, led by visual cues, even in the 
absence of active accommodation as demonstrated in rhesus monkeys with optic nerve 
section (Raviola and Wiesel, 1990), along with ciliary nerve section (Schmid and Wildsoet, 
1996) and destruction of the Edinger-Westphal nucleus (Schaeffel et al., 1990) in chicks. 
Further, it has also been shown that atropine in chicks reduces experimental myopia but given 
this drug has no effect on the striated ciliary muscle in these animals, the findings point towards 
a non-accommodative mechanism (McBrien et al., 1993). In addition, local growth of the eye 
is influenced by defocus applied regionally; this does not support the theory that 
accommodation is responsible for the modulation of eye growth given that accommodative 
effort changes focus in a uniform manner across the visual field (Diether and Schaeffel, 1997). 
Taken together, these findings indicate that a local mechanism within the eye is responsible 
for eye growth control (Chakraborty et al., 2020). However, the findings above do not entirely 
exclude accommodation as a factor in the process of refractive modulation given its link with 
retinal defocus (Charman, 1999). Allowing brief intervals of clear vision between periods of 
hyperopic defocus impedes the development of experimental myopia in a range of species 
(Schmid and Wildsoet, 1996; Shaikh et al., 1999; Kee et al., 2007). The outcome from this 
work suggests that if it is possible to compensate for induced defocus by accommodating, a 
similar myopia inhibitory effect should occur. With this in mind, a high lag of accommodation 
would be expected to provide a stimulus to the eye to grow from the resultant hyperopic 
defocus (Chakraborty et al., 2020). Efforts to explore this hypothesis have looked at the 
characteristics of accommodation in marmosets before and after experimental myopia has 
been induced (Troilo et al., 2007). The outcome showed that accommodative lag increased 
after lens-induced myopia occurred suggesting this was a consequence rather than a cause 
of this refractive change. The findings also showed that accommodative performance prior to 
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induced defocus was unable to predict the extent of myopia development, a result that is 
supported by additional work in chicks (Aleman and Schaeffel, 2018). Others have evaluated 
how accommodation affects the ability of chicks to decode focusing errors (Diether and 
Wildsoet, 2005). A key outcome revealed that disabling accommodative function through 
ciliary nerve section results in impaired ability to decode and compensate for imposed defocus. 
In particular, when presented with simultaneous hyperopic and myopic signals, the growth 
response is biased towards myopia. This work led to the conclusion that accommodation 
appears to play a part in decoding defocus during the process of emmetropisation. 
Nevertheless, when all this research is considered in tandem, it is clear that a complex process 
exists in relationship to accommodation and emmetropisation with multiple pathways at play. 
 
The research undertaken in animals and the role of accommodation has helped to drive the 
evidence base for humans. Research into the potential link between accommodative lag and 
myopia in children have been spurred on by the work in animals showing that hyperopic 
defocus leads to myopia development. However, the outcomes in this area are equivocal with 
some reporting that increased lags are in place prior to the onset of myopia (Goss, 1991; Drobe 
and de Saint-André, 1995; Gwiazda et al., 2005) whereas others assert that higher levels of 
lag arise after myopia development (Mutti et al., 2006). Although in animals, myopic defocus 
slows or stops myopia development, adopting this rationale to control progression in children 
using bifocal (BF) and MF spectacle lenses has shown mixed outcomes, achieving little (Shih 
et al., 2001; Edwards et al., 2002) to modest success (Leung and Brown, 1999; Gwiazda et 
al., 2003). More recently, research using BF and MF CLs (Anstice and Phillips, 2011; Lam et 
al., 2014; Pauné et al., 2015; Walline, 2016; Aller et al., 2016; Li et al., 2017;  Chamberlain et 
al., 2019) have achieved more impressive results in slowing the progression of myopia, 
although it remains unclear if this is due to the impact of accommodation, peripheral defocus, 
or a combination of factors. Indeed, a recent appraisal of the current evidence does not point 
towards a role for binocular vison and accommodation in the development and progression of 
myopia (Logan et al., 2021).  




1.4.7 High order aberrations 
Although low order aberrations (LOAs) are given prominence when considering the optical 
characteristics of the eye, monochromatic high order aberrations (HOAs) should not be 
overlooked as they can degrade the quality of the retinal image and may contribute to refractive 
error development (Chakraborty et al., 2020). It is thought that HOAs, alongside those of low 
order, can influence depth of focus with a subsequent impact upon ocular development 
(Charman, 1991; Charman, 2005).   
 
Animal work has allowed fundamental understanding of the changes in HOAs that arise during 
emmetropisation and the role they play in leading to refractive errors. In particular, the literature 
shows that in chicks (García de la Cera et al., 2006), marmosets (Coletta et al., 2010) and 
monkeys (Ramamirtham et al., 2006) HOAs reduce with age due to structural changes to the 
cornea and lens, findings that are mirrored in humans (Brunette et al., 2003). The outcomes 
from these studies conclude that HOAs contribute relatively little to the improvements in spatial 
vision and CS that occur during development. Further, it is thought that HOA reduction is a 
passive process without significant influence from the visual environment (Artal et al., 2001). 
The association between induced ametropias and HOAs have also been explored in a range 
of species including chicks (García de la Cera et al., 2006; Kisilak et al., 2006) and monkeys 
(Ramamirtham et al., 2007). Results from this work show that experimental myopia, induced 
by form deprivation and exposure to hyperopic defocus, are associated with increased levels 
of HOAs. Interspecies variation exists with ametropias in monkeys linked to higher levels of 
positive spherical aberration (+SA), whereas in chicks, an increase in negative spherical 
aberration occurs. The optical shifts that arise during these experimental conditions are 
thought to be a result of curvature and refractive index changes to the optical structures within 
the eye as well as changes to the crystalline lens position with respect to the cornea 
(Ramamirtham et al., 2007). It is also noteworthy that myopia is associated with greater levels 
of +SA in humans (Llorente et al., 2004). Importantly, it has been shown that increased HOAs 
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have been strongly correlated with the degree of LOAs and axial refractive error in hyperopic 
and myopic monkeys, which implies they arise as a consequence, rather than a cause of 
ametropia (Ramamirtham et al., 2007).  
 
In humans with normal healthy eyes, spherical aberration, coma and trefoil are the key HOAs. 
Nevertheless, the type and amount of HOAs varies significantly between individuals 
(Charman, 1991; Thibos et al., 2002; Castejón-Mochón et al., 2002). The role that HOAs play 
in the development of refractive error, in humans and animals, remains unclear. Some suggest 
that spherical aberration and coma in particular are associated with myopia (He et al., 2002; 
Paquin et al., 2002) whereas others have found no significant change in HOAs with myopia 
(Carkeet et al., 2002; Cheng et al., 2003; Atchison et al., 2006). The picture is clouded further 
by the influence of accommodation which results in dynamic changes to both HOA and LOAs 
(Lopez-Gil et al., 1998; Vilupuru et al., 2004). Further longitudinal studies are required to clarify 
the potential role of HOAs in driving emmetropisation and refractive error (Chakraborty et al., 
2020).  
 
1.4.8 Spectral and temporal light characteristics 
In addition to monochromatic aberrations, the influence of other factors on ocular growth and 
development, such as longitudinal chromatic aberration (LCA), wavelength, intensity and 
duration of exposure need consideration. 
 
Evidence from work in guinea pigs (Liu et al., 2011) and chicks (Rucker and Wallman, 2009) 
indicates that the eye uses LCA to help steer axial growth and refraction. As LCA results in 
long wavelengths of light to be focused in a more hyperopic plane than short wavelengths of 
light, the eye’s refractive state is relatively hyperopic for long-wavelength light. Colour fringes 
that arise from broadband light, which are component parts of the retinal image, provide cues 
to the nature of defocus, that is to say, hyperopic or myopic (Rucker, 2013). Although the 
literature highlights that LCA can provide a directional signal for accommodation in humans, 
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its role in the process of emmetropisation remains uncertain (Kruger et al., 1993; Seidemann 
and Schaeffel, 2002). Detection of LCA relies upon the presence of short, medium and long 
wavelength cones (Gisbert and Schaeffel, 2018); however, in humans, short-wavelength 
cones are more scarce than medium and long wavelength variants (Roorda and Williams, 
1999). It has been shown from electrophysiological research that the sensitivity of short-
wavelength cones is reduced in myopia (Kawabata et al., 1996; Yamamoto et al., 1997) while 
others suggest that retinal ganglion cells, which have high sensitivity to short-wavelength light 
may offer a spectral tuning mechanism to differentiate between long and short wavelengths of 
light (Gamlin et al., 2007). 
 
In animals, the spectral influences of light upon eye growth appear to be species dependent. 
In fish (Kröger and Wagner, 1996), chicks (Seidemann and Schaeffel, 2002; Foulds et al., 
2013; Torii et al., 2017) and guinea pigs (Liu et al., 2011; Jiang et al., 2014), eyes become less 
myopic when reared under short-wavelength light compared to those exposed to long-
wavelength light. In the short-term, the direction and extent of growth match the model 
predictions; however, growth rates under these conditions for a longer period exceed the 
expected outcome suggesting that a more complex process is at play (Seidemann and 
Schaeffel, 2002; Rucker and Osorio, 2008). One hypothesis proposes that blue light may be 
responsible for preferential stimulation of the ‘ON’ pathway to inhibit myopia progression (Jiang 
et al., 2014). In contrast to the species above, non-human primates raised under long-
wavelength light exhibit decreased eye growth (Hung et al., 2018); this finding is supported by 
work showing that rhesus monkeys exposed to conditions predominated by long-wavelength 
light demonstrate slowed eye growth (Smith et al., 2015). In tree shrews, exposure to red (long-
wavelength) light results in hyperopia (Gawne et al., 2017a), whereas myopia occurs under 
conditions of short-wavelength light (Gawne et al., 2017b) even in the presence of defocus. In 
other words, the chromatic signals dictated the direction of eye growth to an extent where the 
defocus conditions were largely ignored. In particular, even when exposed to hyperopic 
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defocus, with expectation that myopia would follow, the animals remained relatively hyperopic. 
The underlying reasons for these outcomes remain obscure (Chakraborty et al., 2020). 
 
A selection of studies has shown that the status of ambient lighting also has a role in regulating 
eye growth with increased levels having a protective effect against myopia under conditions of 
form deprivation (Cohen et al., 2011; Smith et al., 2012; Chen et al., 2017). The findings here 
may align to work showing that time outdoors can curb myopia development in children (Xiong 
et al., 2017; Morgan et al., 2021; Wolffsohn et al., 2021). The underlying mechanisms relating 
to these protective effects are yet to be established but neurochemical factors, such as 
melanopsin and dopamine, have been implicated (Ashby and Schaeffel, 2010; Ostrin, 2018; 
Flanagan et al., 2020). In an outdoor setting, light levels range from 1000 lux under cloudy 
conditions to 150,000 lux on a bright day (Ostrin, 2017) with a broad spectral composition. 
With this in mind, it is difficult to pinpoint if the protective effects of time outdoors in relation to 
myopia can be attributed to a specific region of the spectrum. The situation is complicated by 
the fact that greater time outdoors reduces the potential for accommodation-related defocus 
experienced during near tasks in an indoor environment. 
 
1.4.9 Summary 
The extensive body of work on animals outlined here affirms the role of the visual environment 
in guiding refractive state by mediating eye growth. The vast range of studies have furthered 
our understanding of the process of emmetropisation and refractive error development in 
humans. Taken together, the outcomes demonstrate that several cues exist to allow the eye 
to modulate its growth during emmetropisation. In particular, visual signals provided by 
accommodation, peripheral defocus, HOAs and chromatic aberrations, serve to direct the sign 
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1.5 Optical interventions for refractive error modulation in humans 
 
1.5.1 Background  
Here, optical interventions for modulating refractive error in humans will be considered. It is 
striking that this entire body work relates exclusively to the realm of myopia. As such, it may 
be more appropriate to consider this section as a summary of ‘lessons from myopia’, which 
provides an opportunity to ponder if, and how, these approaches could be applied to a 
hyperopic cohort.  
 
1.5.2 Undercorrection of myopia 
As outlined earlier (see section 1.4.3), it has been shown in animals that myopic defocus can 
inhibit axial growth during development (Schaeffel et al., 1988; Wildsoet and Wallman, 1995 
Trolio et al., 2019). The overarching outcome from these studies has led practitioners to 
purposefully avoid fully correcting myopia for distance vision (DV) in an attempt to slow the 
progression of refractive error (Tang et al., 2020). As close work and accommodation have 
been implicated as possible factors that lead to the development of, and drive, the progression 
of myopia, the rationale was that undercorrection of the refractive error would reduce 
accommodative demand and exert some influence over the outcome. 
 
In contrast to the findings in animal studies, evidence from two clinical studies in humans has 
revealed that undercorrection accelerates the development and progression of myopia (Chung 
et al., 2002; Adler and Millodot, 2006). In particular, a randomised trial has shown that 
undercorrection of refractive error rendering the child unable to see beyond 6/12 leads to a 
mean myopic progression of 1.00 D over two years versus 0.77 D in those receiving full 
correction (Chung et al., 2002). The findings from this study are mirrored in a retrospective 
review of clinical data, once again showing that undercorrection of myopia leads to greater 
levels of progression (Adler and Millodot, 2006). However, the outcomes here are contested 
by evidence from a study reporting that children with no refractive correction showed slower 
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progression and less axial growth than those given full correction, by a magnitude of 0.27 D 
over 2 years (Sun et al., 2017). Despite the equivocal findings from this work, the argument for 
undercorrection of myopia to prevent progression, remains unconvincing (Tang et al., 2020; 
Logan and Wolffsohn, 2020; Jonas et al., 2021).   
 
1.5.3 Spectacle lens correction 
Over the past 20 years, numerous studies have explored the effect of BF, MF and progressive 
addition lenses (PALs) on the progression of myopia (see Table 1.2). The general rationale for 
these approaches is to allow the wearer to utilise the top part of the spectacle lens to see 
clearly in the distance through full refractive correction, with the addition power in the bottom 
part of the lens designed to reduce accommodative effort and lag.  
 
Study Duration Details Cohort Intervention *Effect 
Fulk et al., 
2000 2.5 years 
Randomised, 
masked 6-13 years 
SV (n = 40) 










SV (n = 132) 




al., 2003 3 years 
Randomised, 
masked 6-11 years 
SV (n = 233) 
PAL 2.00 D add (n = 229) 
0.20 D 
(14%) 
Yang et al., 





SV (n = 75) 














1 year Randomised 6-16 years Chinese 
Type I, Type III, SV (n = 
50 per group 




al., 2012 1 year 
Randomised, 
masked 6-11 years 
SV (n = 42) 










SV (n = 44) 
PAL 1.50 D add (n = 42) 
Phase 1: 
0.31 D (18%) 
Phase 2: 
0.02 D (2%) 
Cheng et 





SV (n = 41) 
BF 1.50 D add (n = 48) 
PBF 1.50 D add 3 Δ base 
in (n = 48) 
BF: 0.81 D 
(39%) 
PBF: 1.05 D 
(51%) 
Lam et al., 





SV (n = 90) 
DIMS (n = 93) 
0.44 D 
(52%) 
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Table 1.2 Summary of myopia control studies using spectacle lens correction with single vision 
(SV), BF/prismatic bifocal (PBF), PALs and defocus incorporated multiple segments (DIMS). 
Adapted from Tang et al., 2020. *Dioptric treatment effect in slowing myopia progression over 
study period. ** In a subgroup of children (with myopic parents) using Type III lenses. 
 
For PALs, the studies (COMET2, 2001; Edwards et al., 2002; Gwiazda et al., 2003; Yang et 
al., 2009; Berntsen et al., 2012; Hasebe et al., 2014) point towards an insignificant effect of 
myopia retardation overall although children with esophoria and accommodative lag may 
benefit from a greater effect (Tang et al., 2020). 
 
For BF spectacle lenses, an early study showed that a 1.50 D add slowed progression of 
myopia in children with near-point esophoria by 20% compared to SV lenses, which equated 
to 0.25 D over 30 months (Fulk et al., 2000). A more recent study has shown that executive 
BFs both with and without base in prism can exert control on progression of myopia in fast 
progressors, particularly for those with a low accommodative lag (Cheng et al., 2014). Although 
the inclusion of base in prism to reduce fusional vergence achieved a greater dioptric effect 
than lenses without prism, AL length changes were similar for both lens types. 
 
A more complex paradigm was explored in a study using 3 bespoke lens designs aimed at 
reducing relative peripheral hyperopic defocus (RPHD) in myopes (Sankaridurg et al., 2010). 
Only one type of lens design managed to achieve a meaningful effect of 30% reduction in 
progression compared to SV lenses in a subgroup of younger participants aged 6 to 12 years 
whose parents were both myopic. This ‘Type III’ lens had an asymmetrical design with a central 
clear aperture with positive additional power in the horizontal meridian, optimised to reduce 
astigmatism in that meridian. The other, ineffective lens variants consisted of rotationally 
symmetric designs each with differing amounts of positive peripheral power surrounding a 
clear central aperture. 
 
A recent novel design termed DIMS has shown more promise as a myopia control spectacle 
lens option (Lam et al., 2019; Jonas et al., 2021). The DIMS lens offers simultaneous vision 
I.G.Beasley, PhD Thesis, Aston University 2021 
 
61 
with a central optic zone which provides full refractive correction, surrounded by multiple 
segments which deliver constant myopic defocus of +3.50 D. Initial results from the 2-year 
clinical trial have shown that children wearing the experimental design had 52% less myopic 
progression and 62% less axial growth than SV controls. Recently, follow up results have 
shown that the myopia control effect was sustained in the third year for children who had used 
the DIMS in the original 2 years of the study and was also shown in children switching from 
SV lenses during the first 2 years of the study to the DIMS lens in the third year (Lam et al., 
2021). 
 
1.5.4 CL correction 
The following sections outline the attempts to arrest the progression of myopia through use of 
various CL designs. 
 
1.5.4.1 Rigid gas permeable (RGP) CLs 
Several studies have considered the impact of daytime wear of RGP CLs on myopia 
progression. Outcomes from early work in this area were limited by study design, such as lack 
of randomisation or participant age criteria being outside the expected range of likely 
progression (Stone, 1976; Perrigin et al., 1990; Khoo et al., 1999). Nevertheless, two 
randomised clinical trials (Walline et al., 2004; Katz et al., 2003) have shown that RGP CLs do 
not appear to influence axial growth, although one of the studies did report slower progression 
of myopia in participants wearing RGP CLs versus those wearing soft CL (Walline et al., 2004). 
It is thought that the effect of RGP CLs on the refractive outcome in this study occurred at a 
corneal level and that any apparent retardation of myopia was likely to be transient. Taking all 
of the above into account, daytime wear of RGP CLs is not considered to be a credible 




I.G.Beasley, PhD Thesis, Aston University 2021 
 
62 
1.5.4.2 Soft CLs 
BF and MF soft CLs have become increasingly popular interventions to attempt to control 
myopia progression in children (Wolffsohn et al., 2021). The ease of adaptation, along with the 
cosmetic and practical advantages that soft CLs offer, make them an attractive option for the 
patient. For the practitioner, having a simple fitting approach without the need for specialist 
equipment makes soft CLs an accessible entry point into myopia management. Numerous 
studies have explored the efficacy of BF and MF CLs, the outcomes from which are 
summarised in Table 1.3. 
 












DF 2.00 D add (n = 
40) 
SV (n = 40) 
0-10 months: 0.25 
D (37%) 









RPH CL (n = 45) 
SV (n = 40) 
0.29 D 
(34%) 
Walline et al., 
2013 
24 
months Matched study 8-11 years 
Proclear multifocal 
2.00 D add (n = 40) 
SVCL (n = 40) 
0.52 D 
(50%) 









DISC 2.5 D add (n = 
65) 
SVCL (n = 63) 
0.21 D (25%) 
0.44 D (50%) > 6 h 
0.54 D (58%) > 7 h 
0.53 D (60%) > 8 h 









SRRG (n = 30) 
OK (n = 29) 
SV (n = 41) 
0.42 
(43%) 





masked 8-18 years 
BFSCL (n = 39) 
SVCL (n = 40) 
0.57 D (72% in 
those with eso 
fixation disparity) 







8-11 years +SA (n = 64) SVCL (n = 63) 
0-6 months: 
0.21 D (54%) 
At 12 months: 
0.14 D (20%) 
Chamberlain 







DF 2.00 D add (n = 
70) 











DF 2.00 D add (n = 
46) 
SVCL (n = 33) 
0.29 
(39%) 
Table 1.3 Summary of myopia control studies using soft BF and MF CLs comparing: SV CL; 
dual focus (DF); reduction of RPH design; SV spectacle lens; defocus incorporated soft CL 
(DISC); soft radial refractive gradient (SRRG) CL; OK; bifocal soft CL (BFSCL); and soft CL 
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with +SA. Adapted from Tang et al., 2020. *Dioptric treatment effect in slowing myopia 
progression over study period.  
 
For soft BF CLs, there are broadly two approaches taken in the attempt to control progression 
of myopia. In both scenarios, the CL design consists of a central distance zone providing full 
correction of myopia. However, the guiding principle of one design is to have a peripheral 
annulus of relative positive power around the central zone to reduce peripheral hyperopic 
defocus (see Figure 1.5). The second design, often termed ‘DF’, also exposes the eye to 
myopic defocus in the periphery but in this case the design consists of concentric rings which 
alternate between full distance correction and relative positive power (see Figure 1.6). 
 
Figure 1.5 RPHD corrected with a centre-distance BF CL while full refractive error is corrected 
centrally 
 




Figure 1.6 DF CL with central distance zone and alternating concentric zones of myopic 
defocus and full refractive error correction 
 
Other lens designs exist which also target reduction of RPH. For instance, a novel soft lens 
design with a clear central zone surrounded by an annulus that increases in relative positive 
power towards the periphery, has been reported to achieve 34% less progression in refractive 
error and an estimated 33% slowing in axial growth compared to spectacle wearers over a 12-
month period (Sankaridurg et al., 2011). Impressive results from a randomised, masked study 
showed a 72% slowing of myopia progression using a BF CL compared to SV CLs, although 
this effect was limited to children with eso fixation disparities at near (Aller et al., 2016). The 
addition of the Vistakon Acuvue Bifocal (Johnson & Johnson, Vision) used in the study was 
selected to neutralise the associated phoria in each participant. 
 
A study, using a soft, centre-distance, MF CLs intended for presbyopes, the Proclear multifocal 
(CooperVision), reported a 50% reduction in myopia progression along with 29% less axial 
elongation over a 2-year period (Walline et al., 2013). In further work, a SRRG design was 
utilised to correct central refraction while exposing the eye to myopic defocus that gradually 
increased with eccentricity; this intervention resulted in retardation of myopia progression over 
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a 2-year period of 43% with 27% less axial growth than SV spectacle-wearing controls (Pauné 
et al., 2015).  
 
CL designs incorporating +SA have also been considered based upon the observation that 
myopic children with higher levels of +SA demonstrate slower eye growth (Hiraoka et al., 2017; 
Lau et al., 2018). A unique lens incorporating +SA into the design to reduce RPH showed a 
slowing in axial growth compared to controls, although this did not translate into sustained 
refractive error control at the 12-month timepoint (Cheng et al., 2016).  
 
A paired eye control, cross-over trial investigated the use of an experimental concentric BF, or 
DF soft CL, which provided 2.00 D of myopic defocus (Anstice and Philips, 2011). Participants 
were assigned randomly to have the intervention in one eye and a SV CL in the fellow eye for 
10 months with the lens types then switched over for a further 10 months. In the first 10 months, 
the intervention lens resulted in a 37% slowing of myopia progression compared to the control 
condition; axial growth in the intervention eye was almost half the rate of the fellow eye. 
Following cross-over, the outcome achieved in the second period showed a reduction of 54% 
in refractive change and 80% in axial growth in the intervention eye versus the control eye. 
 
A novel design, termed the defocus incorporated soft CL (DISC) with 2.50 D of myopic defocus 
reported impressive dose-dependent results achieving a slowing of myopia progression of 
50%, 58% and 60% for children wearing the intervention for >6, >7 and >8 hours, respectively 
(Lam et al., 2014). AL changes were consistent with the refractive findings, although precise 
dose-dependent values for this outcome measure were not reported. 
 
Data from ‘Part 1’ of a multicentre, randomised, double masked trial using a DF, daily 
disposable soft lens showed a slowing in myopia progression and axial elongation by 59% and 
52%, respectively, over a 3-year period compared to children wearing SV CLs (Chamberlain 
et al., 2019a). The lens is available commercially in various parts of the world as MiSight 
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(CooperVision). Part 2 of the study was initiated at the 3-year point where children in the control 
arm of the study were refitted with the intervention lens; these participants were tracked 
separately from children who had worn the DF lens from the outset. Results after 5 years 
showed that children from the original control group matched the performance of those wearing 
the intervention lens from the beginning of the study in terms of refractive error change and 
axial growth (Chamberlain et al., 2019b). A recent update has revealed that 23% of eyes after 
6 years of intervention displayed a total MSE refractive change of less than -0.25 D 
(Chamberlain et al., 2020). Another study in Spain also investigated the efficacy of the MiSight 
CL and showed a 39% and 36% slowing in myopia progression and axial elongation, 
respectively, over a 2-year timeframe (Ruiz-Pomeda et al., 2018). However, this study lacked 
masking as controls were wearing spectacles, which in turn may have altered compliance with 
the wearing time (WT) of control correction. 
 
1.5.4.3 OK 
In recent decades, OK has become a popular option for myopia management in children. Not 
only does this modality enhance unaided vision it also provides control of myopia progression 
as highlighted in a number of studies (see Table 1.4). 
Study Duration Details Cohort Intervention *Effect 
Cho et al., 2005 2 years Self-selected, prospective 
7-12 
years 
OK (n = 35) 
SV (n = 35) 
0.25 mm 
(46%) 
Walline et al., 





OK (n = 28) 
SVCL (n = 28) 
0.32 mm 
(56%) 
Kakita et al., 2011 2 years Self-selected, retrospective 
10-15 
years 
OK (n = 45) 
SV (n = 60) 
0.22 mm 
(36%) 
Cho and Cheung, 





OK (n = 37) 
SV (n = 41) 
0.27 mm 
(43%) 
Hiraoka et al., 





OK (n = 29) 




Rubido et al., 
2012 
2 years Self-selected, prospective 
6-12 
years 
OK (n = 31) 
SV (n = 30) 
0.22 mm 
(32%) 
Charm and Cho, 





OK (n = 12) 
SV (n = 16) 
0.32 mm 
(63%) 
Chen et al., 2013 2 years Self-selected, prospective 
6-12 
years 
OK (n = 35) 
SV (n = 23) 
0.33 mm 
(52%) 
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Table 1.4 Summary of myopia control studies using OK comparing: SV CL; SV spectacle lens. 
Adapted from Tang et al., 2020. *Mean AL difference between intervention and control 
participants over study period.  
 
Modern OK designs comprise a central optic zone, a reverse curve zone, an alignment zone 
and a peripheral zone (Swarbrick, 2006; Lipson et al., 2018). The central zone is used to 
correct the refractive error and also assists with flattening of the central cornea. The steeply 
designed reverse curve helps to steer corneal reshaping and maximise reduction of myopia, 
while the alignment zone maintains lens centration. The peripheral zone is important as it 
allows tear exchange to take place. 
 
It is thought that the myopia control effect facilitated by OK is due to the imposition of myopic 
defocus on the peripheral retina (Tahhan et al., 2003). Following OK treatment, the corneal 
shape becomes more oblate which leads to a reduction in RPHD (Kang and Swarbrick, 2011). 
The clinical studies summarised in Table 1.4 demonstrate that the effect of OK on slowing 
axial elongation ranges from 32% to 63%.  
 
Although the maximum power of myopia reduction possible with OK is yet to be established 
definitively, -4.00 D is typically taken as the exclusion criteria in most studies (Tang et al., 
2020). Nevertheless, partial correction of high myopia with OK, with residual refractive error 
correction with spectacles, still affords a comparable myopia control effect to studies in low to 
moderate myopes (Charm and Cho, 2013; Wolffsohn et al., 2021). While OK is a useful option 
for myopia control, with significant impact upon mean rates of axial growth retardation, there 
does appear to be variability in the individual response to this intervention. AL change over 3 
years in children receiving OK treatment showed that while 65% showed axial elongation of 
0.5 mm or less, 15% of participants experienced growth of more than 1.00 mm (Lipson et al., 
2018). It has been proposed that age, baseline myopia, corneal profile and pupil size are all 
possible factors that could influence treatment outcomes (Cho et al., 2005; Cho and Cheung, 
2012; Hiraoka et al., 2012; Santodomingo-Rubido et al., 2013; Lipson et al., 2018). 





The research to date has shown that careful selection of the method for correction of myopia 
can, to some extent, dictate the refractive outcome and extent of axial elongation. 
Undercorrection of myopia should be avoided and a blanket approach to spectacle correction 
with BFs, MFs or PALs is likely to deliver underwhelming results. However, the encouraging 
results from the recent DIMS study points towards a more optimistic future for myopia control 
in spectacle form. In addition, existing soft CLs along with OK have proven to be important 
options for myopia management in contemporary clinical practice.  
 
1.6 Thesis aims 
The literature has highlighted the deleterious effects that hyperopia can have upon visual 
development and educational attainment throughout childhood, alongside elevating the risk of 
numerous ocular comorbidities later in life. Research from animal work demonstrates that 
growth of the eye can be modulated in response to defocus in a range of species. The 
outcomes from this body work have been successfully translated from the laboratory to the 
clinic, with a growing armamentarium of interventions available for use in mainstream practice 
to slow the progression of axial growth in myopes. 
 
Research in the field of refractive error modulation in hyperopia is conspicuous by its absence. 
With this in mind, the experimental chapters that follow will focus on the potential to accelerate 
axial growth in children with iso- and anisohyperopia. The aim is to apply the overarching 
principles highlighted in the animal literature, along with lessons learned from myopia in a 
human cohort, to assess the impact of imposing hyperopic defocus, on axial growth and 
refractive error in children with hyperopia.  
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If the hypothesis is proven, then this body of work offers the potential to mitigate for the effects 
of hyperopia, thereby permitting normal visual development in childhood and reducing the risk 
































This chapter outlines details of the equipment utilised throughout the experimental chapters. 
All measurements were undertaken using equipment available for standard optometric 
practice following standard operating procedures and professional guidance (The College of 
Optometrists, Guidance for Professional Practice). 
 
2.2 Assessment of unaided vision and VA 
In keeping with other refractive modulation studies (Anstice and Phillips, 2011; Chamberlain 
et al., 2019; Lam et al., 2019, Ruiz-Pomeda et al., 2019), measures of distance monocular 
vision, distance monocular VA and near monocular VA were undertaken using logMAR charts 
to assess the impact of the intervention on these parameters. The standard room illumination 
was measured at 440 lux using a digital light meter (LX1330B, Dr.meter, US), which falls within 
the suggested range to avoid the reduction in acuity measures that can arise due to inadequate 
illumination (Tidbury et al., 2016). 
 
The Bailey-Lovie logMAR chart was originally designed to improve the measurement of VA for 
patients with age-related macular degeneration (AMD) by providing five letters on each line, 
thereby avoiding problems with letter memorisation (Bailey et al., 1976). The chart has uniform 
spacing between letters which is equivalent to one letter width. Spacing between lines is equal 
to the letter height of the row below. 
 
Use of logMAR notation mitigates for some of the widely acknowledged issues with Snellen 
charts (McGraw et al., 1995), for example, disproportionate letter crowding between the lower 
and upper ends of the acuity scale. Other limitations of Snellen charts are the variation in letter 
legibility and a non-logarithmic scaling of letter size between successive lines; this results in 
relatively small gaps between lines at the higher end of the acuity scale.  




In all experimental chapters, visions and VAs for distance were determined using a 
computerised test chart (Thomson Software Solutions, Herts, UK) at 6 m equivalent, which 
allowed changing of optotypes to avoid letter memorisation. For monocular near visual acuity 
(NVA), a handheld LogMAR chart at 0.25 m was used.  
 
2.3 Assessment of intraocular pressure 
Measures of intraocular pressure (IOP) were taken prior to instillation of a cycloplegic using a 
rebound tonometer, the iCare TA01i (iCare Finland Oy, Helsinki, Finland). The literature has 
shown that this instrument is adequate as a screening tool in comparison to Goldmann 
applanation tonometry (GAT) (Clement Clarke International, Harlow, UK) and other handheld 
tonometers (Fernandes et al., 2005; Beasley et al., 2013) and is a recommended safeguard 
when instilling a cycloplegic (The College of Optometrists, Guidance for Professional Practice).  
 
The iCare TA01i rebound tonometer consists of a solenoid and housing, a magnetised probe, 
and other electronic components. The probe is 40 mm long, 0.3 mm in diameter with a 1.7mm 
diameter plastic end-tip (Davies et al., 2006). The device uses a solenoid to fire the magnetised 
probe towards the cornea. Electronics monitor the movement of the probe, allowing its speed 
and direction to be monitored and converted to a measure of IOP. The device is well tolerated, 




Cycloplegic refraction was undertaken at specified data collection points as outlined in the 
experimental chapters. 1 drop of cyclopentolate hydrochloride (HCl) 1% in minim form (Bausch 
+ Lomb, Kingston upon Thames, UK) was instilled in each eye to help control accommodation, 
thereby facilitating more stable measures of objective refraction, which were taken 30 minutes 
after the drugs were instilled. 




Cyclopentolate prevents the action of acetylcholine at muscarinic sites. As muscarinic 
receptors are abundant in the iris and ciliary body, mydriasis and accommodative inhibition 
occur with the use of this drug (Kyei et al., 2017). 
 
Cyclopentolate is widely used in routine optometric practice as the cycloplegic agent of choice 
in children due to a relatively short duration of action (Doherty et al., 2019).  Importantly, 
cyclopentolate has been shown to be as effective at achieving adequate cycloplegia but with 
fewer side effects than other drugs such as atropine (Farhood, 2012). Tropicamide has the 
benefit of a short duration of action but may not provide sufficient paralysis of accommodation 
required for accurate refraction in young children, particularly in those with high hyperopia 
(Yazdani et al., 2018). Further, cyclopentolate 1% is recommended as the agent of choice for 
cycloplegic refraction in children under 12 years of age with 0.5% reserved for those under the 
age of 6 months (The Royal College of Ophthalmologists, 2012). 
 
2.5 Biometry 
Following the approach of earlier work, throughout the experimental chapters, biometric 
assessment included measures of AL, ACD and CC Walline et al., 2013; Aller et al., 2016; 
Ruiz-Pomeda et al., 2019). Data were collected using the Zeiss IOLMaster 500 (Zeiss, 













Figure 2.1 The IOLMaster 500 
 
The IOLMaster 500 is an instrument that uses the principle of PCI and is considered ideal for 
the purposes of AL monitoring in clinical practice where available (Gifford et al., 2019). It 
permits a range of ocular parameters to be measured using a non-contact technique, which 
avoids the need for topical anaesthesia. The instrument works by producing a dual beam of 
infrared light using a beam splitter and two mirrors, one fixed and the other moveable (see 
Figure 2.2). As the light enters the eye, it rebounds off the retinal pigment epithelium (RPE) 
and the anterior surface of the cornea resulting in four emerging beams. A photodetector 
analyses the interference patterns of the beams which the instrument uses to calculate the AL 
(Santodomingo-Rubido et al., 2002). 
 




Figure 2.2 The PCI principle utilised by the IOLMaster 500  
 
 
The IOLMaster 500 is considered to be the gold-standard instrument for taking accurate and 
reliable biometric measures in both adults (Lam et al., 2001; Kielhorn et al., 2003) and children 
(Carkeet et al., 2004; Hussin et al., 2006; Kimura et al., 2007). The PCI method of 
measurement is reported to give greater repeatability and delivers higher resolution measures 
than using more traditional contact methods of determining AL, namely A-scans 
(Santodomingo-Rubido et al., 2002; Carkeet et al., 2004; Hussin et al., 2006). There is 
conjecture relating to agreement between PCI and A-scan methods with some reporting that 
the IOLMaster records consistently higher readings for AL than the latter technique (Goyal et 
al., 2003; Rose and Moshegov, 2003) whereas others have found that the two instrument types 
produce comparable results (Santodomingo-Rubido et al., 2002; Hussin et al., 2006). As the 
non-contact method of PCI records the signal from the RPE whereas A-scans require a degree 
of applanation with the signal originating from the internal limiting membrane (ILM), this may 
explain the measurement differences reported by some. More recent methods of measuring 
IOLMaster: A Practical Operation Guide
Taking Measurements 4-2
☞ Important Note: Unlike A-scan ultrasound, which reflects off the wide cupped
surface of the macula, the IOLMaster beam passes through the translucent
surface of the retina and back further to the more opaque pigment layer. The
computer corrects for this difference.
In addition, the use of contact ultrasound will indent the cornea, thus
decreasing the distance between the cornea and the retina and artificially
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AL, for instance, the swept-source technology embedded within the IOLMaster 700, shows 
good agreement with the PCI method utilised by the IOLMaster 500 (Kunert et al., 2016). 
 
Measures of CC are determined by analysing images taken from the anterior surface of the 
cornea (Elbaz et al., 2007); these measures compare well with those taken by other methods 
including Javal-Schiotz keratometers and videokeratoscopy (Santodomingo-Rubido et al., 
2002; Németh et al., 2003). 
 
Measurement of ACD using the IOLMaster 500 is achieved by projecting a narrow optic 
section, temporal to fixation through the anterior chamber. When the instrument is suitably 
aligned, the operator presses the joystick button to take a photograph. The distance from the 
anterior corneal surface and anterior crystalline lens surface is then calculated. When 
comparing measures taken with different methods, evidence appears equivocal with some 
reporting shorter ACD when measured by the IOLMaster 500 compared to A-scans 
(Santodomingo-Rubido et al., 2002) whereas others have demonstrated the opposite (Lam et 
al., 2001). 
Calibration of the instrument should be checked prior to each measurement session as 
outlined in the manufacturer’s instructions (Carl Zeiss Meditec). To prepare for measurement, 
the patient is asked to fixate on the central fixation light while the practitioner evaluates the 
integrity of the tear film. The practitioner can instruct the patient to blink if the image quality of 
the mires is poor. Using the overview mode, the practitioner should align the 6 illumination 
LEDs around the pupil. A traffic light display helps to identify when the optimum measurement 
position has been achieved, as the light changes from red to yellow and finally, green. 
 
2.5.1 AL and CC measurement 
After performing the initial set up using the overview mode described above, the dual 
measurement mode is selected to capture AL and CC parameters in a single step. Three 
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measures of CC are taken and displayed as a mean value. Five measures of AL are taken 
automatically and reported as a composite AL value with the signal-to-noise-ratio (SNR) 
displayed alongside. For the purposes of experimental data collection, 10 measures of AL 
were taken for each eye. If a measurement point is not correctly identified, a blue flashing dot 
appears indicating that a further measurement should be taken. If the instrument detects any 
measurement errors, for example, deviations within the last three measurements, ‘Evaluation’ 
appears in the display indicating that it should be repeated until the results are within tolerance.  
 
2.5.2 ACD measurement 
After establishing the initial setup using the overview mode, the ACD mode should be selected 
and the patient advised to look straight into the yellow light. As a white light is introduced from 
the side, the patient should be reminded to continue looking at the yellow light only. The 
manufacturer advises that the best results are obtained with dilated pupils and to minimise 
potential reflections from other light sources. The instrument displays an average of 5 readings. 
Measures of ACD were undertaken following cycloplegia at timepoints outlined in Chapters 3 
and 4. 
 
2.6 Central refraction 
Refraction was undertaken prior to instillation of cyclopentolate 1% HCl using standard 
optometric techniques, namely using retinoscopy and subjective methods to evaluate the 
latent and manifest status of refractive error.  
Objective central refraction was undertaken 30 minutes after instillation of the cycloplegic 
agent using the Grand Seiko Auto Ref/Keratometer WAM-5500 autorefractor (Shin-Nippon, 
Rexxam, Japan) (see Figure 2.3). Use of an autorefractor provides more repeatable results 
than subjective refraction or other objective techniques such as retinoscopy and is, therefore, 
the favoured method for use in refractive error studies (Bullimore et al., 1998; Davies et al., 
2003; Mallen et al., 2015). 




The Grand Seiko Auto Ref/Keratometer WAM-5500 autorefractor has an open-field design 
which permits the use of real-world targets and control over viewing distance, thereby reducing 
the effects of proximal accommodation. As such, this type of instrument has become a 
standard method for use in studies of human refractive error (Logan et al., 2005; O’Donoghue 
et al., 2015; Chamberlain et al., 2019). Use of an LCD display allows easy alignment and 
monitoring of fixation. A target of infrared light is projected onto the retina and the reflection is 
utilised by a moveable lens to focus the device. The output is analysed to provide refraction 
data in sphero-cylindrical form in increments of 0.01 D and axes to 1°. The instrument provides 




Figure 2.3 Grand Seiko WAM-5500 autorefractor 
 
2.7 Peripheral refraction 
Peripheral refraction measures were undertaken during the studies outlined in Chapters 3 and 
4 using the Grand Seiko Auto Ref/Keratometer WAM-5500 autorefractor. Open-field 
autorefractors are frequently used to measure changes in both central and peripheral refraction 
over time. Measurements with the Grand Seiko Auto Ref/Keratometer WAM-5500 
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autorefractor show good repeatability although this decreases with eccentricity, particularly at 
measures extending to 40° (Moore and Berntsen, 2014). Perhaps unsurprisingly, repeatability 
has been shown to be better under cycloplegic conditions compared to studies where a 
cycloplegic was not used (Mallen et al., 2001; Davies et al., 2003). 
 
Throughout the experimental chapters (see Chapters 3 and 4), peripheral refraction was 
undertaken under cycloplegic conditions at 30° temporally, 30° nasally, 20° superiorly and 20° 
inferiorly in line with other examples of peripheral refraction work (Mutti et al., 2000; Davies 
and Mallen, 2009; Chen et al., 2010). Participants were asked to fixate Maltese crosses which 
were placed on a wall to achieve the desired eccentricity points for each of the four peripheral 
measures. An average of three readings was recorded for each location. 
 
2.8 Pupil size 
Assessment of pupil size was undertaken as outlined in the experimental chapters (see 
Chapters 3 and 4), mirroring the approach taken by others (Anstice and Phillips, 2011; Lam et 
al., 2014). The size of the pupil was recorded using data obtained from the Grand Seiko Auto 
Ref/Keratometer WAM-5500 autorefractor. The instrument automatically detects the iris 
boundary and superimposes a best-fit circle to determine pupil size (Sheppard et al., 2010). 
Previous work has shown there is a tendency for the instrument to slightly overestimate pupil 
size except at the smaller end of pupil size range (Sheppard et al., 2010). 
 
Pupil size was assessed under photopic and mesopic conditions. Room illumination was 
established, using a digital light meter (LX1330B, Dr.meter, US) as 440 lux and 11 lux in 
photopic and mesopic conditions, respectively; these levels are considered suitable to create 
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2.9 Accommodative lag 
Lag of accommodation occurs when the accommodative effort is lower than that expected for 
a given stimulus. For instance, in experimental Chapters 3 and 4, a target placed at 0.33 m 
provides an accommodative stimulus of 3.00 D. However, an individual’s response to this 
stimulus will often fall short resulting in accommodative lag. As the magnitude of 
accommodative lag appears to be associated with changes to refractive error, namely 
progression of myopia (Gwiazda et al., 2004), and in line with previous work (Anstice and 
Phillips, 2011; Lam et al., 2019; Ruiz-Pomeda et al., 2019), measures were incorporated into 
the experimental protocols outlined in Chapters 3 and 4. 
 
An average of 3 measures of accommodative lag were taken using the Grand Seiko Auto 
Ref/Keratometer WAM-5500 autorefractor. The participant was asked to view a target (Maltese 
cross) at 0.33 m wearing either their spectacle refractive correction in a trial frame or their 
prescribed CLs as outlined in the respective study protocols. Participants viewed the target 
binocularly, but measures of accommodative lag were taken in the dominant eye only (Flitcroft 
and Morley, 1997). Dominance was established using the hole-in-the-card test which involves 
holding a rectangular card with a small hole in it of ~ 3cm in diameter and held at arm’s length. 
In this method, the participant is instructed to view the investigator’s nose through the hole in 
the card (see Figure 2.4); this allows the investigator to identify the participant’s dominant eye.  
 
 
Figure 2.4 Hole-in-the-card method for establishing dominance 




Some object to the use of so-called ‘sighting dominance’ tests as they fail to identify cases of 
central eye dominance (Portal and Romano, 1988). Nevertheless, in the context of the 
refractive error modulation experiments it is desirable to establish a binary outcome through a 
forced-choice method such as the hole-in-the-card test. Furthermore, the hole-in-the-card test 
is widely used by others (Lopes-Ferreira et al., 2013). 
 
2.10 Amplitude of accommodation 
Amplitude of accommodation is typically measured in clinical practice using a Royal Air Force 
(RAF) rule (Burns et al., 2020) and is also a technique used in refractive error modulation 
studies (Anstice and Phillips, 2011; Lam et al., 2019). The test should be performed with the 
patient’s optimal distance correction in situ (Sterner et al., 2004). There is debate as to whether 
the test should be performed with the target pushed up towards the patient or away from them. 
The result tends to be overestimated when the target is ‘pushed-up’ and underestimated when 
it is ‘pulled-down’ (Rosenfield and Cohen, 1996). Amplitude of accommodation was performed 
with the mean of 3 push-up and 3 pull-down measures as outlined in experimental Chapters 3 
and 4. 
 
2.11 Contrast sensitivity 
Contrast sensitivity (CS) is a useful way to assess visual function in refractive error modulation 
work (Anstice and Phillips, 2011; Lam et al., 2019) by providing more of a real-world measure. 
Whereas VA assesses an individual’s ability to see small objects at high contrast, CS allows 
an assessment at lower contrasts (Koch, 1989; Elliott and Hurst, 1990). The CS function (CSF) 
provides a more complete insight into visual status as VA can be unaffected by certain 
conditions even though peak CS may be reduced (Pelli and Bex, 2013). 
 
CS can be affected for several reasons including pupil miosis, changes to the crystalline lens 
and reduction in retinal luminance (Pelli and Bex, 2013). Both central and peripheral CS can 
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be impaired by wearing MF CLs designed to control myopia progression (Kang et al., 2017; 
Przekoracka et al., 2020).  
 
Central CS was measured at timepoints specified in experimental Chapters 3 and 4 both with 
spectacle and CL correction using a computerised version of the Pelli-Robson chart (Thomson 
Software Solutions, Herts, UK). The Pelli-Robson chart uses triplets of Sloan letters as stimuli, 
which progressively reduce in contrast. As the initial stimuli are presented at high contrast, 
they are easily recognisable by the participant. The use of letters as a target provides a multiple 
forced-choice method which makes it less prone to guessing than other methods. Each triplet 
of letters carries a score of 0.15 log units and the range of CS measured is between 0.00-2.25 
log units. Single letter measurement can be used with each letter scoring 0.05 log units (Elliott 
et al., 1991). Measurement is ceased when the observer identifies 2 or 3 letters within a given 
triplet incorrectly. When the test is conducted at a distance of 1 M, the letters equate to 
approximately 1 CPD allowing measures at low spatial frequency (SF). 
 
2.12 Stereoacuity 
An assessment of stereoacuity provides insight into how visual function may be affected by 
the introduction of novel forms of refractive correction (Lam et al., 2019; Ruiz-Pomeda et al., 
2019), using a test of relatively short duration.  
 
The Frisby Near Stereotest (FNS) (Frisby stereotests, UK) is the most commonly used test in 
clinical practice for measuring stereoacuity, followed by the TNO (Vancleef and Read, 2019). 
However, the TNO appears to be more sensitive at detecting subtle binocular abnormalities, 
for instance, in cases of anisometropia, compared to other tests (Ateiza and Davis, 2019; 
Nabie et al., 2019). 
 
Stereoacuity was measured during specified visits with spectacle and CL correction as outlined 
in experimental Chapters 3 and 4 using the TNO Randot Stereotest (TNO) at a distance of 40 
I.G.Beasley, PhD Thesis, Aston University 2021 
 
82 
cm (Edition 15, Laméris Ootech BV, Netherlands). The test measures resolution of fine texture 
and simulates stereoscopic depth by the horizontal displacement of 2 images while the 
participant wears red/green glasses. The test figures in the screening plates have disparities 
of 2000″ whereas the quantitative plates allow measurement of stereoacuity from 480″ to 
15″ (Charman and Jennings, 1995). Although, no obvious changes have been made to 
different editions of this test, there is evidence to show that results are not comparable 
between, for instance, TNO 13 and TNO 15 (van Doorn et al., 2014). Nevertheless, for the 
purposes of the experiments here, a single edition was used consistently throughout the data 
collection points.  
 
Visual correction with MF lenses, including those designed for myopia control do not appear 
to significantly affect stereoacuity (Sha et al., 2015; Kang and Wildsoet, 2016; Ruiz-Pomeda 
et al., 2018). Nevertheless, measures of stereoacuity with novel forms of visual correction in 
situ offers value in understanding the visual impact of these interventions on participants. 
Furthermore, it is important to establish if improvements to stereoacuity can be achieved by 
taking this unique approach to vision correction in iso- and anisohyperopes.  
 
2.13 CLs 
CLs were used as the optical intervention outlined in Chapters 3 and 4. Monthly disposable 
Biofinity multifocal (centre-near design with an add power of +2.00 D) and Biofinity SV CLs 
were supplied by CooperVision under the following terms: 
‘The CLs in the study were supplied free of charge by CooperVision. CooperVision did not 
sponsor the research and does not support or have an opinion regarding any of the content in 
the study.’ A +2.00 D add was selected in line with previous refractive error modulation studies 
studies (Anstice and Phillips, 2011; Walline et al., 2013; Chamberlain et al., 2019a) and aimed 
to strike a balance between ensuring adequate visual performance (Sha et al., 2015) while 
imposing peripheral defocus at a level sufficient to test the hypothesis (Walline et al., 2020).   




Biofinity multifocal CLs are manufactured using a silicone hydrogel material (comfilcon A) with 
a low modulus and high oxygen transmissibility (Dk/t) of 142 and 160 for the MF and SV 
modalities, respectively. The MF design is available in centre-distance and centre-near 
designs with add powers in 0.50 D increments from +1.00 D to +2.50 D (CooperVision, UK). 
Use of silicone hydrogel versus hydrogel material reportedly reduces limbal hyperaemia 
(Maldonado-Codina et al., 2004) and mitigates for the risk of hypoxic changes that can arise 
with low Dk/t CLs (Covey et al., 2001). CLs appear to be safe for children to wear with scarce 
reports of serious complications in Europe and the US (Bullimore, 2017). Adverse events from 
clinical trials involving children and CLs are not widely reported (Bullimore, 2017). Interestingly, 
the rate of corneal infiltrative events in young CL wearers is no higher than in adults and in the 
range of 8 to 11 years, it may be markedly lower (Bullimore, 2017). 
 
Measures of the power profile of Biofinity multifocal centre-distance lenses show that they have 
a constant power in the central 1.5 mm zone with an annular zone where the power increases 
almost linearly and finally an outer zone demonstrating a slow, linear increase in power that is 
almost independent of the add power (Plainis et al., 2013). The centre-near design is broadly 
similar to the centre-distance design (Plainis et al., 2013). In the centre-distance design, the 
change between the distance to near zone power occurs from 1.6 mm to 2.1 mm radius. In the 
centre-near design, the transition from the near to distance zone power occurs from 1.2 mm 
to 2.0 mm radius. The measured add amplitude between the 1.6 mm to 2.1 mm zone for a 
nominal add power of 2.00 D in the centre-distance design has been reported as 1.01 D. 
However, for the centre-near design, the power between the 1.6 mm to 2.1 mm zone has been 
shown to be much closer to its nominal add of 2.00 D being measured at 1.83 D (Kim et al., 
2017). 
 
Previous CL wear was stated as an exclusion criterion for the studies outlined in Chapters 3 
and 4; this was due to the recognised variability in peripheral power profiles across different 
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Despite the known visual consequences and pathological implications of hyperopia (see 
1.3.2.1), there has been inertia to address the modulation of refractive error in this cohort of 
individuals. Given the extensive literature, which reveals the ability to both accelerate and 
retard axial growth in a range of species (see 1.4.3), it seems plausible that these principles 
could be applied to children with hyperopia.  
 
Peripheral refraction measures differ between myopes and hyperopes as a result of retinal 
shape (see 1.4.5); myopes typically exhibit RPH whereas hyperopes tend to be relatively 
myopic in the periphery. As discussed previously (see 1.5.4.2), soft centre-distance BF CLs 
have been used as a myopia management strategy in children by correcting distance refractive 
error through the central optic zone, while simultaneously reducing RPHD through the outer 
optic zone. For hyperopes, using soft centre-near BF CLs to correct distance refractive error 
through the central optic zone, while simultaneously imposing RPHD through the outer optic 
zone, could provide a stimulus to axial growth (see Figure 3.1). For example, a child with 5.00 
D of hyperopia could be fitted with a centre-near CL with a prescription of +3.00 D add +2.00 
D; this specification would provide 5.00 D of refractive correction in the central portion, while 
imposing 2.00 D of relative hyperopia in the periphery. 
 
Hitherto, there has been no attempt to impose RPHD to modulate refractive error and axial 
growth in human isohyperopes. 
 




Figure 3.1 Schematic to demonstrate RPHD imposed with a centre-near BF CL while full 
refractive error is corrected centrally 
 
3.2 Objective 
The objective of this clinical trial was to understand the natural progression of axial eye growth 
and refractive error in children with isohyperopia. Considering the paucity of literature to date, 
this work sought to establish whether axial eye growth and refractive error could be modified 
in this cohort by imposing relative hyperopic defocus bilaterally using MF CLs.  
 
3.3 Methods 
Suitable candidates for the study were recruited by displaying notices at the research venues. 
Potential participants were also sourced through a database search at the research venues to 
identify individuals that met the age and refractive error inclusion criteria.  
 
Participants were allocated to 1 of 2 groups: 
(1) Natural progression group: refractive error and axial growth was followed over a 3-year 
period with recruitment open to hyperopes aged between 5 and <20 years-of-age to gain an 
understanding of natural progression of these parameters in the specified cohort. This arm of 
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the study did not involve an intervention and therefore served as a control group for the clinical 
trial. 
(2) Hyperopic intervention group: for the intervention arm of the trial, hyperopes wore centre-
near MF soft CLs (See Chapter 2.11) between the 6- and 30-month timepoints of the 3-year 
trial. The CLs provided clear central vision at both distance and near through the near central 
zone while simultaneously exposing the retina to RPHD from the outer distance zone. 
Participants aged between 8 and <16 years-of-age were recruited for this arm of the study. 
 
Sample size calculation indicated that 22 participants would be required to achieve 80% power 
for an effect size of 0.25 at a significance level of 5% using a mixed factor repeated measures 
ANOVA design (G*Power 3.1, Franz Faul, Universität Kiel, Germany). The aim was to recruit 
28 participants to allow for an attrition rate of 20%. Allocation to the respective arms of the 
study was not randomised. Individuals who were willing and able to use CLs were given the 
opportunity to be included in the CL arm of the study in the first instance; those who did not 
want to wear, were unable to handle, or considered unsuitable for CLs, were given the 
opportunity to participate in the natural progression arm of the study.  
 
Prior to commencing the research, ethical approval was obtained from both the National Health 
Service Health Research Authority (see Appendix 1) and Aston University’s Research Ethics 
Committees (see Appendix 2) with the study designed to follow the tenets of the Declaration 
of Helsinki. Each participant, and their parent or guardian where appropriate, was given 
detailed information regarding the nature of the study, both verbally and in written form; this 
allowed informed consent and assent to take place prior to participation. The participants were 
required to complete a short questionnaire to ensure that they met the inclusion criteria (see 
Appendix 3). The programme of research was registered as a clinical trial: ClinicalTrials.gov 
NCT02686879. The participant’s general practitioner was notified of their inclusion in the study 
(see Appendix 4).  
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Inclusion criteria were as follows: 
• Aged between 5 and < 20 years-of-age at the initial examination for the natural progression 
group 
• Aged between 8 and < 16 years-of-age at the initial examination for the intervention group 
• For participants < 16 years-of-age, parents must have read, understood and signed the 
informed consent form (see Appendix 5) 
• Participants must have read, understood and signed the consent or assent form as 
appropriate (see Appendix 6 and 7) 
• Participants in the intervention group agreed to wear the prescribed CLs for a minimum of 
10 hours per day, at least 6 days per week for the 2-year duration of the intervention period 
• Be in good general health with no contraindications to CL wear 
• Maximum manifest spherical refractive error of +6.00 D 
• Maximum manifest cylindrical refractive error of -1.00 D 
• Maximum manifest anisometropia of 1.00 D (mean spherical error)  
• Minimum mean post-cycloplegic spherical refractive error of +2.00D in the more hyperopic 
eye for inclusion in the intervention group 
• Be competent at handling CLs and understand the instructions given to ensure safe wear. 
 
Exclusion criteria were as follows: 
• Previous CL wear  
• Participating in another clinical study 
• Regular use of medication to treat ocular conditions 
• Current use of systemic medication that could impact upon successful CL wear or affect 
focusing ability 
• Known ocular or systemic disease 
• Findings identified during CL assessment that would preclude CL wear 
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• Participants who were not able to provide informed consent without the aid of an interpreter 
due to lack of funding available for the provision of this facility. 
 
A summary of the procedures conducted at each visit are detailed below and in Table 3.1 and 
Table 3.2, for the intervention and control groups, respectively. Visits 1 to 7 were undertaken 
at 6-monthly intervals (± 2 weeks) for all participants. For participants in the intervention group, 
CL fitting, CL aftercare at 1 to 2 weeks after the initial fitting and CL aftercare 1 month after the 
first aftercare were also scheduled. At visit 1, all participants completed a background 
questionnaire (see Appendix 3) to elicit detail of previous ocular history and general health 
status. At visits 2 to 8, all participants completed a follow-up questionnaire (see Appendix 8) 
to elicit detail of any changes to ocular history and general health status. 
 

















Unaided DV ✅ ✅   ✅ ✅ ✅ ✅ ✅ 
Subjective refraction ✅ ✅   ✅ ✅ ✅ ✅ ✅ 
DVA ✅ ✅   ✅ ✅ ✅ ✅ ✅ 
NVA ✅ ✅   ✅ ✅ ✅ ✅ ✅ 
Lag of 
accommodation ✅ ✅   ✅ ✅ ✅ ✅ ✅ 
Lag with CL in situ     ✅  ✅   
Amplitude of 
accommodation ✅ ✅   ✅ ✅ ✅ ✅ ✅ 
Stereoacuity ✅ ✅   ✅ ✅ ✅ ✅ ✅ 
Stereoacuity with CL 
in situ     ✅  ✅   
Cover test ✅ ✅   ✅ ✅ ✅ ✅ ✅ 
CC ✅ ✅   ✅ ✅ ✅ ✅ ✅ 
Slit lamp 
examination ✅ ✅    ✅  ✅ ✅ 
AL ✅ ✅   ✅ ✅ ✅ ✅ ✅ 
IOP ✅ ✅    ✅  ✅ ✅ 
Post-cycloplegic 
autorefraction ✅ ✅    ✅  ✅ ✅ 
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Peripheral refraction ✅ ✅    ✅  ✅ ✅ 
CS  ✅      ✅ ✅ 
CS with CL in situ   ✅     ✅  
ACD ✅ ✅   ✅   ✅ ✅ 
Pupil size     ✅     
CL fitting  ✅        
CL aftercare   ✅ ✅ ✅ ✅ ✅ ✅  
Central refraction 
with CL in situ     ✅     
Peripheral refraction 
with CL in situ     ✅     
Table 3.1 Procedures undertaken for participants in the intervention group at each visit 
 













Unaided DV ✅ ✅ ✅ ✅ ✅ ✅ ✅ 
Subjective refraction ✅ ✅ ✅ ✅ ✅ ✅ ✅ 
DVA ✅ ✅ ✅ ✅ ✅ ✅ ✅ 
NVA ✅ ✅ ✅ ✅ ✅ ✅ ✅ 
Lag of 
accommodation ✅ ✅ ✅ ✅ ✅ ✅ ✅ 
Amplitude of 
accommodation ✅ ✅ ✅ ✅ ✅ ✅ ✅ 
Stereoacuity ✅ ✅ ✅ ✅ ✅ ✅ ✅ 
Cover test ✅ ✅ ✅ ✅ ✅ ✅ ✅ 
CC ✅ ✅ ✅ ✅ ✅ ✅ ✅ 
Slit lamp 
examination ✅ ✅  ✅  ✅ ✅ 
AL ✅ ✅ ✅ ✅ ✅ ✅ ✅ 
IOP ✅ ✅  ✅  ✅ ✅ 
Post-cycloplegic 
autorefraction ✅ ✅  ✅  ✅ ✅ 
Peripheral refraction ✅ ✅  ✅  ✅ ✅ 
CS  ✅    ✅ ✅ 
ACD ✅ ✅  ✅  ✅ ✅ 
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Pupil size   ✅     
Table 3.2 Procedures undertaken for participants in the control group at each visit 
 
3.4 Statistical analysis 
All data were analysed using the commercially available software, SPSS, v. 25, IBM, New 
York, U.S.A. Data were examined with mixed factor repeated measures analysis of variance 
(ANOVA) with one within-subject factor (time) and one between-subject factor (intervention or 
control). Bonferroni correction was applied and a significance level of α < 0.05 used throughout 
(Armstrong et al., 2011; Armstrong et al., 2002). Where within-subject factors had three 
categories or more, sphericity was considered with Greenhouse-Geisser results reported 
where appropriate. For the primary outcome measures, the mean longitudinal change to AL 
was the same for right and left eyes (F1,10 = 0.678, P = 0.429); this was also the case for post-
cycloplegic refractive error (F1,10 = 0.281, P = 0.608). As such data is presented for the right 
only, which was selected at random (Armstrong, 2013). 
 
3.5 Results  
Data were analysed to compare the primary (see 3.5.1) and secondary (see 3.5.2) outcome 
measures for the intervention group and control group.  
 
28 participants were recruited in total, with 16 in the intervention group and 12 in the control 
group. Due to attrition, 5 participants in the intervention group and 2 participants in the control 
group did not complete the study, with 1 participant transferring from the intervention group to 
the control group at the second visit (see Table 3.3). In total, 22 participants completed the trial 
with 11 in the intervention group (8 females and 3 males) with an age range at baseline of 
8.42-13.5 years (mean 11.13 SD 1.72 years); these data were normally distributed 
(Kolmogorov-Smirnov, Z = 0.166, P = 0.200). The control group consisted of 11 participants 
(9 females and 2 males) with an age range of 8.33-13.92 years (mean 11.42 SD 2.23 years); 
these data were normally distributed (Kolmogorov-Smirnov, Z = 0.187, P = 0.200). The groups 
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were age-matched (unpaired t-test: t = 0.348, df = 20, P = 0.732). The data presented 
throughout this chapter are for participants that completed the full trial. 
 
Group Timepoint (months) Reason for drop out 
Intervention 6 Difficulty with lens handling 
Intervention 6 Cosmetic appearance; transferred to control group 
Intervention 8 Difficulty with lens handling 
Intervention 9 Poor CL compliance 
Intervention 10 Parent cited ‘external issues’ 
Control 7 Moved away 
Control 12 Lost to follow up 
Table 3.3 Summary of attrition in the intervention and control groups 
 
A summary of descriptive data from questionnaires undertaken at each visit is detailed in Table 
3.4 and Table 3.5 for the intervention group and control group, respectively.  
 Visit 1 Follow up visits 
Participant History Medication Notes 
1 Full time spectacles at 4 years of age Nil Spectacles part-time from Visit 5 
2 Full time spectacles at 2 years of age Nil  
3 Spectacles at 6 years of age for concentrated tasks Nil  
4 Full time spectacles at 15 months of age Ventolin  
5 Full time spectacles at 2 years of age Salbutamol Beclometasone PRN 
6 Full time spectacles at 6 years of age Desmopressin 
No medication 
from Visit 2 
7 Full time spectacles at 5 years of age Nil  
8 Full time spectacles at 3 years of age Nil  
9 Full time spectacles at 4 years of age Nil  
10 Full time spectacles at 4 years of age Nil  
11 Spectacles at 6 years of age for concentrated tasks Nil  
Table 3.4 Summary of key information from questionnaires for the intervention group 
 




 Visit 1 Follow up visits 
Participant History Medication Notes 
1 Full time spectacles at 6 years of age Nil  
2 Spectacles at 9 years of age for concentrated tasks Salbutamol 
No medication 
from Visit 4 
3 Full time spectacles at 6 years of age Nil  
4 Full time spectacles at 4 years of age Nil  
5 Spectacles at 7 years of age for concentrated tasks Nil  
6 Full time spectacles at 8 years of age Nil  
7 Full time spectacles at 5 years of age Nil  
8 Full time spectacles at 4 years of age Nil  
9 Full time spectacles at 4 years of age Nil  
10 Full time spectacles at 5 years of age Nil  
11 Full time spectacles at 2 years of age. Occlusion therapy not adhered to Nil  
Table 3.5 Summary of key information from questionnaires for the control group 
 
3.5.1 Primary outcome measures 
 
3.5.1.1 Axial growth  
 
Main findings: 
• AL increased over time (F (6, 120) = 27.091, P < 0.0005) for the intervention group but 
not the control group (F (6, 120) = 4.663, P < 0.0005). Observed power was 0.986 
• For the intervention group, AL did not change during the first 6 months prior to CL wear 
(P = 1.000). Axial growth accelerated throughout the 2 years of intervention (P = < 
0.0005) but did not change once the intervention was withdrawn for the final 6 months 
of the trial 
• For the control group, AL did not change across the 3-year period (P = 0.466). 




Pairwise comparisons for between-visit analysis (see Figure 3.2 and Table 3.6) showed that 
for the intervention group, AL did not change from baseline to the 6-month timepoint (P = 
1.000). However, when the intervention was introduced, axial growth accelerated between the 
6- and 12-month timepoints (P = 0.003), 12- and 18-month timepoints (P = 0.009), 18- and 24-
month timepoints (P = 0.005), and 24- and 30-month timepoints (P = 0.027). Once the 
intervention was withdrawn, AL did not change between the 30- and 36-month timepoints (P = 
1.000). 
 
Pairwise comparisons for between-visit analysis (see Figure 3.2 and Table 3.6) showed that 
for the control group, AL did not change from baseline to the 6-month timepoint (P = 1.000), 
nor between the 6- and 12-month timepoints (P = 0.496), 12- and 18-month timepoints (P = 
1.000), 18- and 24-month timepoints (P = 1.000), 24- and 30-month timepoints (P = 1.000) and 
the 30- and 36-month timepoints (P = 1.000). 
 
Due to the inclusion of amblyopes in the study, the analysis was repeated with data removed 
for the two participants in each group that fell into this category. Reanalysis showed that the 
key outcome did not change, that is to say, AL increased over time (F (6, 96) = 19.905, P < 
0.0005) for the intervention group but not the control group (F (6, 96) = 2.859, P = 0.013). 
Observed power was 0.871. 
 








Timepoint (months) AL (mm) 
Baseline 21.45 ± 0.27 21.81 ± 0.27 
6 21.46 ± 0.27 21.83 ± 0.27 
12 21.50 ± 0.27 21.85 ± 0.28 
18 21.54 ± 0.27 21.86 ± 0.27 
24 21.60 ± 0.28 21.88 ± 0.28 
30 21.63 ± 0.29 21.89 ± 0.28 
36 21.65 ± 0.30 21.91 ± 0.28 
 Intervention (n = 11) Control (n = 11) 
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3.5.1.2 Post-cycloplegic refractive error 
 
Main findings: 
• Post-cycloplegic MSE refractive error decreased over time (F (4, 80) = 6.572, P < 0.0005) 
by a similar amount in both the intervention and control groups (F (4, 80) = 1.463, P = 
0.221) 
• Observed power was 0.435 and partial η2 was 0.068. 
   
Post-cycloplegic MSE refractive error at baseline for the intervention group and the control 
group were the same (unpaired t-test: t = 1.645, df = 20, P = 0.116). 
 
Pairwise comparisons for between-visit analysis (see Figure 3.3 and Table 3.7) showed that 
for the intervention group, post-cycloplegic MSE refractive error did not change from baseline 
to the 6-month timepoint (P = 1.000), nor between the 6- and 18-month timepoints (P = 0.817), 
18- and 30-month timepoints (P = 1.000), and the 30- and 36-month timepoints (P = 1.000). 
 
Pairwise comparisons for between-visit analysis (see Figure 3.3 and Table 3.7) showed that 
for the control group, post-cycloplegic MSE refractive error did not change from baseline to the 
6-month timepoint (P = 1.000), nor between the 6- and 18-month timepoints (P = 1.000), 18- 
and 30-month timepoints (P = 1.000) and the 30- and 36-month timepoints (P = 0.628). 
 
As with AL measures, the data were reanalysed with removal of amblyopic participants. Once 
again, the outcome remained the same with post-cycloplegic MSE refractive error decreasing 
over time (F (4, 64) = 5.260, P = 0.001) by a similar amount in both the intervention and control 
groups (F (4, 64) = 1.161, P = 0.336). Observed power was 0.344 and partial η2 was 0.068. 
 




Figure 3.3 Change in MSE post-cycloplegic central refraction (mean ± SEM) 
 
 
Timepoint (months) Refractive error (D) 
Baseline +5.23 ± 0.68 +3.78 ± 0.57 
6 +5.19 ± 0.67 +3.75 ± 0.56 
18 +5.04 ± 0.72 +3.80 ± 0.56 
30 +4.93 ± 0.72 +3.76 ± 0.60 
36 +4.76 ± 0.69 +3.54 ± 0.59 
 Intervention (n = 11) Control (n = 11) 
Table 3.7 MSE post-cycloplegic central refractive error at each visit (mean ± SEM). 




























































3.5.2 Secondary outcome measures 
 
3.5.2.1 Unaided DV 
 
Main findings: 
• Unaided DV was similar for the intervention and control groups (F (1, 20) = 2.607, P = 
0.122) and did not change over time (F (6, 120) = 1.099, P = 0.367) in either group (F (6, 
120) = 0.536, P = 0.780). 
 
Pairwise comparisons for between-visit analysis (see Figure 3.4 and Table 3.8) showed that 
for the intervention group, unaided DV did not change from baseline to the 6-month timepoint 
(P = 1.000), nor between the 6- and 12-month timepoints (P = 1.000), 12- and 18-month 
timepoints (P = 1.000), 18- and 24-month timepoints (P = 1.000), 24- and 30-month timepoints 
(P = 1.000) and the 30- and 36-month timepoints (P = 1.000). 
 
Pairwise comparisons for between-visit analysis (see Figure 3.4 and Table 3.8) showed that 
for the control group, unaided DV did not change from baseline to the 6-month timepoint (P = 
1.000), nor between the 6- and 12-month timepoints (P = 1.000), 12- and 18-month timepoints 
(P = 1.000), 18- and 24-month timepoints (P = 1.000), 24- and 30-month timepoints (P = 
1.000), and the 30- and 36-month timepoints (P = 1.000). 
 




Figure 3.4 Change in unaided DV at 6 m (mean ± SEM) 
 
 
Timepoint (months) DV (LogMAR) 
Baseline 0.21 ± 0.10 0.06 ± 0.05 
6 0.22 ± 0.09 0.06 ± 0.05 
12 0.22 ± 0.09 0.04 ± 0.05 
18 0.21 ± 0.09 0.04 ± 0.05 
24 0.20 ± 0.09 0.03 ± 0.05 
30 0.21 ± 0.09 0.04 ± 0.05 
36 0.20 ± 0.09 0.04 ± 0.05 
 Intervention (n = 11) Control (n = 11) 
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3.5.2.2 Spectacle DVA 
 
Main findings: 
• Spectacle DVA was similar for the intervention and control groups (F (1, 20) = 2.996, P = 
0.099) and did not change over time (F (6, 120) = 0.647, P = 0.692) in either group (F (6, 
120) = 0.713, P = 0.640).  
 
Pairwise comparisons for between-visit analysis (see Figure 3.5 and Table 3.9) showed that 
for the intervention group, spectacle DVA did not change from baseline to the 6-month 
timepoint (P = 1.000), nor between the 6- and 12-month timepoints (P = 1.000), 12- and 18-
month timepoints (P = 1.000), 18- and 24-month timepoints (P = 1.000), 24- and 30-month 
timepoints (P = 1.000) and the 30- and 36-month timepoints (P = 1.000). 
 
Pairwise comparisons for between-visit analysis (see Figure 3.5 and Table 3.9) showed that 
for the control group, spectacle DVA did not change from baseline to the 6-month timepoint (P 
= 1.000), nor between the 6- and 12-month timepoints (P = 1.000), 12- and 18-month 
timepoints (P = 1.000), 18- and 24-month timepoints (P = 1.000), 24- and 30-month timepoints 
(P = 1.000) and the 30- and 36-month timepoints (P = 1.000). 
 




Figure 3.5 Change in spectacle DVA at 6 m (mean ± SEM) 
 
 
Timepoint (months) DVA (LogMAR) 
Baseline 0.02 ± 0.04 -0.06 ± 0.03 
6 0.03 ± 0.04 -0.07 ± 0.02 
12 0.00 ± 0.03 -0.07 ± 0.03 
18 0.00 ± 0.03 -0.07 ± 0.03 
24 -0.02 ± 0.03 -0.07 ± 0.03 
30 0.00 ± 0.04 -0.07 ± 0.03 
36 -0.01 ± 0.03 -0.06 ± 0.03 
 Intervention (n = 11) Control (n = 11) 
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3.5.2.3 Spectacle DVA versus CL DVA 
 
Main findings: 
• DVA was better with spectacles than CLs (F (1, 10) = 29.321, P < 0.0005) and improved 
over time (F (4, 40) = 4.061, P = 0.007) with both forms of correction (F (4, 40) = 1.315, P = 
0.281). 
 
Pairwise comparisons for between-visit analysis (see Figure 3.6 and Table 3.10) showed that 
with spectacle correction, DVA did not change between the 6- and 12-month timepoints (P = 
0.911), 12- and 18-month timepoints (P = 1.000), 18- and 24-month timepoints (P = 1.000), 
nor the 24- and 30-month timepoints (P = 1.000). 
 
Pairwise comparisons for between-visit analysis (see Figure 3.6 and Table 3.10) showed that 
with CL correction, DVA did not change between the 6- and 12-month timepoints (P = 0.286), 
12- and 18-month timepoints (P = 1.000), 18- and 24-month timepoints (P = 1.000), nor the 
24- and 30-month timepoints (P = 1.000). 




Figure 3.6 Change in spectacle DVA versus CL DVA at 6 m throughout the intervention period 
(mean ± SEM). Measures at the initial timepoint taken at the first CL aftercare visit 
 
 
Timepoint (months) DVA (LogMAR) 
6 0.03 ± 0.04 0.16 ± 0.03 
12 0.00 ± 0.03 0.10 ± 0.03 
18 0.00 ± 0.03 0.09 ± 0.02 
24 -0.02 ± 0.03 0.08 ± 0.03 
30 0.00 ± 0.04 0.09 ± 0.03 
 Spectacles (n = 11) CLs (n = 11) 
Table 3.10 Spectacle DVA versus CL DVA at 6 m throughout the intervention period (mean ± 








































3.5.2.4 Spectacle NVA 
 
Main findings: 
• Spectacle NVA was similar for the intervention and control groups (F (1, 20) = 1.999, P = 
0.173) and improved over time (F (6, 120) = 8.289, P < 0.0005) in both groups (F (6, 120) = 
0.996, P = 0.432).  
 
Pairwise comparisons for between-visit analysis (see Figure 3.7 and Table 3.11) showed that 
for the intervention group, spectacle NVA did not change from baseline to the 6-month 
timepoint (P = 1.000), nor between the 6- and 12-month timepoints (P = 1.000), 12- and 18-
month timepoints (P = 1.000), 18- and 24-month timepoints (P = 1.000), 24- and 30-month 
timepoints (P = 1.000) and the 30- and 36-month timepoints (P = 1.000). 
 
Pairwise comparisons for between-visit analysis (see Figure 3.7 and Table 3.11) showed that 
for the control group, spectacle NVA did not change from baseline to the 6-month timepoint (P 
= 1.000), nor between the 6- and 12-month timepoints (P = 1.000). There was an improvement 
in mean spectacle NVA between the 12- and 18-month timepoints (P = 0.02) but not between 
the 18- and 24-month timepoints (P = 1.000), 24- and 30-month timepoints (P = 1.000), nor 
the 30- and 36-month timepoints (P = 1.000). 
 




Figure 3.7 Change in spectacle NVA at 0.25 m (mean ± SEM) 
 
 
Timepoint (months) NVA (LogMAR) 
Baseline 0.23 ± 0.03 0.18 ± 0.03 
6 0.23 ± 0.03 0.16 ± 0.02 
12 0.21 ± 0.03 0.18 ± 0.04 
18 0.19 ± 0.03 0.13 ± 0.03 
24 0.18 ± 0.03 0.12 ± 0.03 
30 0.18 ± 0.03 0.13 ± 0.03 
36 0.15 ± 0.02 0.13 ± 0.02 
 Intervention (n = 11) Control (n = 11) 
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3.5.2.5 Spectacle NVA versus CL NVA 
 
Main findings: 
• NVA was better with spectacles than CLs (F (1, 10) = 12.000, P = 0.006) and improved 
over time (F (4, 40) = 5.152, P = 0.002) with both forms of correction (F (4, 40) = 0.154, P = 
0.960). 
 
Pairwise comparisons for between-visit analysis (see Figure 3.8 and Table 3.12) showed that 
with spectacle correction, NVA did not change between the 6- and 12-month timepoints (P = 
1.000), 12- and 18-month timepoints (P = 1.000), 18- and 24-month timepoints (P = 1.000), 
nor 24- and 30-month timepoints (P = 1.000). 
 
Pairwise comparisons for between-visit analysis (see Figure 3.8 and Table 3.12) showed that 
with CL correction, NVA did not change between the 6- and 12-month timepoints (P = 0.816), 
12- and 18-month timepoints (P = 1.000), 18- and 24-month timepoints (P = 1.000), nor 24- 
and 30-month timepoints (P = 1.000). 




Figure 3.8 Change in spectacle NVA versus CL NVA at 0.25 m throughout the intervention 
period (mean ± SEM). Measures at the initial timepoint taken at the first CL aftercare visit 
 
 
Timepoint (months) NVA (LogMAR) 
6 0.23 ± 0.03 0.26 ± 0.02 
12 0.21 ± 0.03 0.24 ± 0.02 
18 0.19 ± 0.03 0.22 ± 0.03 
24 0.18 ± 0.03 0.22 ± 0.02 
30 0.18 ± 0.03 0.22 ± 0.02 
 Spectacles (n = 11) CLs (n = 11) 
Table 3.12 Spectacle NVA versus CL NVA at 0.25 m throughout the intervention period (mean 
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3.5.2.6 Stereoacuity with spectacle correction 
 
Main findings: 
• Stereoacuity with spectacles was similar for the intervention and control groups (F (1, 18) 
= 0.856, P = 0.367) and did not change over time (F (6, 108) = 0.838, P = 0.544) for either 
group (F (6, 120) = 0.350, P = 0.908).  
 
Pairwise comparisons for between-visit analysis (see Figure 3.9 and Table 3.13) showed that 
for the intervention group, stereoacuity did not change from baseline to the 6-month timepoint 
(P = 1.000), nor between the 6- and 12-month timepoints (P = 1.000), 12- and 18-month 
timepoints (P = 1.000), 18- and 24-month timepoints (P = 1.000), 24- and 30-month timepoints 
(P = 1.000) and the 30- and 36-month timepoints (P = 1.000). 
 
Pairwise comparisons for between-visit analysis (see Figure 3.9 and Table 3.13) showed that 
for the control group, stereoacuity did not change from baseline to the 6-month timepoint (P = 
1.000), nor between the 6- and 12-month timepoints (P = 1.000), 12- and 18-month timepoints 
(P = 1.000), 18- and 24-month timepoints (P = 1.000), 24- and 30-month timepoints (P = 1.000) 
and the 30- and 36-month timepoints (P = 1.000). 
 




Figure 3.9 Change in stereoacuity with spectacle correction (mean ± SEM). Excludes 
participants that were unable to complete the grading plates 
 
 
Timepoint (months) Stereoacuity (arcsec) 
Baseline 144.00 ± 41.18 99.00 ± 42.44 
6 132.00 ± 39.80 102.00 ± 42.00 
12 150.00 ± 40.25 111.00 ± 41.96 
18 126.00 ± 40.45 90.00 ± 18.44 
24 113.33 ± 17.61 98.18 ± 22.88 
30 133.33 ± 45.28 130.91 ± 40.53 
36 126.67 ± 45.93 136.36 ± 53.73 
 Intervention (n = 10) Control (n = 10) 
Table 3.13 Stereoacuity at each visit (mean ± SEM). Intervention period shaded red. Excludes 
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3.5.2.7 Stereoacuity: spectacle correction versus CL correction 
 
Main findings: 
• Stereoacuity was better with spectacles than CLs (F (1, 9) = 7.071, P = 0.026) and did 
not change over time (F (1, 9) = 0.000, P = 1.000) with either form of correction (F (1, 9) = 
3.692, P = 0.087). 
 
Pairwise comparisons for between-visit analysis (see Table 3.14) showed that with spectacle 
correction, stereoacuity was similar at the 12- and 24-month timepoints (P = 0.373). 
 
Pairwise comparisons for between-visit analysis (see Table 3.14) showed that with CL 
correction, stereoacuity did not change between the 12- and 24-month timepoints (P = 0.168). 
 
Timepoint (months) Stereoacuity (arcsec) 
12 150.00 ± 40.25 192.00 ± 50.44 
24 126.00 ± 20.88 216.00 ± 49.15 
 Spectacles (n = 10) CLs (n = 10) 
Table 3.14 Stereoacuity with spectacle correction versus CL correction (mean ± SEM). 




3.5.2.8 Cover test with spectacle correction 
A summary of binocular status with spectacle correction at distance and near for the 
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 Cover test 
Participant Distance at 6 m Near at 0.25 m 
1 Orthophoria Orthophoria 
2 Orthophoria Orthophoria 
3 Orthophoria Orthophoria 
4 Small esophoria Small esophoria 
5 Orthophoria Orthophoria 
6 Right esotropia Right esotropia 
7 Alternating esotropia 
Alternating 
esotropia 
8 Orthophoria Orthophoria 
9 Orthophoria Orthophoria 
10 Orthophoria Orthophoria 
11 Right esotropia Right esotropia 
Table 3.15 Cover test with spectacle correction at distance and near for the intervention group 
 
 
 Cover test 
Participant Distance at 6 m Near at 0.25 m 
1 Orthophoria Orthophoria 
2 Orthophoria Orthophoria 
3 Orthophoria Orthophoria 
4 Orthophoria Small exophoria 
5 Orthophoria Orthophoria 
6 Orthophoria Orthophoria 
7 Orthophoria Small exophoria 
8 Orthophoria Orthophoria 
9 Orthophoria Small exophoria 
10 Orthophoria Orthophoria 
11 Left esotropia Left esotropia 
Table 3.16 Cover test with spectacle correction at distance and near for the control group 
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• CS with spectacle correction was better in the control group than the intervention group 
(F (1, 20) = 5.125, P = 0.035). This measure did not change over time (F (2, 40) = 1.296, P 
= 0.285) in either group (F (2, 40) = 0.432, P = 0.652).  
 
Pairwise comparisons for between-visit analysis (see Figure 3.10 and Table 3.17) showed that 
for the intervention group, CS with spectacle correction did not change between the 6- and 30-
month timepoints (P = 1.000), nor between the 30- and 36-month timepoints (P = 0.716). 
 
Pairwise comparisons for between-visit analysis (see Figure 3.10 and Table 3.17) showed that 
for the control group, CS with spectacle correction was the same between the 6- and 30-month 
timepoints (P = 1.000) and the 30- and 36-month timepoints (P = 1.000). 
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Timepoint (months) Log CS (CPD) 
6 1.51 ± 0.04 1.62 ± 0.03 
30 1.53 ± 0.03 1.62 ± 0.03 
36 1.57 ± 0.02 1.64 ± 0.03 
 Intervention (n = 11) Control (n = 11) 
Table 3.17 CS with spectacle correction at 1 m. Intervention period shaded red 
 
3.5.2.10 CS: spectacle correction versus CL correction 
 
Main findings: 
• CS was similar with spectacle correction and CL correction (F (1, 10) = 0.000, P = 1.000) 
and did not change over time (F (1, 10) = 1.379, P = 0.267) with either form of correction 
(F (1, 10) = 1.000, P = 0.341). 
 
Pairwise comparisons for between-visit analysis (see Table 3.18) showed that with spectacle 
correction, CS was similar at the 6- and 30-month timepoints (P = 0.588). 
 
Pairwise comparisons for between-visit analysis (see Table 3.18) showed that with CL 
correction, CS was similar at the 6- and 30-month timepoints (P = 0.192). 
 
Timepoint (months) Log CS (Cycles per degree) (CPD)) 
6 1.51 ± 0.04 1.50 ± 0.03 
30 1.53 ± 0.03 1.54 ± 0.03 
 Spectacles (n = 11) CLs (n = 11) 
Table 3.18 CS with spectacle correction versus CL correction at 1 m (mean ± SEM). 











• CC was similar for the intervention and control participants (F (1, 20) = 0.578, P = 0.456) 
and did not change over time (F (6, 120) = 0.547, P = 0.772) in either group (F (6, 120) = 
0.525, P = 0.788).  
 
Pairwise comparisons for between-visit analysis (see Figure 3.11 and Table 3.19) showed that 
for the intervention group, CC did not change from baseline to the 6-month timepoint (P = 
1.000), nor between the 6- and 12-month timepoints (P = 1.000), 12- and 18-month timepoints 
(P = 1.000), 18- and 24-month timepoints (P = 1.000), 24- and 30-month timepoints (P = 1.000) 
and the 30- and 36-month timepoints (P = 1.000). 
 
Pairwise comparisons for between-visit analysis (see Figure 3.11 and Table 3.19) showed that 
for the control group, CC did not change from baseline to the 6-month timepoint (P = 1.000), 
nor between the 6- and 12-month timepoints (P = 1.000), 12- and 18-month timepoints (P = 
1.000), 18- and 24-month timepoints (P = 1.000), 24- and 30-month timepoints (P = 1.000) and 
the 30- and 36-month timepoints (P = 1.000). 
 




Figure 3.11 Change in CC (mean ± SEM) 
 
 
Timepoint (months) CC (mm) 
Baseline 7.80 ± 0.08 7.71 ± 0.09 
6 7.80 ± 0.08 7.70 ± 0.10 
12 7.79 ± 0.08 7.72 ± 0.09 
18 7.81 ± 0.08 7.71 ± 0.09 
24 7.79 ± 0.08 7.70 ± 0.09 
30 7.80 ± 0.08 7.71 ± 0.09 
36 7.80 ± 0.08 7.70 ± 0.09 
 Intervention (n = 11) Control (n = 11) 





































• ACD was similar for the intervention and control groups (F (1, 20) = 1.167, P = 0.293). 
ACD changed over time (F (4, 80) = 7.041, P < 0.0005) in both the intervention group and 
the control group (F (4, 80) = 0.740, P = 0.568).  
 
Pairwise comparisons for between-visit analysis (see Figure 3.12 and Table 3.20) showed that 
for the intervention group, ACD did not change from baseline to the 6-month timepoint (P = 
1.000), nor between the 6- and 18-month timepoints (P = 0.211), 18- and 30-month timepoints 
(P = 1.000) and the 30- and 36-month timepoints (P = 1.000). 
 
Pairwise comparisons for between-visit analysis (see Figure 3.12 and Table 3.20) showed that 
for the control group, ACD did not change from baseline to the 6-month timepoint (P = 1.000), 
nor between the 6- and 18-month timepoints (P = 1.000), 18- and 30-month timepoints (P = 
1.000) and the 30- and 36-month timepoints (P = 0.386). 




Figure 3.12 Change in ACD (mean ± SEM) 
 
 
Timepoint (months) ACD (mm) 
Baseline 3.32 ± 0.11 3.48 ± 0.07 
6 3.32 ± 0.12 3.47 ± 0.07 
18 3.34 ± 0.11 3.48 ± 0.06 
30 3.35 ± 0.12 3.49 ± 0.07 
36 3.36 ± 0.12 3.50 ± 0.07 
 Intervention (n = 11) Control (n = 11) 
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3.5.2.13 Pupil size 
 
Main findings: 
• Pupil size was similar for the intervention and control groups (F (3, 43) = 2.250, P = 0.293) 
and was smaller under photopic conditions than mesopic conditions (F (3, 43) = 12.883, 
P = 0.001) in both the intervention group and the control group (F (3, 43) = 0.103, P = 
0.750) (see Table 3.21). 
 
 











12 5.92 ± 0.21 6.23 ± 0.16 6.58 ± 0.16 6.78 ± 0.15 
Table 3.21 Pupil size in photopic and mesopic conditions for the intervention and control 
participants (mean ± SEM) 
 
 
3.5.2.14 Amplitude of accommodation 
 
Main findings: 
• Amplitude of accommodation was similar for the intervention and control groups (F (1, 
20) = 0.049, P = 0.827) and did not change over time (F (6, 120) = 1.469, P = 0.195) in 
either group (F (6, 120) = 0.275, P = 0.948).  
 
Pairwise comparisons for between-visit analysis (see Figure 3.13 and Table 3.22) showed that 
for the intervention group, amplitude of accommodation did not change from baseline to the 6-
month timepoint (P = 1.000), nor between the 6- and 12-month timepoints (P = 1.000), 12- and 
18-month timepoints (P = 1.000), 18- and 24-month timepoints (P = 1.000), 24- and 30-month 
timepoints (P = 1.000) and the 30- and 36-month timepoints (P = 1.000). 
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Pairwise comparisons for between-visit analysis (see Figure 3.13 and Table 3.22) showed that 
for the control group, amplitude of accommodation did not change from baseline to the 6-
month timepoint (P = 1.000), nor between the 6- and 12-month timepoints (P = 1.000), 12- and 
18-month timepoints (P = 1.000), 18- and 24-month timepoints (P = 1.000), 24- and 30-month 
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Timepoint (months) Amplitude of accommodation (D) 
Baseline 11.61 ± 0.53 11.61 ± 0.46 
6 11.44 ± 0.51 11.73 ± 0.38 
12 11.39 ± 0.50 11.39 ± 0.27 
18 11.18 ± 0.40 11.11 ± 0.39 
24 11.03 ± 0.37 11.33 ± 0.44 
30 11.15 ± 0.43 11.00 ± 0.36 
36 10.86 ± 0.34 11.21 ± 0.36 
 Intervention (n = 11) Control (n = 11) 
Table 3.22 Amplitude of accommodation at each visit (mean ± SEM). Intervention period 
shaded red 
 
3.5.2.15 Lag of accommodation with spectacle correction 
 
Main findings: 
• Lag of accommodation with spectacle correction was similar for the intervention and 
control groups (F (1, 20) = 2.139, P = 0.159) and increased over time (F (6, 120) = 3.477, P 
= 0.003) in both groups (F (6, 120) = 1.793, P = 0.106).  
 
Pairwise comparisons for between-visit analysis (see Figure 3.14 and Table 3.23) showed that 
for the intervention group, lag of accommodation with spectacle correction did not change from 
baseline to the 6-month timepoint (P = 1.000), nor between the 6- and 12-month timepoints (P 
= 1.000), 12- and 18-month timepoints (P = 1.000), 18- and 24-month timepoints (P = 1.000), 
24- and 30-month timepoints (P = 1.000) and the 30- and 36-month timepoints (P = 1.000). 
 
Pairwise comparisons for between-visit analysis (see Figure 3.14 and Table 3.23) showed that 
for the control group, lag of accommodation with spectacle correction did not change from 
baseline to the 6-month timepoint (P = 1.000), nor between the 6- and 12-month timepoints (P 
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= 1.000), 12- and 18-month timepoints (P = 1.000), 18- and 24-month timepoints (P = 1.000), 
24- and 30-month timepoints (P = 1.000), and the 30- and 36-month timepoints (P = 1.000). 
 
 
Figure 3.14 Change in accommodative lag with spectacle correction for a target at 0.33 m 
(mean ± SEM) 
 
 
Timepoint (months) Accommodative lag (D) 
Baseline 0.76 ± 0.11 0.82 ± 0.12 
6 1.01 ± 0.10 0.86 ± 0.14 
12 1.16 ± 0.08 0.93 ± 0.09 
18 1.23 ± 0.09 0.84 ± 0.10 
24 1.10 ± 0.05 0.99 ± 0.10 
30 1.11 ± 0.06 1.13 ± 0.09 
36 1.09 ± 0.10 1.11 ± 0.08 
 Intervention (n = 11) Control (n = 11) 
Table 3.23 Accommodative lag with spectacle correction for a target at 0.33 m (mean ± SEM). 
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3.5.2.16 Lag of accommodation: spectacle correction versus CL correction 
 
Main findings: 
• For the intervention group, lag of accommodation was higher with CL correction than 
spectacle correction (F (1, 10) = 5.94, P = 0.035) and did not change over time (F (1, 10) = 
0.516, P = 0.489) with either form of correction (F (1, 10) = 0.101, P = 0.757). 
 
Pairwise comparisons for between-visit analysis (see Table 3.24) showed that with spectacle 
correction, lag of accommodation was similar at the 12- and 24-month timepoints (P = 0.476). 
 
Pairwise comparisons for between-visit analysis (see Table 3.24) showed that with CL 
correction, lag of accommodation was similar at the 12- and 24-month timepoints (P = 0.591). 
 
Timepoint (months) Accommodative lag (D) 
12 1.16 ± 0.08 1.48 ± 0.20 
24 1.10 ± 0.05 1.34 ± 0.18 
 Spectacles (n = 11) CLs (n = 11) 
Table 3.24 Accommodative lag with spectacle correction versus CL correction for a target at 
0.33 m (mean ± SEM). Intervention period shaded red 
 
 
3.5.2.17 Central CL power 
 
Main findings: 
• Central CL power reduced over time (F (4, 40) = 21.174, P < 0.0005).  
 
Pairwise comparisons for between-visit analysis (see Figure 3.15 and Table 3.25) showed that 
central CL power did not change between the 6- and 12-month timepoints (P = 0.162), nor 
between the 12- and 18-month timepoints (P = 0.379). There was a decrease in central CL 
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power between the 18- and 24-month timepoints (P = 0.019) but not between the 24- and 30-
month timepoints (P = 1.000). 
 
 
Figure 3.15 Change in central CL power (mean ± SEM) 
 
 
Timepoint (months) Central CL power (D) 
6 3.93 ± 0.74 
12 3.82 ± 0.73 
18 3.73 ± 0.74 
24 3.57 ± 0.73 
30 3.55 ± 0.74 
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3.5.2.18 CL WT 
 
Main findings: 
• CL WT changed over time (F (4, 40) = 3.652, P = 0.013) with a significant increase over 
the first 6 months of wear and remained at that level thereafter. 
 
Pairwise comparisons for between-visit analysis (see Figure 3.16 and Table 3.26) showed that 
mean weekly CL WT increased between the 6- and 12-month timepoints (P = 0.049), but not 
between the 12- and 18-month timepoints (P = 1.000), 18- and 24-month timepoints (P = 
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Timepoint (months) Weekly CL WT (hours) 
6 59.45 ± 1.64 
12 71.09 ± 2.74 
18 71.27 ± 3.54 
24 66.00 ± 2.44 
30 70.45 ± 3.22 
Table 3.26 Typical weekly CL WT (mean ± SEM). Measures at the initial timepoint taken at 




3.5.2.19 Peripheral refraction (MSE) 
 
Main findings: 
• MSE peripheral refraction was relatively myopic in the temporal, nasal, superior, and 
inferior quadrants in the intervention (see Table 3.27) and control groups (Table 3.28). 
• Absolute values for central and peripheral refraction in all four quadrants are detailed 
in Figures 3.17 to 3.20. 
 
 
 Relative peripheral refraction (D) 
Timepoint (months) Temporal 30° Nasal 30° Superior 20° Inferior 20° 
Baseline -2.38 ± 0.52 -0.75 ± 0.30 -0.43 ± 0.14 -0.92 ± 0.25 
6 -2.62 ± 0.53 -0.51 ± 0.25 -0.71 ± 0.14 -0.57 ± 0.22 
18 -2.32 ± 0.61 -0.90 ± 0.30 -1.02 ± 0.34 -0.76 ± 0.20 
30 -2.28 ± 0.59 -1.25 ± 0.52 -0.76 ± 0.14 -0.85 ± 0.22 
36 -2.29 ± 0.52 -0.77 ± 0.31 -0.58 ± 0.25 -0.66 ± 0.31 
Table 3.27 MSE post-cycloplegic relative peripheral refractive error at each visit for the 
intervention group (mean ± SEM). Intervention period shaded red 
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 Relative peripheral refraction (D) 
Timepoint (months) Temporal 30° Nasal 30° Superior 20° Inferior 20° 
Baseline -1.26 ± 0.37 -0.91 ± 0.27 -0.69 ± 0.22 -0.93 ± 0.30 
6 -1.39 ± 0.33 -1.17 ± 0.28 -0.77 ± 0.22 -0.90 ± 0.31 
18 -1.26 ± 0.28 -1.30 ± 0.26 -0.81 ± 0.20 -0.95 ± 0.29 
30 -0.98 ± 0.40 -1.16 ± 0.43 -0.77 ± 0.28 -0.75 ± 0.22 
36 -0.75 ± 0.40 -0.66 ± 0.39 -0.49 ± 0.19 -0.47 ± 0.22 
Table 3.28 MSE post-cycloplegic relative peripheral refractive error at each visit for the control 




Figure 3.17 Absolute MSE post-cycloplegic central refraction compared to peripheral 
































 Intervention group - central  Control group - central
 Intervention group - temporal  Control group - temporal
INTERVENTION PERIOD




Figure 3.18 Absolute MSE post-cycloplegic central refraction compared to peripheral 




Figure 3.19 Absolute MSE post-cycloplegic central refraction compared to peripheral 
































 Intervention group - central  Control group - central































 Intervention group - central  Control group - central
 Intervention group - superior  Control group - superior
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Figure 3.20 Absolute MSE post-cycloplegic central refraction compared to peripheral 




Analysis of the main effects showed that for the intervention group, relative MSE peripheral 
refraction varied by location (F (3, 30) = 7.006, [Greenhouse-Geisser P = 0.011, Epsilon 0.489]) 
(See Figure 3.21). A greater degree of relative MSE myopia was found in the temporal 
quadrant compared to the nasal quadrant (P = 0.023). The temporal quadrant was similar to 
the superior (P = 0.125) and inferior (P = 0.101) quadrants. Relative MSE peripheral myopia 
in the nasal quadrant was similar to the superior (P = 1.000) and inferior (P = 1.000) quadrants; 
































 Intervention group - central  Control group - central
 Intervention group - inferior  Control group - inferior
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Figure 3.21 MSE post-cycloplegic relative peripheral refractive error at each visit for the 
intervention group (mean ± SEM) 
 
Analysis of the main effects showed that for the control group, relative peripheral MSE 
refraction did not vary by location (F (3, 30) = 1.173, P = 0.336) (See Figure 3.22). Relative 
peripheral MSE myopia in the temporal quadrant was similar to the nasal (P = 1.000), superior 
(P = 0.731), and inferior (P = 1.000) quadrants; this was also the case when comparing the 
nasal quadrant to the superior (P = 1.000) and the inferior quadrants (P = 1.000). The superior 











































 Intervention group - temporal  Intervention group - nasal
 Intervention group - superior  Intervention group - inferior
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Figure 3.22 MSE post-cycloplegic relative peripheral refractive error at each visit for the control 
group (mean ± SEM) 
 
 
Analysis of the main effects showed that relative peripheral MSE refraction in the temporal 
quadrant was similar for the intervention and control groups (F (1, 20) = 4.200, P = 0.056) and 
did not change over time (F (4, 80) = 1.618, P = 0.178) in either group (F (4, 80) = 0.415, P = 0.797).  
 
Pairwise comparisons for between-visit analysis (see Figures 3.17 and 3.21, and Table 3.27) 
showed that for the intervention group, relative peripheral MSE refraction in the temporal 
quadrant did not change from baseline to the 6-month timepoint (P = 1.000), nor between the 
6- and 18-month timepoints (P = 1.000), 18- and 30-month timepoints (P = 1.000) and the 30- 
and 36-month timepoints (P = 1.000).  
 
Pairwise comparisons for between-visit analysis (see Figures 3.17 and 3.22, and Table 3.28) 
showed that for the control group, relative peripheral MSE refraction in the temporal quadrant 
did not change from baseline to the 6-month timepoint (P = 1.000), nor between the 6- and 18-
month timepoints (P = 1.000), 18- and 30-month timepoints (P = 1.000) and the 30- and 36-




































Control group - temporal Control group - nasal
Control group - superior Control group - inferior
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Analysis of the main effects showed that relative peripheral MSE refraction in the nasal 
quadrant was similar for the intervention and control groups (F (1, 20) = 0.250, P = 0.622) and 
did not change over time (F (4, 80) = 2.046, P = 0.096) in either group (F (4, 80) = 1.282, P = 0.284).  
 
Pairwise comparisons for between-visit analysis (see Figures 3.18 and 3.21, and Table 3.27) 
showed that for the intervention group, relative peripheral MSE refraction in the nasal quadrant 
did not change from baseline to the 6-month timepoint (P = 1.000), nor between the 6- and 18-
month timepoints (P = 0.511), 18- and 30-month timepoints (P = 1.000) and the 30- and 36-
month timepoints (P = 1.000).  
 
Pairwise comparisons for between-visit analysis (see Figures 3.18 and 3.22, and Table 3.28) 
showed that for the control group, relative peripheral MSE refraction in the nasal quadrant did 
not change from baseline to the 6-month timepoint (P = 1.000), nor between the 6- and 18-
month timepoints (P = 1.000), 18- and 30-month timepoints (P = 1.000) and the 30- and 36-
month timepoints (P = 1.000). 
 
Analysis of the main effects showed that relative peripheral MSE refraction in the superior 
quadrant was similar for the intervention and control groups (F (1, 20) = 0.001, P = 0.977) and 
did not change over time (F (4, 80) = 2.044, P = 0.096) in either group (F (4, 80) = 0.631 P = 0.642).  
 
Pairwise comparisons for between-visit analysis (see Figures 3.19 and 3.21, and Table 3.27) 
showed that for the intervention group, relative peripheral MSE refraction in the superior 
quadrant did not change from baseline to the 6-month timepoint (P = 1.000), nor between the 
6- and 18-month timepoints (P = 1.000), 18- and 30-month timepoints (P = 1.000) and the 30- 
and 36-month timepoints (P = 1.000).  
 
Pairwise comparisons for between-visit analysis (see Figures 3.19 and 3.22, and Table 3.28) 
showed that for the control group, relative peripheral MSE refraction in the superior quadrant 
I.G.Beasley, PhD Thesis, Aston University 2021 
 
132 
did not change from baseline to the 6-month timepoint (P = 1.000), nor between the 6- and 18-
month timepoints (P = 1.000), 18- and 30-month timepoints (P = 1.000) and the 30- and 36-
month timepoints (P = 1.000). 
 
Analysis of the main effects showed that relative peripheral MSE refraction in the inferior 
quadrant was similar for the intervention and control groups (F (1, 20) = 0.031, P = 0.863) and 
did not change over time (F (4, 80) = 1.153, P = 0.338) in either group (F (4, 80) = 0.679 P = 0.608).  
 
Pairwise comparisons for between-visit analysis (see Figures 3.20 and 3.21, and Table 3.27) 
showed that for the intervention group, relative peripheral MSE refraction in the inferior 
quadrant did not change from baseline to the 6-month timepoint (P = 1.000), nor between the 
6- and 18-month timepoints (P = 1.000), 18- and 30-month timepoints (P = 1.000) and the 30- 
and 36-month timepoints (P = 1.000).  
 
Pairwise comparisons for between-visit analysis (see Figures 3.20 and 3.22, and Table 3.28) 
showed that for the control group, relative peripheral MSE refraction in the inferior quadrant 
did not change from baseline to the 6-month timepoint (P = 1.000), nor between the 6- and 18-
month timepoints (P = 1.000), 18- and 30-month timepoints (P = 1.000) and the 30- and 36-
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3.5.2.20 Peripheral refraction (J0) 
 
Main findings: 
• J0 peripheral refraction for the intervention group varied by location (F (3, 30) = 47.032, 
P < 0.0005) (See Figure 3.23). The temporal quadrant showed a greater degree of 
relative myopia to the nasal (P < 0.0005), superior (P < 0.0005), and inferior (P < 
0.0005) quadrants. The nasal quadrant also demonstrated greater relative peripheral 
myopia compared to the superior (P = 0.001) and inferior (P = 0.041) quadrants. The 
superior and inferior quadrants were similar to each other (P = 1.000) 
• For the control group, analysis of the main effects showed that J0 peripheral refraction 
varied by location (F (3, 30) = 13.008, P < 0.0005) (See Figure 3.28). The temporal 
quadrant was similar to the nasal quadrant (P = 1.000) but relatively more myopic than 
both the superior (P = 0.006), and inferior (P = 0.033) quadrants. The nasal quadrant 
also demonstrated greater relative peripheral myopia compared to the superior (P = 
0.004) and inferior (P = 0.005) quadrants. The superior and inferior quadrants were 
similar to each other (P = 1.000). 
 
Analysis of the main effects showed that J0 peripheral refraction in the temporal quadrant was 
similar for the intervention and control groups (F (1, 20) = 2.132, P = 0.160) and did not change 
over time (F (4, 80) = 0.166, P = 0.955) in either group (F (4, 80) = 0.692, P = 0.600).  
 
Pairwise comparisons for between-visit analysis (see Figure 3.23 and Table 3.29) showed that 
for the intervention group, measures in the temporal quadrant did not change from baseline to 
the 6-month timepoint (P = 1.000), nor between the 6- and 18-month timepoints (P = 1.000), 
18- and 30-month timepoints (P = 1.000) and the 30- and 36-month timepoints (P = 1.000).  
 
Pairwise comparisons for between-visit analysis (see Figure 3.24 and Table 3.30) showed that 
for the control group, measures in the temporal quadrant did not change from baseline to the 
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6-month timepoint (P = 1.000), nor between the 6- and 18-month timepoints (P = 1.000), 18- 
and 30-month timepoints (P = 1.000) and the 30- and 36-month timepoints (P = 1.000). 
 
Analysis of the main effects showed that J0 peripheral refraction in the nasal quadrant was 
similar for the intervention and control groups (F (1, 20) = 4.054, P = 0.058) and did not change 
over time (F (4, 80) = 1.376, P = 0.250) in either group (F (4, 80) = 2.309, P = 0.065).  
 
Pairwise comparisons for between-visit analysis (see Figure 3.23 and Table 3.29) showed that 
for the intervention group, measures in the nasal quadrant did not change from baseline to the 
6-month timepoint (P = 1.000), nor between the 6- and 18-month timepoints (P = 1.000), 18- 
and 30-month timepoints (P = 1.000) and the 30- and 36-month timepoints (P = 1.000).  
 
Pairwise comparisons for between-visit analysis (see Figure 3.24 and Table 3.30) showed that 
for the control group, measures in the nasal quadrant did not change from baseline to the 6-
month timepoint (P = 1.000), nor between the 6- and 18-month timepoints (P = 1.000), 18- and 
30-month timepoints (P = 0.610) and the 30- and 36-month timepoints (P = 1.000). 
 
Analysis of the main effects showed that J0 peripheral refraction in the superior quadrant were 
relative more myopic in the control group compared to the intervention group (F (1, 20) = 7.525, 
P = 0.013) and changed over time (F (4, 80) = 4.613, P = 0.002) in the intervention group (F (4, 
80) = 2.925 P = 0.026).  
 
Pairwise comparisons for between-visit analysis (see Figure 3.23 and Table 3.29) showed that 
for the intervention group, measures in the superior quadrant did not change from baseline to 
the 6-month timepoint (P = 1.000), nor between the 6- and 18-month timepoints (P = 0.159), 
18- and 30-month timepoints (P = 0.285) and the 30- and 36-month timepoints (P = 1.000).  
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Pairwise comparisons for between-visit analysis (see Figure 3.24 and Table 3.30) showed that 
for the control group, measures in the superior quadrant did not change from baseline to the 
6-month timepoint (P = 1.000), nor between the 6- and 18-month timepoints (P = 1.000), 18- 
and 30-month timepoints (P = 1.000), and the 30- and 36-month timepoints (P = 1.000). 
 
Analysis of the main effects showed that J0 peripheral refraction in the inferior quadrant were 
relative more myopic in the control group compared to the intervention group (F (1, 20) = 5.297, 
P = 0.032) but did not change over time (F (4, 80) = 0.863, P = 0.490) in either group (F (4, 80) = 
1.179 P = 0.327).  
 
Pairwise comparisons for between-visit analysis (see Figure 3.23 and Table 3.29) showed that 
for the intervention group, measures in the inferior quadrant did not change from baseline to 
the 6-month timepoint (P = 0.434), nor between the 6- and 18-month timepoints (P = 0.827), 
18- and 30-month timepoints (P = 1.000) and the 30- and 36-month timepoints (P = 1.000).  
 
Pairwise comparisons for between-visit analysis (see Figure 3.24 and Table 3.30) showed that 
for the control group, relative peripheral refraction in the inferior quadrant did not change from 
baseline to the 6-month timepoint (P = 1.000), nor between the 6- and 18-month timepoints (P 
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 Peripheral refraction (D) 
Timepoint (months) Temporal 30° Nasal 30° Superior 20° Inferior 20° 
Baseline -1.61 ± 0.32 -0.27 ± 0.22 0.43 ± 0.07 0.71 ± 0.13 
6 -1.50 ± 0.27 -0.24 ± 0.14 0.51 ± 0.09 0.44 ± 0.23 
18 -1.38 ± 0.32 -0.43 ± 0.19 0.91 ± 0.15 0.66 ± 0.14 
30 -1.59 ± 0.28 -0.36 ± 0.29 0.64 ± 0.10 0.60 ± 0.16 
36 -1.69 ± 0.25 -0.17 ± 0.30 0.58 ± 0.10 0.31 ± 0.25 
Table 3.29 J0 post-cycloplegic peripheral refractive error at each visit for the intervention group 
(mean ± SEM). Intervention period shaded red 
 
 
 Peripheral refraction (D) 
Timepoint (months) Temporal 30° Nasal 30° Superior 20° Inferior 20° 
Baseline -1.10 ± 0.29 -0.52 ± 0.15 0.13 ± 0.10 0.08 ± 0.19 
6 -1.16 ± 0.23 -0.58 ± 0.16 0.26 ± 0.11 -0.04 ± 0.20 
18 -1.13 ± 0.23 -0.63 ± 0.14 0.24 ± 0.13 -0.07 ± 0.21 
30 -0.98 ± 0.24 -0.90 ± 0.17 0.28 ± 0.14 0.01 ± 0.23 
36 -1.02 ± 0.24 -1.08 ± 0.13 0.26 ± 0.16 0.09 ± 0.20 
Table 3.30 J0 post-cycloplegic peripheral refractive error at each visit for the control group 








Figure 3.23 J0 post-cycloplegic peripheral refractive error at each visit for the intervention 




Figure 3.24 J0 post-cycloplegic peripheral refractive error at each visit for the control group 












































 Intervention group - temporal  Intervention group - nasal


































 Control group - temporal  Control group - nasal
 Control group - superior  Control group - inferior
I.G.Beasley, PhD Thesis, Aston University 2021 
 
138 
3.5.2.21 Peripheral refraction (J45) 
 
Main findings: 
• J45 peripheral refraction for the intervention group varied by location (F (3, 30) = 4.073, 
P = 0.015) (See Figure 3.25). The temporal quadrant was similar to the nasal (P = 
1.000), superior (P = 0.261), and inferior (P = 1.000) quadrants. The nasal quadrant 
was relatively more myopic than the superior quadrant (P = 0.030) but similar to the 
inferior quadrant (P = 1.000). However, the inferior quadrant demonstrated a greater 
degree of relative myopia compared to the superior quadrant (P = 0.008) 
• For the control group, analysis of the main effects showed that J45 peripheral refraction 
did not vary by location (F (3, 30) = 1.252, P = 0.308) (See Figure 3.26). The temporal 
quadrant was similar to the nasal (P = 1.000), superior (P = 0.739), and inferior (P = 
1.000) quadrants. The nasal quadrant was also similar to the superior (P = 1.000) and 
inferior (P = 1.000) quadrants. The superior and inferior quadrants were also 
comparable to each other (P = 0.088). 
 
Analysis of the main effects showed that J45 peripheral refraction in the temporal quadrant 
was similar for the intervention and control groups (F (1, 20) = 0.004, P = 0.951) and did not 
change over time (F (4, 80) = 2.077, P = 0.091) in either group (F (4, 80) = 1.188, P = 0.322).  
 
Pairwise comparisons for between-visit analysis (see Figure 3.25 and Table 3.31) showed that 
for the intervention group, measures in the temporal quadrant did not change from baseline to 
the 6-month timepoint (P = 1.000), nor between the 6- and 18-month timepoints (P = 0.550), 
18- and 30-month timepoints (P = 1.000) and the 30- and 36-month timepoints (P = 1.000).  
 
Pairwise comparisons for between-visit analysis (see Figure 3.26 and Table 3.32) showed that 
for the control group, measures in the temporal quadrant did not change from baseline to the 
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6-month timepoint (P = 1.000), nor between the 6- and 18-month timepoints (P = 1.000), 18- 
and 30-month timepoints (P = 1.000) and the 30- and 36-month timepoints (P = 1.000). 
 
Analysis of the main effects showed that J45 peripheral refraction in the nasal quadrant was 
similar for the intervention and control groups (F (1, 20) = 0.002, P = 0.963) and did not change 
over time (F (4, 80) = 1.158, P = 0.336) in either group (F (4, 80) = 0.888, P = 0.475).  
 
Pairwise comparisons for between-visit analysis (see Figure 3.25 and Table 3.31) showed that 
for the intervention group, measures in the nasal quadrant did not change from baseline to the 
6-month timepoint (P = 0.916), nor between the 6- and 18-month timepoints (P = 1.000), 18- 
and 30-month timepoints (P = 1.000) and the 30- and 36-month timepoints (P = 1.000).  
 
Pairwise comparisons for between-visit analysis (see Figure 3.26 and Table 3.32) showed that 
for the control group, measures in the nasal quadrant did not change from baseline to the 6-
month timepoint (P = 1.000), nor between the 6- and 18-month timepoints (P = 1.000), 18- and 
30-month timepoints (P = 0.610) and the 30- and 36-month timepoints (P = 1.000). 
 
Analysis of the main effects showed that J45 peripheral refraction in the superior quadrant 
were relative more myopic in the control group compared to the intervention group (F (1, 20) = 
11.422, P = 0.003) and changed over time (F (4, 80) = 4.843, P = 0.002) in both groups (F (4, 80) 
= 1.909 P = 0.117).  
 
Pairwise comparisons for between-visit analysis (see Figure 3.25 and Table 3.31) showed that 
for the intervention group, measures in the superior quadrant did not change from baseline to 
the 6-month timepoint (P = 0.138), nor between the 6- and 18-month timepoints (P = 0.108), 
18- and 30-month timepoints (P = 0.570), and the 30- and 36-month timepoints (P = 0.723).  
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Pairwise comparisons for between-visit analysis (see Figure 3.26 and Table 3.32) showed that 
for the control group, measures in the superior quadrant did not change from baseline to the 
6-month timepoint (P = 1.000), nor between the 6- and 18-month timepoints (P = 1.000), 18- 
and 30-month timepoints (P = 1.000) and the 30- and 36-month timepoints (P = 1.000). 
 
Analysis of the main effects showed that J45 peripheral refraction in the inferior quadrant was 
similar for the intervention and control groups (F (1, 20) = 0.493, P = 0.491) and did not change 
over time (F (4, 80) = 0.498, P = 0.737) in either group (F (4, 80) = 1.052, P = 0.386).  
 
Pairwise comparisons for between-visit analysis (see Figure 3.25 and Table 3.31) showed that 
for the intervention group, measures in the inferior quadrant did not change from baseline to 
the 6-month timepoint (P = 1.000), nor between the 6- and 18-month timepoints (P = 1.000), 
18- and 30-month timepoints (P = 0.363) and the 30- and 36-month timepoints (P = 1.000).  
 
Pairwise comparisons for between-visit analysis (see Figure 3.26 and Table 3.32) showed that 
for the control group, relative peripheral refraction in the inferior quadrant did not change from 
baseline to the 6-month timepoint (P = 1.000), nor between the 6- and 18-month timepoints (P 
= 1.000), 18- and 30-month timepoints (P = 1.000) and the 30- and 36-month timepoints (P = 
1.000). 
 
 Peripheral refraction (D) 
Timepoint (months) Temporal 30° Nasal 30° Superior 20° Inferior 20° 
Baseline -0.20 ± 0.21 0.18 ± 0.16 0.34 ± 0.13 -0.10 ± 0.13 
6 -0.24 ± 0.25 0.02 ± 0.09 0.55 ± 0.08 -0.07 ± 0.09 
18 0.18 ± 0.16 -0.06 ± 0.14 0.42 ± 0.10 -0.12 ± 0.08 
30 0.08 ± 0.16 -0.12 ± 0.18 0.34 ± 0.09 -0.29 ± 0.11 
36 -0.01 ± 0.16 -0.10 ± 0.16 0.26 ± 0.08 -0.13 ± 0.16 
Table 3.31 J45 post-cycloplegic peripheral refractive error at each visit for the intervention 
group (mean ± SEM). Intervention period shaded red 




 Peripheral refraction (D) 
Timepoint (months) Temporal 30° Nasal 30° Superior 20° Inferior 20° 
Baseline -0.10 ± 0.10 -0.01 ± 0.06 0.14 ± 0.05 -0.12 ± 0.05 
6 -0.04 ± 0.10 0.00 ± 0.06 0.13 ± 0.05 -0.12 ± 0.09 
18 -0.06 ± 0.06 0.02 ± 0.06 0.07 ± 0.04 -0.09 ± 0.05 
30 0.08 ± 0.07 -0.12 ± 0.15 0.01 ± 0.04 -0.06 ± 0.06 
36 -0.01 ± 0.06 0.06 ± 0.10 0.05 ± 0.05 -0.01 ± 0.07 
Table 3.32 J45 post-cycloplegic peripheral refractive error at each visit for the control group 





Figure 3.25 J45 post-cycloplegic peripheral refractive error at each visit for the intervention 
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Figure 3.26 J45 post-cycloplegic peripheral refractive error at each visit for the control group 
(mean ± SEM) 
 
 
3.5.2.22 Relative peripheral refraction with CL in situ 
 
Main findings: 
• Non-cycloplegic peripheral refraction with CL correction in situ demonstrated relative 
hyperopia in all four quadrants although the magnitude varied by location (F (3, 30) = 
6.991, P = 0.001). 
 
Pairwise comparisons (see Figure 3.27 and Table 3.33) showed that the temporal quadrant 
was similar to the nasal (P = 1.000), superior (P = 0.165), and inferior quadrants (P = 0.239), 
respectively. The nasal quadrant demonstrated a greater degree of relative hyperopia 
compared to the superior (P = 0.013) and inferior quadrants (P = 0.016), while the superior 
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 Peripheral refraction (D) 
Timepoint (months) Temporal 30° Nasal 30° Superior 20° Inferior 20° 
12 1.91 ± 0.60 1.90 ± 0.33 0.33 ± 0.35 0.46 ± 0.36 





This clinical trial has shown for the first time that the imposition of RPHD using MF CLs, can 
accelerate axial growth in children with isohyperopia. Participants in the control arm of the 
study demonstrated axial growth rates that were similar to other longitudinal observations in 
UK children with hyperopia (Breslin et al., 2013). Crucially, the axial growth rates seen in 
controls were significantly outpaced by participants receiving the intervention over the two-
year period of wearing MF CLs. In the 6 months prior to receiving the intervention, axial growth 
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ceased during the final 6 months of the trial, the faster growth rates experienced by the 
intervention group during the two-year period of wearing CLs, reverted to a pace that matched 
the control group.  
 
As participants in the intervention arm of the trial experienced a faster rate of axial growth than 
controls, it would be expected that a decrease in hyperopia would also occur. However, 
although the overall trend showed a greater reduction in post-cycloplegic refractive error in 
those receiving the intervention compared to the control group, this did not reach a level of 
significance nor achieve adequate statistical power. Nevertheless, the mean reduction in 
refractive error for participants receiving the intervention was almost double the decrease in 
the control group at 0.47 D and 0.24 D, respectively, which offers optimism for further research 
in this area. Unlike AL, post-cycloplegic refraction was only measured at 5 out of 7 timepoints. 
Although capturing data at these 2 additional timepoints would have increased statistical 
power, this has to be balanced against placing additional burden upon participants, which 
could in turn, affect rates of attrition. Given the effect size, it is estimated that to achieve 
statistical power at 80% over 5 data collection points, a sample size of 23 participants per 
group would be required. 
 
In terms of secondary outcome measures, the results were largely in keeping with expectation. 
For parameters related to vision, unaided DV and spectacle DVA were similar for the 
intervention and control groups and did not change; this is unsurprising given the age of 
participants and relatively small reduction in refractive error over the period of the trial. Both 
DVA and NVA were better in spectacles than CLs, which is line with previous findings when 
comparing SV with MF CL correction (Sha et al., 2016). Nevertheless, VA improved over time 
with both forms of correction at distance and near. Taking into account the mean DVA values, 
there was greater improvement over time with CLs compared to spectacles which is likely to 
reflect a period of adaptation. Although stereoacuity with spectacles was similar for both 
groups and did not change over time, in the intervention group it was poorer with CL correction 
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compared to spectacles and failed to improve during the two-year period of CL wear; this is in 
contrast to findings from earlier work demonstrating that stereoacuity appears to be preserved 
in MF CL wear compared to SV correction, albeit in a presbyopic cohort (Ferrer-Blasco and 
Madrid-Costa, 2011). From the start, CS was better in the control group than the intervention 
group and did not change over time. Encouragingly, CS was similar with spectacle and CL 
correction. For measures of anterior eye parameters, as with previous refractive modulation 
work in myopes (Sankaridurg et al., 2001; Lam et al., 2014; Aller et al., 2016), CC did not 
change over time in either group. ACD changed over time in both the control and intervention 
groups by a comparable amount; this suggests that the greater AL change observed in the 
intervention group is attributable primarily to VCD growth. Evaluation of accommodation 
revealed that lag with spectacles was similar for intervention and control participants and 
increased over time; this is surprising, particularly given that NVA improved over time in both 
groups. Perhaps of greater relevance is that accommodative lag was greater with CL 
correction than spectacle correction, which may reflect that hyperopes would be expected to 
converge less through the former. Given that accommodative lag has been implicated in 
myopia progression (Mutti et al., 2006; Chakraborty et al., 2020) it is plausible that lag may be 
a factor in driving axial growth in CL-wearing participants in the present study. It is noteworthy 
that central CL power decreased significantly over time although this measure was determined 
under non-cycloplegic conditions. Nevertheless, the mean power reduction of 0.38 D over the 
two-year intervention period was in broad agreement with the reduction in spectacle refraction 
recorded under cycloplegia in these participants over the same time period.  
 
In line with previous work, peripheral refraction was relatively myopic in all four quadrants 
(Atchison et al., 2005; Gilmartin et al., 2005; Charman and Radhakrishnan, 2010; Atchison 
and Charman, 2011; Schmid, 2011; Verkicharla et al., 2012). Importantly, while wearing the 
intervention, relative peripheral refraction was hyperopic in all four quadrants, demonstrating 
merit in using centre-near CLs to expose the peripheral retina to hyperopic defocus. There 
remains conjecture regarding the role of peripheral hyperopic defocus in the progression of 
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myopia (Charman and Radhakrishnan, 2010; Mutti et al., 2019). As outlined earlier (see 
Sections 1.5.3 and 1.5.4), studies evaluating the benefit of spectacle lenses that manipulate 
peripheral defocus in myopes report inconsistent results whereas soft multifocal contact lenses 
targeting a similar objective, are, with a moderate certainty of evidence, capable of slowing 
axial growth in this refractive cohort. Further, it is proposed that customising the CL design 
with the express purpose of achieving a greater shift in peripheral defocus may be of value, 
although further evidence using this approach is required (Nemeth et al., 2021). At a simple 
level, it is clear that ocular shape and peripheral characteristics are different between refractive 
subtypes. Specifically, myopic eyes tend to be relatively prolate, exhibit relative peripheral 
hyperopia with a slowing of axial growth in response to the imposition of myopic defocus. 
Conversely, hyperopes have a more oblate shape, are relatively myopic in the periphery, and 
on the basis of the present work, demonstrate accelerated axial growth in response to the 
imposition of RPHD. Indeed, the outcome witnessed in the intervention group offers credibility 
to the hypothesis that exposing the hyperopic eye to RPHD may provide the necessary signal 
to stimulate axial growth in children.  
 
Participants in the intervention arm of the study proved to be adept at handling and maintaining 
their CLs which is in keeping with earlier work on the safety of CLs in children (Bullimore, 2017; 
Chalmers et al., 2021). Two participants failed to handle CLs adequately and did not proceed; 
interestingly, both were teenagers rather than younger children. Almost all of the participants 
that successfully transitioned the application and removal phase of the study continued to wear 
CLs for the full two years of intervention with just one being withdrawn due to poor compliance. 
 
In future work, it would be important to establish if a greater effect can be achieved through 
earlier intervention. Exposing the hyperopic eye to peripheral hyperopic defocus at a younger 
age when natural growth is faster may yield better results as well as potentially improving the 
visual outcome, for instance, measures of VA and stereopsis. Nevertheless, it is important to 
recognise the difficulties of recruiting hyperopes, particularly at a young age. Given the nature 
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of refractive error distribution, hyperopes are relatively scarce in comparison to their myopic 
counterparts. Furthermore, in the absence of amblyopia, many isohyperopes may pass vision 
screening protocols as they enter the school system and remain unidentified. For those who 
fail vision screening, many are diverted to secondary care for several years making recruitment 
at a young age more difficult in a primary care setting.  
 
In terms of the main objective, the results demonstrating the effect of the intervention on axial 
growth is encouraging. However, it is important to recognise the limitation of this work in terms 
of refractive error outcome, which lacked statistical power and did not reach a significant level. 
Further work would benefit from a larger scale study undertaken as a double-masked, 
randomised control trial. An additional limitation is the reporting of CL compliance, specifically 
with respect to wearing times as these were self-reported by participants. Still, anecdotally, the 
majority of participants were disappointed to reach the end of the intervention period as they 
were keen to continue with CL wear, which suggests that in most cases, compliance was high.  
 
Inclusion of amblyopes formed part of the study protocol to ensure that participants were drawn 
from a representative sample. Nevertheless, to disentangle this potential confounding variable 
from the main dataset, further analysis with the exclusion of amblyopic participants was 
undertaken for the primary outcome measures. Interestingly, this reanalysis did not impact 
upon the findings for AL or refractive error, suggesting that the effect of the intervention is not 
influenced by the presence of amblyopia. 
 
Having identified a mechanism to modulate axial growth holds promise for hyperopes and 
provides a platform for an extension to this work. The ability to accelerate axial growth in 
hyperopes may help to decrease the risk of ocular comorbidities associated with small globes 
as well as reduce the burden of refractive error in these children. Furthermore, MF CLs in 
children with isohyperopia appear to be well tolerated both from a handling and wearing 
perspective as well as providing adequate visual performance. 
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In Chapter 3, the impact of imposing RPHD in isohyperopes using soft centre-near BF CLs 
was explored. The aim with this approach was to attempt to accelerate axial growth bilaterally 
to reduce the overall level of refractive error. A natural extension to this work is to consider a 
similar method with anisohyperopes. The aim here would be to accelerate axial growth 
unilaterally, that is to say, in the more hyperopic eye, to reduce the overall level of 
anisometropia thereby providing a platform for a more natural binocular status. In addition to 
the risk of amblyopia and strabismus in anisohyperopia, accelerating the growth of the smaller 
eye could help to mitigate for conditions with known association to eyes of short axial length 
including angle closure glaucoma, early AMD, and vascular events, such as branch and central 
retinal vein occlusion. 
 
Take for example, a child with the following refractive error: R +5.00 D L +2.50 D. In this case, 
the child could be fitted with a centre-near CL with a prescription of +3.00 D add +2.00 D in 
the right eye; this specification would provide 5.00 D of refractive correction in the central 
portion, while imposing 2.00 D of relative hyperopia in the periphery. In the left eye, a SV CL 
could be used with a power of +2.50 D. 
 
To date, there has been no attempt to impose RPHD to modulate refractive error and axial 
growth in human anisohyperopes. 
 
4.2 Objective 
The objective of this clinical trial was to establish whether axial eye growth and refractive error 
could be modified in an anisohyperopic cohort by imposing relative hyperopic defocus using a 
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MF CL in the more hyperopic eye. The aim here was to reduce the interocular difference in 
refractive error thereby mitigating for the effects of anisohyperopia. 
 
4.3 Methods 
Sample size calculation indicated that 11 participants would be required to achieve 80% power 
for an effect size of 0.25 at a significance level of 5% using a mixed factor repeated measures 
ANOVA design (G*Power 3.1, Franz Faul, Universität Kiel, Germany). The aim was to recruit 
13 participants to achieve statistical power and allow for attrition. Suitable candidates for the 
3-year study were recruited by displaying notices at the research venues. Potential participants 
were also sourced through a database search at the research venues to identify individuals 
that met the age and refractive error inclusion criteria.  
 
During the 6- to 30-month timepoints, participants were fitted with a centre-near MF soft CL in 
their more hyperopic eye, while the fellow eye was fitted with a SV CL if required (see Chapter 
2.11). Participants aged between 8 and <16 years-of-age were recruited for the study. 
 
Prior to commencing the research, ethical approval was obtained from both the NHS (see 
Appendix 1) and Aston University’s Research Ethics Committees (see Appendix 2) with the 
study designed to follow the tenets of the Declaration of Helsinki. Each participant, and their 
parent or guardian where appropriate, was given detailed information regarding the nature of 
the study, both verbally and in written form; this allowed informed consent and assent to take 
place prior to participation. The participants were required to complete a short questionnaire 
to ensure that they met the inclusion criteria (see Appendix 3). The programme of research 
was registered as a clinical trial: ClinicalTrials.gov NCT02686879. The participant’s general 
practitioner was notified of their inclusion in the study (see Appendix 4).  
 
Inclusion criteria were as follows: 
• Aged between 8 and < 16 years-of-age at the initial examination 
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• Parents must have read, understood and signed the informed consent form (see Appendix 
5) 
• Participants must have read, understood and signed the consent or assent form as 
appropriate (see Appendix 6 and 7) 
• Participants agreed to wear the prescribed CLs for a minimum of 10 hours per day, at least 
6 days per week for the 2-year duration of the intervention period 
• Be in good general health with no contraindications to CL wear 
• Maximum manifest spherical refractive error of +6.00 D 
• Maximum manifest cylindrical refractive error of -1.00 D 
• Manifest anisometropia of >1.00 D (mean spherical error)  
• Minimum mean spherical refractive error of +2.00D in the more hyperopic eye for inclusion 
in the intervention group 
• Be competent at handling CLs and understand the instructions given to ensure safe wear. 
 
Exclusion criteria were as follows: 
• Previous CL wear  
• Participating in another clinical study 
• Regular use of medication to treat ocular conditions 
• Current use of systemic medication that could impact upon successful CL wear or affect 
focusing ability 
• Known ocular or systemic disease 
• Findings identified during CL assessment that would preclude CL wear 
• Participants who were not able to provide informed consent without the aid of an interpreter 
due to lack of funding available for the provision of this facility. 
 
A summary of the procedures conducted at each visit are detailed below and in Table 4.1. 
Visits 1 to 7 were undertaken at 6-monthly intervals (± 2 weeks) for all participants. For 
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participants in the intervention group, CL fitting, CL aftercare at 1 to 2 weeks after the initial 
fitting and CL aftercare 1 month after the first aftercare were also scheduled. At visit 1, all 
participants completed a background questionnaire (see Appendix 3) to elicit detail of previous 
ocular history and general health status. At visits 2 to 8, all participants completed a follow-up 
questionnaire (see Appendix 8) to elicit detail of any changes to ocular history and general 
health status. 
 

















Unaided DV ✅ ✅   ✅ ✅ ✅ ✅ ✅ 
Subjective refraction ✅ ✅   ✅ ✅ ✅ ✅ ✅ 
DVA ✅ ✅   ✅ ✅ ✅ ✅ ✅ 
NVA ✅ ✅   ✅ ✅ ✅ ✅ ✅ 
Lag of 
accommodation ✅ ✅   ✅ ✅ ✅ ✅ ✅ 
Lag with CL in situ     ✅  ✅   
Amplitude of 
accommodation ✅ ✅   ✅ ✅ ✅ ✅ ✅ 
Stereoacuity ✅ ✅   ✅ ✅ ✅ ✅ ✅ 
Stereoacuity with CL 
in situ     ✅  ✅   
Cover test ✅ ✅   ✅ ✅ ✅ ✅ ✅ 
CC ✅ ✅   ✅ ✅ ✅ ✅ ✅ 
Slit lamp 
examination ✅ ✅    ✅  ✅ ✅ 
AL ✅ ✅   ✅ ✅ ✅ ✅ ✅ 
IOP ✅ ✅    ✅  ✅ ✅ 
Post-cycloplegic 
autorefraction ✅ ✅    ✅  ✅ ✅ 
Peripheral refraction ✅ ✅    ✅  ✅ ✅ 
CS  ✅      ✅ ✅ 
CS with CL in situ   ✅     ✅  
ACD ✅ ✅   ✅   ✅ ✅ 
Pupil size     ✅     
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CL fitting  ✅        
CL aftercare   ✅ ✅ ✅ ✅ ✅ ✅  
Central refraction 
with CL in situ     ✅     
Peripheral refraction 
with CL in situ     ✅     
Table 4.1 Procedures undertaken for all participants at each visit 
 
4.4 Statistical analysis 
All data were analysed using the commercially available software, SPSS, v. 25, IBM, New 
York, U.S.A. Data were examined with mixed factor repeated measures analysis of variance 
(ANOVA) with one within-subject factor (time) and one between-subject factor (intervention or 
control). Bonferroni correction was applied and a significance level of α < 0.05 used throughout 
(Armstrong et al., 2011; Armstrong et al., 2002). 
 
4.5 Results  
Data were analysed to compare the primary (see 4.5.1) and secondary (see 4.5.2) outcome 
measures for the intervention eye group and control eye group. In total, 11 participants were 
recruited, all of whom completed the trial and comprised of 8 females and 3 males with an age 
range at baseline of 8.25-13.42 years (mean 10.56 SD 1.43 years); these data were normally 
distributed (Kolmogorov-Smirnov, Z = 0.179, P = 0.200). A summary of descriptive data from 
questionnaires undertaken at each visit is detailed in Table 4.2. 
 
 Visit 1 Follow up visits 
Participant History Medication Notes 
1 Full time spectacles at 2 years of age. Occlusion therapy until 3 years of age. Nil  
2 Full time spectacles at 5 years of age Nil  




4 Full time spectacles at 3 years of age Nil  
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5 Full time spectacles at 6 years of age Nil  
6 Full time spectacles at 7 years of age Nil  
7 Full time spectacles at 4 years of age Nil  
8 Full time spectacles at 4 years of age. Occlusion therapy until 5 years of age. Nil  




10 Full time spectacles at 7 years of age Nil  
11 Full time spectacles at 4 years of age Nil  
Table 4.2 Summary of key information from questionnaires  
 
4.5.1 Primary outcome measures 
 
4.5.1.1 Axial growth  
 
Main findings: 
• AL changed over time (F (6, 60) = 14.808, P < 0.0005) for the control eye group but not 
the intervention eye group (F (6, 60) = 2.609, P = 0.026)  
• Observed power was 0.816. 
 
Pairwise comparisons for between-visit analysis (see Figure 4.1 and Table 4.3) showed that 
for the intervention eye group, AL did not change from baseline to the 6-month timepoint (P = 
1.000). When the intervention was introduced, AL did not change between the 6- and 12-month 
timepoints (P = 0.452) but did change between the 12- and 18-month timepoints (P = 0.049). 
There was no change in AL between the 18- and 24-month timepoints (P = 0.700) or the 24- 
and 30-month timepoints (P = 1.000). Once the intervention was withdrawn, AL did not change 
between the 30- and 36-month timepoints (P = 1.000). 
 
Pairwise comparisons for between-visit analysis (see Figure 4.1 and Table 4.3) showed that 
for the control eye group, AL did not change from baseline to the 6-month timepoint (P = 0.052), 
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nor between the 6- and 12-month timepoints (P = 1.000) but did change between the 12- and 
18-month timepoints (P = 0.003). There was no change in AL between the 18- and 24-month 
timepoints (P = 1.000), 24- and 30-month timepoints (P = 0.820) and the 30- and 36-month 





Figure 4.1 Change in AL (mean ± SEM) 
 
 
Timepoint (months) AL (mm) 
Baseline 21.67 ± 0.20 22.19 ± 0.21 
6 21.70 ± 0.19 22.27 ± 0.21 
12 21.74 ± 0.19 22.30 ± 0.21 
18 21.77 ± 0.19 22.35 ± 0.21 
24 21.80 ± 0.18 22.34 ± 0.20 
30 21.81 ± 0.19 22.42 ± 0.22 
36 21.84 ± 0.19 22.43 ± 0.22 
 Intervention (n = 11) Control (n = 11) 
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4.5.1.2 Post-cycloplegic refractive error 
 
Main findings: 
• Post-cycloplegic MSE refractive error decreased over time (F (4, 40) = 4.601, P = 0.004) 
for both the intervention eye group and the control eye group (F (4, 40) = 0.318, P = 
0.864)  
• Observed power was 0.114 and partial η2 was 0.031. 
 
Pairwise comparisons for between-visit analysis (see Figure 4.2 and Table 4.4) showed that 
for the intervention eye group, post-cycloplegic MSE refractive error did not change from 
baseline to the 6-month timepoint (P = 0.318), nor between the 6- and 18-month timepoints (P 
= 1.000), 18- and 30-month timepoints (P = 1.000) and the 30- and 36-month timepoints (P = 
1.000). 
 
Pairwise comparisons for between-visit analysis (see Figure 4.2 and Table 4.4) showed that 
for the control eye group, post-cycloplegic MSE refractive error did not change from baseline 
to the 6-month timepoint (P = 1.000), nor between the 6- and 18-month timepoints (P = 0.076), 
18- and 30-month timepoints (P = 1.000) and the 30- and 36-month timepoints (P = 1.000). 
 




Figure 4.2 Change in MSE post-cycloplegic central refraction (mean ± SEM) 
 
 
Timepoint (months) Refractive error (D) 
Baseline +5.28 ± 0.44 +3.37 ± 0.35 
6 +5.06 ± 0.46 +3.28 ± 0.37 
18 +4.95 ± 0.41 +3.02 ± 0.39 
30 +4.83 ± 0.45 +2.98 ± 0.41 
36 +4.94 ± 0.56 +3.01 ± 0.44 
 Intervention (n = 11) Control (n = 11) 
Table 4.4 MSE post-cycloplegic central refractive error at each visit (mean ± SEM). 


















































 Intervention eye  Control eye
INTERVENTION PERIOD
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4.5.2 Secondary outcome measures 
 
4.5.2.1 Unaided DV 
 
Main findings: 
• Unaided DV was better for the control eye group than the intervention eye group (F (1, 
10) = 18.730, P = 0.001) 
• Unaided DV did not change over time (F (6, 60) = 1.155, P = 0.343) in either group (F (6, 
60) = 0.615, P = 0.717).  
 
Pairwise comparisons for between-visit analysis (see Figure 4.3 and Table 4.5) showed that 
for the intervention eye group, unaided DV did not change from baseline to the 6-month 
timepoint (P = 1.000), nor between the 6- and 12-month timepoints (P = 1.000), 12- and 18-
month timepoints (P = 0.797), 18- and 24-month timepoints (P = 1.000), 24- and 30-month 
timepoints (P = 0.860) and the 30- and 36-month timepoints (P = 1.000). 
 
Pairwise comparisons for between-visit analysis (see Figure 4.3 and Table 4.5) showed that 
for the control eye group, unaided DV did not change from baseline to the 6-month timepoint 
(P = 1.000), nor between the 6- and 12-month timepoints (P = 1.000), 12- and 18-month 
timepoints (P = 0.164), 18- and 24-month timepoints (P = 1.000), 24- and 30-month timepoints 
(P = 1.000) and the 30- and 36-month timepoints (P = 1.000). 
 
 




Figure 4.3 Change in unaided DV (mean ± SEM) 
 
 
Timepoint (months) DV (LogMAR) 
Baseline 0.18 ± 0.04 -0.01 ± 0.02 
6 0.19 ± 0.04 -0.02 ± 0.02 
12 0.17 ± 0.04 -0.01 ± 0.02 
18 0.16 ± 0.04 -0.03 ± 0.02 
24 0.15 ± 0.04 -0.04 ± 0.02 
30 0.17 ± 0.04 -0.03 ± 0.03 
36 0.17 ± 0.05 -0.04 ± 0.03 
 Intervention (n = 11) Control (n = 11) 





























 Intervention eye  Control eye
INTERVENTION PERIOD
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4.5.2.2 Spectacle DVA 
 
Main findings: 
• Spectacle DVA was better for the control eye group than the intervention eye group (F 
(1, 10) = 11.988, P = 0.006) and changed over time (F (6, 60) = 4.479, P = 0.001) in both 
groups (F (6, 60) = 1.437, P = 0.216).  
 
Pairwise comparisons for between-visit analysis (see Figure 4.4 and Table 4.6) showed that 
for the intervention eye group, spectacle DVA did not change from baseline to the 6-month 
timepoint (P = 1.000), nor between the 6- and 12-month timepoints (P = 1.000), 12- and 18-
month timepoints (P = 1.000), 18- and 24-month timepoints (P = 1.000), 24- and 30-month 
timepoints (P = 0.102) and the 30- and 36-month timepoints (P = 1.000). 
 
Pairwise comparisons for between-visit analysis (see Figure 4.4 and Table 4.6) showed that 
for the control eye group, spectacle DVA did not change from baseline to the 6-month timepoint 
(P = 0.956), nor between the 6- and 12-month timepoints (P = 1.000), 12- and 18-month 
timepoints (P = 1.000), 18- and 24-month timepoints (P = 1.000), 24- and 30-month timepoints 
(P = 0.223) and the 30- and 36-month timepoints (P = 1.000). 
 
 




Figure 4.4 Change in spectacle DVA at 6 m (mean ± SEM) 
 
 
Timepoint (months) DVA (LogMAR) 
Baseline 0.05 ± 0.04 -0.09 ± 0.02 
6 0.06 ± 0.04 -0.07 ± 0.01 
12 0.03 ± 0.04 -0.09 ± 0.01 
18 0.03 ± 0.04 -0.10 ± 0.01 
24 0.03 ± 0.04 -0.11 ± 0.01 
30 0.07 ± 0.04 -0.09 ± 0.01 
36 0.08 ± 0.04 -0.06 ± 0.01 
 Intervention (n = 11) Control (n = 11) 
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4.5.2.3 CL DVA 
 
Main findings: 
• CL DVA was better for the control eye group than the intervention eye group (F (1, 10) = 
40.193, P < 0.0005) and improved over time (F (6, 60) = 4.441, P = 0.005) in both groups 
(F (6, 60) = 2.019, P = 0.110).  
 
Pairwise comparisons for between-visit analysis (see Figure 4.5 and Table 4.7) showed that 
for the intervention eye group, CL DVA did not change between the 6- and 12-month timepoints 
(P = 0.075), 12- and 18-month timepoints (P = 1.000), 18- and 24-month timepoints (P = 1.000) 
and the 24- and 30-month timepoints (P = 1.000). 
 
Pairwise comparisons for between-visit analysis (see Figure 4.5 and Table 4.7) showed that 
for the control eye group, CL DVA did not change between the 6- and 12-month timepoints (P 
= 1.000), 12- and 18-month timepoints (P = 1.000), 18- and 24-month timepoints (P = 1.000) 
and the 24- and 30-month timepoints (P = 1.000). 








Timepoint (months) DVA (LogMAR) 
6 0.24 ± 0.04 0.02 ± 0.02 
12 0.16 ± 0.03 0.00 ± 0.02 
18 0.17 ± 0.04 -0.03 ± 0.02 
24 0.16 ± 0.04 -0.03 ± 0.02 
30 0.19 ± 0.04 -0.04 ± 0.02 
 Intervention (n = 11) Control (n = 11) 
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4.5.2.4 Spectacle DVA versus CL DVA 
 
Main findings: 
• For the intervention eye group, DVA was better with spectacles than CLs (F (1, 10) = 
0.547, P < 0.0005) and changed over time (F (4, 40) = 4.306, P = 0.005) with both forms 
of correction (F (4, 40) = 2.045, P = 0.106) (see Figure 4.6 and Table 4.8) 
• For the control eye group, DVA was better with spectacles than CLs (F (1, 10) = 25.883, 
P < 0.0005) and changed over time (F (4, 40) = 3.811, P = 0.010) with both forms of 




Figure 4.6 Change in spectacle DVA versus CL DVA at 6 m for the intervention eye group 


































 Spectacles  Contact lenses
INTERVENTION PERIOD
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Timepoint (months) DVA (LogMAR) 
6 0.06 ± 0.04 0.24 ± 0.04 
12 0.03 ± 0.04 0.16 ± 0.03 
18 0.03 ± 0.04 0.17 ± 0.04 
24 0.03 ± 0.04 0.16 ± 0.04 
30 0.07 ± 0.04 0.19 ± 0.04 
 Spectacles (n = 11) CLs (n = 11) 
Table 4.8 Spectacle DVA versus CL DVA at 6 m for the intervention eye group (mean ± SEM). 




Figure 4.7 Change in spectacle DVA versus CL DVA at 6 m for the control eye group (mean 






























 Spectacles  Contact lenses
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Timepoint (months) DVA (LogMAR) 
6 -0.07 ± 0.01 0.02 ± 0.02 
12 -0.09 ± 0.01 0.00 ± 0.02 
18 -0.10 ± 0.01 -0.03 ± 0.02 
24 -0.11 ± 0.01 -0.03 ± 0.02 
30 -0.09 ± 0.01 -0.04 ± 0.02 
 Spectacles (n = 11) CLs (n = 11) 
Table 4.9 Spectacle DVA versus CL DVA at 6 m for the control eye group (mean ± SEM). 
Measures at the first timepoint taken at the first CL aftercare visit 
 
 
4.5.2.5 Spectacle NVA 
 
Main findings: 
• Spectacle NVA was better for the control eye group than the intervention eye group (F 
(1, 10) = 26.532, P < 0.0005) and improved over time (F (6, 60) = 9.838, P < 0.0005) in both 
groups (F (6, 60) = 1.643, P = 0.151).  
 
Pairwise comparisons for between-visit analysis (see Figure 4.8 and Table 4.10) showed that 
for the intervention eye group, spectacle NVA did not change from baseline to the 6-month 
timepoint (P = 1.000), nor between the 6- and 12-month timepoints (P = 1.000), 12- and 18-
month timepoints (P = 1.000), 18- and 24-month timepoints (P = 0.797), 24- and 30-month 
timepoints (P = 1.000) and the 30- and 36-month timepoints (P = 1.000). 
 
Pairwise comparisons for between-visit analysis (see Figure 4.8 and Table 4.10) showed that 
for the control eye group, spectacle NVA did not change from baseline to the 6-month timepoint 
(P = 1.000), nor between the 6- and 12-month timepoints (P = 1.000) or the 12- and 18-month 
timepoints (P = 1.000). Spectacle NVA improved between the 18- and 24-month timepoints (P 
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= 0.039) but did not change between the 24- and 30-month timepoints (P = 1.000) nor the 30- 





Figure 4.8 Change in spectacle NVA at 0.25 m (mean ± SEM) 
 
 
Timepoint (months) NVA (LogMAR) 
Baseline 0.28 ± 0.02 0.19 ± 0.02 
6 0.25 ± 0.02 0.18 ± 0.01 
12 0.27 ± 0.02 0.16 ± 0.02 
18 0.25 ± 0.02 0.17 ± 0.01 
24 0.21 ± 0.02 0.11 ± 0.02 
30 0.22 ± 0.02 0.11 ± 0.02 
36 0.22 ± 0.02 0.13 ± 0.02 
 Intervention (n = 11) Control (n = 11) 
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4.5.2.6 CL NVA 
 
Main findings: 
• CL NVA was better for the control eye group than the intervention eye group (F (1, 10) = 
45.000, P < 0.0005) and improved over time (F (6, 60) = 6.378, P < 0.0005) in both groups 
(F (6, 60) = 1.034, P = 0.401).  
 
Pairwise comparisons for between-visit analysis (see Figure 4.9 and Table 4.11) showed that 
for the intervention eye group, CL NVA did not change between the 6- and 12-month timepoints 
(P = 0.959), 12- and 18-month timepoints (P = 1.000), 18- and 24-month timepoints (P = 1.000) 
and the 24- and 30-month timepoints (P = 1.000). 
 
Pairwise comparisons for between-visit analysis (see Figure 4.9 and Table 4.11) showed that 
for the control eye group, CL NVA did not change between the 6- and 12-month timepoints (P 
= 1.000), 12- and 18-month timepoints (P = 1.000), 18- and 24-month timepoints (P = 0.816) 
and the 24- and 30-month timepoints (P = 1.000). 
 
 








Timepoint (months) NVA (LogMAR) 
6 0.30 ± 0.02 0.22 ± 0.01 
12 0.25 ± 0.02 0.20 ± 0.00 
18 0.24 ± 0.02 0.19 ± 0.01 
24 0.24 ± 0.02 0.16 ± 0.02 
30 0.22 ± 0.01 0.17 ± 0.01 
 Intervention (n = 11) Control (n = 11) 
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4.5.2.7 Spectacle NVA versus CL NVA 
 
Main findings: 
• For the intervention eye group, NVA was similar with spectacles and CLs (F (1, 10) = 
0.558, P = 0.472) and improved over time (F (4, 40) = 5.523, P = 0.001) with CL correction 
only (F (4, 40) = 3.320, P = 0.019) (see Figure 4.10 and Table 4.12) 
• For the control eye group, NVA was better with spectacles than CLs (F (1, 10) = 17.872, 
P = 0.002) and improved over time (F (4, 40) = 9.744, P < 0.0005) with both forms of 





Figure 4.10 Change in spectacle NVA versus CL NVA at 0.25 m for the intervention eye group 
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Timepoint (months) NVA (LogMAR) 
6 0.25 ± 0.02 0.30 ± 0.02 
12 0.27 ± 0.02 0.25 ± 0.02 
18 0.25 ± 0.02 0.24 ± 0.02 
24 0.21 ± 0.02 0.24 ± 0.02 
30 0.22 ± 0.02 0.22 ± 0.01 
 Spectacles (n = 11) CLs (n = 11) 
Table 4.12 Spectacle NVA versus CL NVA at 0.25 m for the intervention eye group (mean ± 





Figure 4.11 Change in spectacle NVA versus CL NVA at 0.25 m for the control eye group 
































 Spectacles  Contact lenses
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Timepoint (months) NVA (LogMAR) 
6 0.18 ± 0.01 0.22 ± 0.01 
12 0.16 ± 0.02 0.20 ± 0.00 
18 0.17 ± 0.01 0.19 ± 0.01 
24 0.11 ± 0.02 0.16 ± 0.02 
30 0.11 ± 0.02 0.17 ± 0.01 
 Spectacles (n = 11) CLs (n = 11) 
Table 4.13 Spectacle NVA versus CL NVA at 0.25 m for the control eye group (mean ± SEM). 
Measures at the initial timepoint taken at the first CL aftercare visit 
 
 
4.5.2.8 Stereoacuity with spectacle correction 
 
Main findings: 
• Stereoacuity did not change over time (F (6, 54) = 1.070, P = 0.392). 
 
Pairwise comparisons for between-visit analysis (see Figure 4.12 and Table 4.14) showed that 
stereoacuity did not change from baseline to the 6-month timepoint (P = 1.000), nor between 
the 6- and 12-month timepoints (P = 1.000), 12- and 18-month timepoints (P = 1.000), 18- and 
24-month timepoints (P = 1.000), 24- and 30-month timepoints (P = 1.000) and the 30- and 
36-month timepoints (P = 1.000). 
 
 




Figure 4.12 Change in stereoacuity with spectacle correction (mean ± SEM). Excludes 1 
participant who was unable to complete the grading plates 
 
 
Timepoint (months) Stereoacuity (arcsec) 
Baseline 78.00 ± 9.17 
6 84.00 ± 9.80 
12 90.00 ± 10.00 
18 72.00 ± 8.00 
24 78.00 ± 9.17 
30 72.00 ± 8.00 
36 90.00 ± 10.00 
 (n = 10) 
Table 4.14 Stereoacuity at each visit (mean ± SEM). Intervention period shaded red. Excludes 
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4.5.2.9 Stereoacuity: spectacle correction versus CL correction 
 
Main findings: 
• Stereoacuity was similar with spectacles and CLs (F (1, 9) = 4.338, P = 0.067) and did 
not change over time (F (1, 9) = 3.524, P = 0.093) with either form of correction (F (1, 9) = 
3.128, P = 0.111). 
 
Pairwise comparisons for between-visit analysis (see Table 4.15) showed that with spectacle 
correction, stereoacuity was similar at the 12- and 24-month timepoints (P = 0.168). 
 
Pairwise comparisons for between-visit analysis (see Table 4.15) showed that with CL 
correction, stereoacuity was similar at the 12- and 24-month timepoints (P = 0.095). 
 
Timepoint (months) Stereoacuity (arcsec) 
12 90.00 ± 10.00 168.00 ± 39.80 
24 78.00 ± 9.17 114.00 ± 16.61 
 Spectacles (n = 10) CLs (n = 10) 
Table 4.15 Stereoacuity with spectacle correction versus CL correction (mean ± SEM). 
Intervention period shaded red. Excludes participants that were unable to complete the grading 
plates 
 
4.5.2.10 Cover test with spectacle correction 
A summary of binocular status with spectacle correction at distance and near for the 
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 Cover test 
Participant Distance at 6 m Near at 0.25 m 
1 Orthophoria Orthophoria 
2 Orthophoria Orthophoria 
3 Orthophoria Small exophoria 
4 Orthophoria Orthophoria 
5 Orthophoria Orthophoria 
6 Orthophoria Orthophoria 
7 Orthophoria Orthophoria 
8 Orthophoria Orthophoria 
9 Orthophoria Orthophoria 
10 Orthophoria Orthophoria 
11 Orthophoria Orthophoria 
Table 4.16 Cover test with spectacle correction at distance and near for the intervention group 
 
 
4.5.2.11 CS with spectacle correction 
 
Main findings: 
• CS with spectacle correction was better in the control eye group than the intervention 
eye group (F (1, 10) = 9.146, P = 0.013) and did not change over time (F (2, 20) = 0.510, P 
= 0.608) in either group (F (2, 20) = 0.377, P = 0.690).  
 
Pairwise comparisons for between-visit analysis (see Figure 4.13 and Table 4.17) showed that 
for the intervention eye group, CS with spectacle correction did not change between the 6- and 
30-month timepoints (P = 1.000), nor between the 30- and 36-month timepoints (P = 1.000). 
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Pairwise comparisons for between-visit analysis (see Figure 4.13 and Table 4.17) showed that 
for the control eye group, CS with spectacle correction did not change between the 6- and 30-
month timepoints (P = 0.501), nor between the 30- and 36-month timepoints (P = 1.000). 
 
 
Figure 4.13 Change in CS with spectacle correction at 1 m (mean ± SEM) 
 
 
Timepoint (months) Log CS (CPD) 
6 1.51 ± 0.02 1.58 ± 0.02 
30 1.54 ± 0.03 1.61 ± 0.02 
36 1.53 ± 0.04 1.62 ± 0.03 
 Intervention (n = 11) Control (n = 11) 
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4.5.2.12 CS with CL correction 
 
Main findings: 
• CS with CL correction was better for the control eye group than the intervention eye 
group (F (1, 10) = 5.213, P = 0.046) and did not change over time (F (1, 10) = 0.290, P = 
0.602) in either group (F (1, 10) = 3.378, P = 0.096).  
 
Pairwise comparisons for between-visit analysis (see Table 4.18) showed that for the 
intervention eye group, CS with CL correction did not change between the 6- and 30-month 
timepoints (P = 0.796). 
 
Pairwise comparisons for between-visit analysis (see Table 4.18) showed that for the control 
eye group, CS with CL correction did not change between the 6- and 30-month timepoints (P 
= 0.104). 
 
Timepoint (months) Log CS (CPD) 
6 1.53 ± 0.02 1.54 ± 0.02 
30 1.51 ± 0.03 1.60 ± 0.02 
 Intervention (n = 11) Control (n = 11) 
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4.5.2.13 CS: spectacle correction versus CL correction 
 
Main findings: 
• For the intervention eye group, mean CS was similar with spectacle correction and CL 
correction (F (1, 10) = 0.102, P = 0.756) and did not change over time (F (1, 10) = 0.036, P 
= 0.852) with either form of correction (F (1, 10) = 0.506, P = 0.493) (see Table 4.19) 
• For the control eye group, mean CS was similar with spectacle correction and CL 
correction (F (1, 10) = 2.222, P = 0.167) and did not change over time (F (1, 10) = 3.750, P 
= 0.082) with either form of correction (F (1, 10) = 1.000, P = 0.341) (see Table 4.20). 
 
 
Timepoint (months) Log CS (CPD) 
6 1.51 ± 0.02 1.53 ± 0.03 
30 1.54 ± 0.03 1.51 ± 0.03 
 Spectacles (n = 11) CLs (n = 11) 
Table 4.19 CS with spectacle correction versus CL correction at 1 m for the intervention eye 
group (mean ± SEM). Intervention period shaded red. Measures at the initial timepoint taken 
at the first CL aftercare visit 
 
 
Timepoint (months) Log CS (CPD) 
6 1.58 ± 0.02 1.54 ± 0.02 
30 1.61 ± 0.02 1.60 ± 0.02 
 Spectacles (n = 11) CLs (n = 11) 
Table 4.20 CS with spectacle correction versus CL correction at 1 m for the control eye group 
(mean ± SEM). Intervention period shaded red. Measures at the initial timepoint taken at the 











• CC was similar for the intervention eye group and control eye group (F (1, 10) = 0.143, P 
= 0.713) and did not change over time (F (6, 60) = 1.704, P = 0.136) in either group (F (6, 
120) = 0.767, P = 0.599).  
 
Pairwise comparisons for between-visit analysis (see Figure 4.14 and Table 4.21) showed that 
for the intervention eye group, CC did not change from baseline to the 6-month timepoint (P = 
1.000), nor between the 6- and 12-month timepoints (P = 1.000), 12- and 18-month timepoints 
(P = 0.222), 18- and 24-month timepoints (P = 1.000), 24- and 30-month timepoints (P = 1.000) 
and the 30- and 36-month timepoints (P = 1.000). 
 
Pairwise comparisons for between-visit analysis (see Figure 4.14 and Table 4.21) showed that 
for the control eye group, CC did not change from baseline to the 6-month timepoint (P = 
0.950), nor between the 6- and 12-month timepoints (P = 1.000), 12- and 18-month timepoints 
(P = 1.000), 18- and 24-month timepoints (P = 1.000), 24- and 30-month timepoints (P = 1.000) 
and the 30- and 36-month timepoints (P = 1.000). 
 




Figure 4.14 Change in CC (mean ± SEM) 
 
 
Timepoint (months) CC (mm) 
Baseline 7.78 ± 0.10 7.76 ± 0.09 
6 7.79 ± 0.09 7.79 ± 0.09 
12 7.79 ± 0.10 7.79 ± 0.09 
18 7.82 ± 0.09 7.79 ± 0.08 
24 7.81 ± 0.10 7.81 ± 0.09 
30 7.79 ± 0.10 7.80 ± 0.08 
36 7.79 ± 0.09 7.78 ± 0.09 
 Intervention (n = 11) Control (n = 11) 








































• ACD was greater for the control eye group than intervention eye group (F (1, 10) = 8.401, 
P = 0.016) and did not change over time (F (4, 40) = 1.436, P = 0.240) in either group (F 
(4, 40) = 0.487, P = 0.745).  
 
Pairwise comparisons for between-visit analysis (see Figure 4.15 and Table 4.22) showed that 
for the intervention eye group, ACD did not change from baseline to the 6-month timepoint (P 
= 0.212), nor between the 6- and 18-month timepoints (P = 0.066), 18- and 30-month 
timepoints (P = 1.000) and the 30- and 36-month timepoints (P = 1.000). 
 
Pairwise comparisons for between-visit analysis (see Figure 4.15 and Table 4.22) showed that 
for the control eye group, ACD did not change from baseline to the 6-month timepoint (P = 
0.063), nor between the 6- and 18-month timepoints (P = 1.000), 18- and 30-month timepoints 
(P = 1.000) and the 30- and 36-month timepoints (P = 1.000). 
 




Figure 4.15 Change in ACD (mean ± SEM) 
 
 
Timepoint (months) ACD (mm) 
Baseline 3.33 ± 0.09 3.45 ± 0.08 
6 3.35 ± 0.09 3.48 ± 0.08 
18 3.37 ± 0.09 3.49 ± 0.08 
30 3.36 ± 0.09 3.48 ± 0.08 
36 3.37 ± 0.09 3.47 ± 0.08 
 Intervention (n = 11) Control (n = 11) 
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4.5.2.16 Pupil size 
 
Main findings: 
• Pupil size was similar for the intervention eye group and control eye group (F (1, 10) = 
1.432, P = 0.259)  
• Pupil size was smaller in photopic conditions than in mesopic conditions (F (1, 10) = 
55.694, P < 0.0005) in both groups (F (1, 10) = 0.226, P = 0.645) (see Figure 4.16 and 
Table 4.23).  
 
 
Figure 4.16 Pupil size in photopic and mesopic conditions for the intervention eye group and 































I.G.Beasley, PhD Thesis, Aston University 2021 
 
183 
 Pupil size (mm) 







12 6.31 ± 0.21 6.45 ± 0.26 7.01 ± 0.20 7.12 ± 0.21 
Table 4.23 Pupil size in photopic and mesopic conditions for the intervention eye group and 
control eye group with CL in situ (mean ± SEM) 
 
 
4.5.2.17 Amplitude of accommodation 
 
Main findings: 
• Amplitude of accommodation was similar for the intervention eye and control eye 
groups (F (1, 10) = 3.778, P = 0.081) and did not change over time (F (6, 60) = 0.404, P = 
0.873) in either group (F (6, 60) = 2.157, P = 0.060).  
 
Pairwise comparisons for between-visit analysis (see Figure 4.17 and Table 4.24) showed that 
for the intervention eye group, amplitude of accommodation did not change from baseline to 
the 6-month timepoint (P = 1.000), nor between the 6- and 12-month timepoints (P = 1.000), 
12- and 18-month timepoints (P = 1.000), 18- and 24-month timepoints (P = 1.000), 24- and 
30-month timepoints (P = 1.000) and the 30- and 36-month timepoints (P = 1.000). 
 
Pairwise comparisons for between-visit analysis (see Figure 4.17 and Table 4.24) showed that 
for the control eye group, amplitude of accommodation did not change from baseline to the 6-
month timepoint (P = 1.000), nor between the 6- and 12-month timepoints (P = 1.000), 12- and 
18-month timepoints (P = 1.000), 18- and 24-month timepoints (P = 1.000), 24- and 30-month 
timepoints (P = 1.000) and the 30- and 36-month timepoints (P = 1.000). 
 




Figure 4.17 Change in amplitude of accommodation (mean ± SEM) 
 
 
Timepoint (months) Amplitude of accommodation (D) 
Baseline 11.01 ± 0.48 11.33 ± 0.38 
6 10.94 ± 0.37 11.11 ± 0.37 
12 10.74 ± 0.40 11.54 ± 0.26 
18 11.31 ± 0.50 11.30 ± 0.29 
24 10.95 ± 0.46 11.54 ± 0.38 
30 11.02 ± 0.37 11.18 ± 0.31 
36 10.79 ± 0.40 11.62 ± 0.29 
 Intervention (n = 11) Control (n = 11) 
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4.5.2.18 Lag of accommodation with spectacle correction 
 
Main findings: 
• Lag of accommodation with spectacle correction did not change over time (F (6, 60) = 
2.222, P = 0.053). 
 
Pairwise comparisons for between-visit analysis (see Figure 4.18 and Table 4.25) showed that 
lag of accommodation with spectacle correction did not change from baseline to the 6-month 
timepoint (P = 1.000), nor between the 6- and 12-month timepoints (P = 1.000), 12- and 18-
month timepoints (P = 1.000), 18- and 24-month timepoints (P = 1.000), 24- and 30-month 
timepoints (P = 1.000) and the 30- and 36-month timepoints (P = 1.000). 
 
 
Figure 4.18 Change in accommodative lag with spectacle correction for a target at 0.33 m 
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Timepoint (months) Accommodative lag (D) 
Baseline 0.78 ± 0.10 
6 0.93 ± 0.06 
12 1.04 ± 0.12 
18 0.93 ± 0.12 
24 1.00 ± 0.10 
30 1.10 ± 0.08 
36 1.16 ± 0.12 
 Intervention (n = 11) 
Table 4.25 Accommodative lag with spectacle correction for a target at 0.33 m (mean ± SEM). 
Intervention period shaded red 
 
 
4.5.2.19 Lag of accommodation: spectacle correction versus CL correction 
 
Main findings: 
• Lag of accommodation was less with spectacle correction than CL correction (F (1, 10) = 
20.845, P = 0.001) and did not change over time (F (1, 10) = 0.816, P = 0.388) with either 
form of correction (F (1, 10) = 0.096, P = 0.763). 
 
Pairwise comparisons for between-visit analysis (see Table 4.26) showed that with spectacle 
correction, lag of accommodation was similar at the 12- and 24-month timepoints (P = 0.741). 
 
Pairwise comparisons for between-visit analysis (see Table 4.26) showed that with CL 









Timepoint (months) Accommodative lag (D) 
12 1.04 ± 0.12 1.70 ± 0.09 
24 1.00 ± 0.10 1.60 ± 0.11 
 Spectacles (n = 11) CLs (n = 11) 
Table 4.26 Accommodative lag with spectacle correction versus CL correction for a target at 
0.33 m (mean ± SEM). Intervention period shaded red 
 
 
4.5.2.20 Central CL power 
 
Main findings: 
• Central CL power reduced over time (F (4, 40) = 18.408, P < 0.0005) for the intervention 
eye group only (F (4, 40) = 3.866, P = 0.010). 
 
Pairwise comparisons for between-visit analysis (see Figure 4.19 and Table 4.27) showed that 
for the intervention eye group, central CL power did not change between the 6- and 12-month 
timepoints (P = 0.119) but decreased between the 12- and 18-month timepoints (P = 0.019) 
and the 18- and 24-month timepoints (P = 0.039) but not between the 24- and 30-month 
timepoints (P = 1.000). 
 
Pairwise comparisons for between-visit analysis (see Figure 4.19 and Table 4.27) showed that 
for the control eye group, central CL power did not change between the 6- and 12-month 
timepoints (P = 0.531), nor between the 12- and 18-month timepoints (P = 0.251), the 18- and 
24-month timepoints (P = 0.379) and the 24- and 30-month timepoints (P = 1.000). 
 








Timepoint (months) Central CL power (D) 
6 3.59 ± 0.42 2.00 ± 0.39 
12 3.41 ± 0.44 1.89 ± 0.41 
18 3.25 ± 0.46 1.75 ± 0.43 
24 3.07 ± 0.43 1.66 ± 0.43 
30 3.14 ± 0.47 1.68 ± 0.45 
 Intervention (n = 11) Control (n = 11) 
Table 4.27 Central CL power (mean ± SEM) 
 
4.5.2.21 CL WT 
 
Main findings: 
• CL WT changed over time (F (4, 40) = 4.476, P = 0.004), increasing over the first 6 months 

































 Intervention eye  Control eye




Pairwise comparisons for between-visit analysis (see Figure 4.20 and Table 4.28) showed that 
mean weekly CL WT increased between the 6- and 12-month timepoints (P = 0.009), but not 
between the 12- and 18-month timepoints (P = 1.000), 18- and 24-month timepoints (P = 




Figure 4.20 Change in typical weekly CL WT (mean ± SEM). 
 
 
Timepoint (months) Weekly CL WT (hours) 
6 59.64 ± 1.98 
12 69.91 ± 3.18 
18 69.82 ± 3.26 
24 71.82 ± 3.57 
30 71.45 ± 2.67 
Table 4.28 Typical weekly CL WT (mean ± SEM). Measures at the initial timepoint taken at 
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4.5.2.22 Peripheral refraction MSE 
 
Main findings: 
• MSE peripheral refraction was relatively myopic in the temporal, nasal, superior, and 
inferior quadrants in the intervention eye and control eye groups (see Table 4.29 and 
Table 4.30)  
• Absolute values for central and peripheral refraction in all four quadrants are detailed 
in Figures 4.21 to 4.24. 
 
 
 Relative peripheral refraction (D) 
Timepoint (months) Temporal 30° Nasal 30° Superior 20° Inferior 20° 
Baseline -2.40 ± 0.46 -0.55 ± 0.48 -0.43 ± 0.27 -0.71 ± 0.13 
6 -2.68 ± 0.54 -1.12 ± 0.44 -0.45 ± 0.32 -0.26 ± 0.27 
18 -2.24 ± 0.64 -1.11 ± 0.52 -0.86 ± 0.45 -0.16 ± 0.34 
30 -2.15 ± 0.70 -2.18 ± 0.81 -0.66 ± 0.40 -0.62 ± 0.17 
36 -2.18 ± 0.76 -1.47 ± 0.66 -0.54 ± 0.41 -0.86 ± 0.12 
Table 4.29 MSE post-cycloplegic relative peripheral refractive error at each visit for the 
intervention eye group (mean ± SEM). Intervention period shaded red 
 
 
 Relative peripheral refraction (D) 
Timepoint (months) Temporal 30° Nasal 30° Superior 20° Inferior 20° 
Baseline -1.45 ± 0.30 -0.39 ± 0.26 -0.36 ± 0.26 -0.21 ± 0.17 
6 -1.81 ± 0.51 -0.69 ± 0.41 -0.41 ± 0.25 -0.05 ± 0.21 
18 -1.27 ± 0.70 -0.96 ± 0.43 -0.52 ± 0.37 -0.36 ± 0.35 
30 -1.27 ± 0.51 -0.98 ± 0.60 -0.56 ± 0.33 -0.60 ± 0.35 
36 -1.50 ± 0.53 -0.94 ± 0.45 -0.60 ± 0.29 -0.52 ± 0.41 
Table 4.30 MSE post-cycloplegic relative peripheral refractive error at each visit for the control 
eye group (mean ± SEM) 




Figure 4.21 Absolute MSE post-cycloplegic central refraction compared to peripheral 





Figure 4.22 Absolute MSE post-cycloplegic central refraction compared to peripheral 






























































 Intervention eye - central  Control eye - central  Intervention eye - nasal  Control eye - nasal
INTERVENTION PERIOD




Figure 4.23 Absolute MSE post-cycloplegic central refraction compared to peripheral 




Figure 4.24 Absolute MSE post-cycloplegic central refraction compared to peripheral 



























































 Intervention eye - central  Control eye - central  Intervention  eye - inferior  Control eye - inferior
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For the intervention eye group, relative MSE peripheral refraction varied by location (F (3, 30) = 
6.179, P = 0.002) (See Figure 4.25). The temporal quadrant demonstrated a similar degree of 
relative myopia compared to the nasal (P = 0.186) and superior (P = 0.110) quadrants, 
respectively but was relatively more myopic than the inferior quadrant (P = 0.033). Relative 
MSE peripheral myopia in the nasal quadrant was similar to the superior (P = 1.000) and 
inferior (P = 0.822) quadrants; this was also the case when comparing the superior quadrant 
to the inferior quadrant (P = 1.000). 
 
 
Figure 4.25 MSE post-cycloplegic relative peripheral refractive error at each visit for the 
intervention eye group (mean ± SEM) 
 
For the control eye group, relative peripheral MSE refraction did not vary by location (F (3, 30) = 
2.744, [Greenhouse-Geisser P = 0.104, Epsilon 0.613]) (See Figure 4.26). Relative peripheral 
MSE myopia in the temporal quadrant was similar to the nasal (P = 1.000), superior (P = 
0.646), and inferior (P = 0.466) quadrants, respectively; this was also the case when comparing 
the nasal quadrant to the superior (P = 1.000) and the inferior quadrants (P = 1.000). The 












































 Intervention eye - temporal  Intervention eye - nasal  Intervention eye - superior  Intervention eye - inferior
INTERVENTION PERIOD




Figure 4.26 MSE post-cycloplegic relative peripheral refractive error at each visit for the control 
eye group (mean ± SEM) 
 
Relative peripheral MSE refraction in the temporal quadrant was more myopic for the 
intervention eye group than the control eye group (F (1, 10) = 11.139, P = 0.008) and did not 
change over time (F (4, 40) = 0.825, P = 0.517) in either group (F (4, 40) = 0.087, P = 0.986).  
 
Pairwise comparisons for between-visit analysis (see Figures 4.21 and 4.25, and Table 4.29) 
showed that for the intervention eye group, relative peripheral MSE refraction in the temporal 
quadrant did not change from baseline to the 6-month timepoint (P = 1.000), nor between the 
6- and 18-month timepoints (P = 1.000), 18- and 30-month timepoints (P = 1.000) and the 30- 
and 36-month timepoints (P = 1.000).  
 
Pairwise comparisons for between-visit analysis (see Figures 4.21 and 4.26, and Table 4.30) 
showed that for the control eye group, relative peripheral MSE refraction in the temporal 
quadrant did not change from baseline to the 6-month timepoint (P = 1.000), nor between the 
6- and 18-month timepoints (P = 1.000), 18- and 30-month timepoints (P = 1.000) and the 30- 







































 Control eye - temporal  Control eye - nasal  Control eye - superior  Control eye - inferior
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Relative peripheral MSE refraction in the nasal quadrant was similar for the intervention eye 
and control eye groups (F (1, 10) = 2.463, P = 0.148) and did not change over time (F (4, 40) = 
2.522, P = 0.056) in either group (F (4, 40) = 1.197, P = 0.327).  
 
Pairwise comparisons for between-visit analysis (see Figures 4.22 and 4.25, and Table 4.29) 
showed that for the intervention eye group, relative peripheral MSE refraction in the nasal 
quadrant did not change from baseline to the 6-month timepoint (P = 0.488), nor between the 
6- and 18-month timepoints (P = 0.511), 18- and 30-month timepoints (P = 0.651) and the 30- 
and 36-month timepoints (P = 0.696).  
 
Pairwise comparisons for between-visit analysis (see Figures 4.22 and 4.26, and Table 4.30) 
showed that for the control eye group, relative peripheral MSE refraction in the nasal quadrant 
did not change from baseline to the 6-month timepoint (P = 1.000), nor between the 6- and 18-
month timepoints (P = 1.000), 18- and 30-month timepoints (P = 1.000) and the 30- and 36-
month timepoints (P = 1.000). 
 
Relative peripheral MSE refraction in the superior quadrant was similar for the intervention eye 
and control eye groups (F (1, 10) = 0.550, P = 0.476) and did not change over time (F (4, 40) = 
0.632, P = 0.642) in either group (F (4, 40) = 0.844 P = 0.506).  
 
Pairwise comparisons for between-visit analysis (see Figures 4.23 and 4.25, and Table 4.29) 
showed that for the intervention eye group, relative peripheral MSE refraction in the superior 
quadrant did not change from baseline to the 6-month timepoint (P = 1.000), nor between the 
6- and 18-month timepoints (P = 1.000), 18- and 30-month timepoints (P = 1.000) and the 30- 
and 36-month timepoints (P = 1.000).  
 
Pairwise comparisons for between-visit analysis (see Figures 4.23 and 4.26, and Table 4.30) 
showed that for the control eye group, relative peripheral MSE refraction in the superior 
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quadrant did not change from baseline to the 6-month timepoint (P = 1.000), nor between the 
6- and 18-month timepoints (P = 1.000), 18- and 30-month timepoints (P = 1.000) and the 30- 
and 36-month timepoints (P = 1.000). 
 
Relative peripheral MSE refraction in the inferior quadrant was similar for the intervention eye 
and control eye groups (F (1, 10) = 0.666, P = 0.433) and did not change over time (F (4, 40) = 
1.434, P = 0.240) in either group (F (4, 40) = 1.125 P = 0.359).  
 
Pairwise comparisons for between-visit analysis (see Figures 4.23 and 4.25, and Table 4.29) 
showed that for the intervention eye group, relative peripheral MSE refraction in the inferior 
quadrant did not change from baseline to the 6-month timepoint (P = 0.877), nor between the 
6- and 18-month timepoints (P = 1.000), 18- and 30-month timepoints (P = 1.000) and the 30- 
and 36-month timepoints (P = 1.000).  
 
Pairwise comparisons for between-visit analysis (see Figures 4.24 and 4.26, and Table 4.30) 
showed that for the control eye group, relative peripheral MSE refraction in the inferior 
quadrant did not change from baseline to the 6-month timepoint (P = 1.000), nor between the 
6- and 18-month timepoints (P = 1.000), 18- and 30-month timepoints (P = 1.000) and the 30- 








4.5.2.23 Peripheral refraction (J0) 
 




• For the intervention eye group, J0 peripheral refraction varied by location (F (3, 30) = 
10.933, [Greenhouse-Geisser P = 0.002, Epsilon 0.618]) (See Figure 4.27). The 
temporal quadrant was similar to the nasal quadrant (P = 0.148) but relatively more 
myopic than the superior (P = 0.005), and inferior (P = 0.014) quadrants, respectively. 
The nasal quadrant was similar to the superior (P = 0.206) and inferior (P = 0.392) 
quadrants, respectively. The superior and inferior quadrants were also similar to each 
other (P = 0.859). 
• For the control eye group, mean J0 peripheral refraction varied by location (F (3, 30) = 
14.319, [Greenhouse-Geisser P < 0.0005, Epsilon 0.711]) (See Figure 4.28). The 
temporal quadrant was similar to the nasal quadrant (P = 0.129) but relatively more 
myopic than both the superior (P = 0.005), and inferior (P = 0.008) quadrants. The 
nasal quadrant was similar to the superior (P = 0.069) and inferior (P = 0.130) 
quadrants, respectively. The superior and inferior quadrants were also similar to each 
other (P = 0.598). 
 
J0 peripheral refraction in the temporal quadrant was similar for the intervention eye and 
control eye groups, respectively (F (1, 10) = 0.394, P = 0.544) and did not change over time (F 
(4, 40) = 0.976, P = 0.431) in either group (F (4, 40) = 0.123, P = 0.974).  
 
Pairwise comparisons for between-visit analysis (see Figure 4.27 and Table 4.31) showed that 
for the intervention eye group, measures in the temporal quadrant did not change from 
baseline to the 6-month timepoint (P = 1.000), nor between the 6- and 18-month timepoints (P 
= 1.000), 18- and 30-month timepoints (P = 1.000) and the 30- and 36-month timepoints (P = 
1.000).  
 
Pairwise comparisons for between-visit analysis (see Figure 4.28 and Table 4.32) showed that 
for the control eye group, measures in the temporal quadrant did not change from baseline to 
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the 6-month timepoint (P = 1.000), nor between the 6- and 18-month timepoints (P = 1.000), 
18- and 30-month timepoints (P = 1.000) and the 30- and 36-month timepoints (P = 1.000). 
 
J0 peripheral refraction in the nasal quadrant was similar for the intervention eye and control 
eye groups, respectively (F (1, 10) = 1.254, P = 0.289) and changed over time (F (4, 40) = 3.355, 
P = 0.018) in both groups (F (4, 40) = 1.167, P = 0.340).  
 
Pairwise comparisons for between-visit analysis (see Figure 4.27 and Table 4.31) showed that 
for the intervention eye group, measures in the nasal quadrant did not change from baseline 
to the 6-month timepoint (P = 1.000), nor between the 6- and 18-month timepoints (P = 1.000), 
18- and 30-month timepoints (P = 0.116) and the 30- and 36-month timepoints (P = 0.897).  
 
Pairwise comparisons for between-visit analysis (see Figure 4.28 and Table 4.32) showed that 
for the control eye group, measures in the nasal quadrant did not change from baseline to the 
6-month timepoint (P = 1.000), nor between the 6- and 18-month timepoints (P = 1.000), 18- 
and 30-month timepoints (P = 1.000), and the 30- and 36-month timepoints (P = 1.000). 
 
J0 peripheral refraction in the superior quadrant was similar for the intervention eye and control 
eye groups, respectively (F (1, 10) = 4.51, P = 0.060) and changed over time (F (4, 40) = 3.216, P 
= 0.022) in both groups (F (4, 40) = 0.440, P = 0.779).  
 
Pairwise comparisons for between-visit analysis (see Figure 4.27 and Table 4.31) showed that 
for the intervention eye group, measures in the superior quadrant did not change from baseline 
to the 6-month timepoint (P = 1.000), nor between the 6- and 18-month timepoints (P = 1.000), 
18- and 30-month timepoints (P = 1.000) and the 30- and 36-month timepoints (P = 1.000).  
 
Pairwise comparisons for between-visit analysis (see Figure 4.28 and Table 4.32) showed that 
for the control eye group, measures in the superior quadrant did not change from baseline to 
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the 6-month timepoint (P = 1.000), nor between the 6- and 18-month timepoints (P = 1.000).  
There was a change between the 18- and 30-month timepoints (P = 0.032) but not between 
the 30- and 36-month timepoints (P = 1.000). 
 
J0 peripheral refraction in the inferior quadrant was similar for the intervention eye and control 
eye groups, respectively (F (1, 10) = 2.285, P = 0.162) and did not change over time (F (4, 40) = 
0.644, P = 0.634) in either group (F (4, 40) = 0.536 P = 0.710).  
 
Pairwise comparisons for between-visit analysis (see Figure 4.27 and Table 4.31) showed that 
for the intervention eye group, measures in the inferior quadrant did not change from baseline 
to the 6-month timepoint (P = 1.000), nor between the 6- and 18-month timepoints (P = 1.000), 
18- and 30-month timepoints (P = 1.000) and the 30- and 36-month timepoints (P = 1.000).  
 
Pairwise comparisons for between-visit analysis (see Figure 4.28 and Table 4.32) showed that 
for the control eye group, relative peripheral refraction in the inferior quadrant did not change 
from baseline to the 6-month timepoint (P = 1.000), nor between the 6- and 18-month 
timepoints (P = 1.000), 18- and 30-month timepoints (P = 1.000) and the 30- and 36-month 








 Peripheral refraction (D) 
Timepoint (months) Temporal 30° Nasal 30° Superior 20° Inferior 20° 
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Baseline -1.48 ± 0.31 -0.29 ± 0.20 0.32 ± 0.12 0.24 ± 0.19 
6 -1.79 ± 0.29 -0.38 ± 0.31 0.37 ± 0.18 0.27 ± 0.14 
18 -1.59 ± 0.37 -0.61 ± 0.37 0.40 ± 0.23 -0.08 ± 0.27 
30 -1.24 ± 0.46 -1.39 ± 0.55 0.16 ± 0.16 -0.05 ± 0.32 
36 -1.19 ± 0.48 -0.98 ± 0.48 0.13 ± 0.14 0.20 ± 0.20 
Table 4.31 J0 post-cycloplegic peripheral refractive error at each visit for the intervention eye 
group (mean ± SEM). Intervention period shaded red 
 
 
 Peripheral refraction (D) 
Timepoint (months) Temporal 30° Nasal 30° Superior 20° Inferior 20° 
Baseline -1.47 ± 0.22 -0.15 ± 0.14 0.43 ± 0.12 0.36 ± 0.11 
6 -1.60 ± 0.42 -0.41 ± 0.30 0.67 ± 0.16 0.36 ± 0.18 
18 -1.31 ± 0.59 -0.58 ± 0.34 0.63 ± 0.10 0.35 ± 0.09 
30 -1.20 ± 0.45 -0.71 ± 0.40 0.33 ± 0.11 0.22 ± 0.15 
36 -1.20 ± 0.51 -0.69 ± 0.35 0.22 ± 0.09 0.28 ± 0.15 
Table 4.32 J0 post-cycloplegic peripheral refractive error at each visit for the control eye group 
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Figure 4.27 J0 post-cycloplegic peripheral refractive error at each visit for the intervention eye 




Figure 4.28 J0 post-cycloplegic peripheral refractive error at each visit for the control eye 





4.5.2.24 Peripheral refraction (J45) 
 
Main findings: 
• For the intervention eye group, J45 peripheral refraction for the intervention eye group 
was similar in all locations (F (3, 30) = 0.612, P = 0.613) (See Figure 4.29). The temporal 
quadrant was similar to the nasal (P = 1.000), superior (P = 1.00), and inferior (P = 
1.000) quadrants, respectively. The nasal quadrant was similar to the superior (P = 
1.000) and inferior (P = 1.000) quadrants, respectively. The superior quadrant was also 
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• For the control eye group, J45 peripheral refraction was similar in all locations (F (3, 30) 
= 0.905, P = 0.450) (See Figure 4.30). The temporal quadrant was similar to the nasal 
(P = 1.000), superior (P = 1.00), and inferior (P = 1.000) quadrants, respectively. The 
nasal quadrant was similar to the superior (P = 1.000) and inferior (P = 1.000) 
quadrants, respectively. The superior quadrant was also similar to the superior 
quadrant (P = 1.000). 
 
J45 peripheral refraction in the temporal quadrant was similar for the intervention eye and 
control eye groups (F (1, 10) = 0.319, P = 0.585) and did not change over time (F (4, 40) = 1.320, 
P = 0.279) in either group (F (4, 40) = 3.822, P = 0.100).  
 
Pairwise comparisons for between-visit analysis (see Figure 4.29 and Table 4.33) showed that 
for the intervention eye group, measures in the temporal quadrant did not change from 
baseline to the 6-month timepoint (P = 1.000), nor between the 6- and 18-month timepoints (P 
= 1.000), 18- and 30-month timepoints (P = 0.078) and the 30- and 36-month timepoints (P = 
1.000).  
 
Pairwise comparisons for between-visit analysis (see Figure 4.30 and Table 4.34) showed that 
for the control eye group, measures in the temporal quadrant did not change from baseline to 
the 6-month timepoint (P = 1.000), nor between the 6- and 18-month timepoints (P = 1.000), 
18- and 30-month timepoints (P = 0.659) and the 30- and 36-month timepoints (P = 1.000). 
 
J45 peripheral refraction in the nasal quadrant was similar for the intervention eye and control 
eye groups (F (1, 10) = 2.296, P = 0.161) and did not change over time (F (4, 40) = 0.262, P = 
0.901) in either group (F (4, 40) = 2.396, P = 0.066).  
 
Pairwise comparisons for between-visit analysis (see Figure 4.29 and Table 4.33) showed that 
for the intervention eye group, measures in the nasal quadrant did not change from baseline 
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to the 6-month timepoint (P = 1.000), nor between the 6- and 18-month timepoints (P = 1.000), 
18- and 30-month timepoints (P = 1.000) and the 30- and 36-month timepoints (P = 1.000).  
 
Pairwise comparisons for between-visit analysis (see Figure 4.30 and Table 4.34) showed that 
for the control eye group, measures in the nasal quadrant did not change from baseline to the 
6-month timepoint (P = 1.000), nor between the 6- and 18-month timepoints (P = 1.000), 18- 
and 30-month timepoints (P = 1.000) and the 30- and 36-month timepoints (P = 1.000). 
 
J45 peripheral refraction in the superior quadrant was similar for the intervention eye and 
control eye groups (F (1, 10) = 0.309, P = 0.590) and did not change over time (F (4, 40) = 1.357, 
P = 0.266) in either group (F (4, 40) = 1.491, P = 0.223).  
 
Pairwise comparisons for between-visit analysis (see Figure 4.29 and Table 4.33) showed that 
for the intervention eye group, measures in the superior quadrant did not change from baseline 
to the 6-month timepoint (P = 1.000), nor between the 6- and 18-month timepoints (P = 1.000), 
18- and 30-month timepoints (P = 1.000) and the 30- and 36-month timepoints (P = 1.000).  
 
Pairwise comparisons for between-visit analysis (see Figure 4.30 and Table 4.34) showed that 
for the control eye group, measures in the superior quadrant did not change from baseline to 
the 6-month timepoint (P = 1.000), nor between the 6- and 18-month timepoints (P = 1.000), 
18- and 30-month timepoints (P = 1.000) and the 30- and 36-month timepoints (P = 1.000). 
 
J45 peripheral refraction in the inferior quadrant was similar for the intervention eye and control 
eye groups (F (1, 10) = 1.670, P = 0.225) and did not change over time (F (4, 40) = 1.318, P = 
0.280) in either group (F (4, 40) = 0.298, P = 0.878).  
 
Pairwise comparisons for between-visit analysis (see Figure 4.29 and Table 4.33) showed that 
for the intervention eye group, measures in the inferior quadrant did not change from baseline 
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to the 6-month timepoint (P = 1.000), nor between the 6- and 18-month timepoints (P = 1.000), 
18- and 30-month timepoints (P = 0.363) and the 30- and 36-month timepoints (P = 1.000).  
 
Pairwise comparisons for between-visit analysis (see Figure 4.30 and Table 4.34) showed that 
for the control eye group, relative peripheral refraction in the inferior quadrant did not change 
from baseline to the 6-month timepoint (P = 1.000), nor between the 6- and 18-month 
timepoints (P = 1.000), 18- and 30-month timepoints (P = 0.517) and the 30- and 36-month 
timepoints (P = 1.000). 
 
 Peripheral refraction (D) 
Timepoint (months) Temporal 30° Nasal 30° Superior 20° Inferior 20° 
Baseline 0.13 ± 0.08 0.08 ± 0.09 0.11 ± 0.07 0.07 ± 0.08 
6 -0.03 ± 0.15 0.02 ± 0.10 -0.14 ± 0.16 0.09 ± 0.09 
18 -0.07 ± 0.13 0.22 ± 0.11 0.10 ± 0.06 0.27 ± 0.17 
30 0.36 ± 0.17 0.21 ± 0.09 0.00 ± 0.10 0.04 ± 0.20 
36 0.38 ± 0.15 0.28 ± 0.13 0.10 ± 0.06 0.15 ± 0.11 
Table 4.33 J45 post-cycloplegic peripheral refractive error at each visit for the intervention eye 
group (mean ± SEM). Intervention period shaded red 
 
 
 Peripheral refraction (D) 
Timepoint (months) Temporal 30° Nasal 30° Superior 20° Inferior 20° 
Baseline 0.03 ± 0.15 0.09 ± 0.13 0.20 ± 0.10 -0.12 ± 0.09 
6 0.06 ± 0.15 -0.01 ± 0.13 0.14 ± 0.12 0.00 ± 0.09 
18 0.27 ± 0.09 -0.17 ± 0.16 0.04 ± 0.10 0.23 ± 0.09 
30 -0.09 ± 0.15 -0.14 ± 0.13 0.08 ± 0.06 -0.10 ± 0.15 
36 0.01 ± 0.11 -0.20 ± 0.14 0.03 ± 0.06 -0.05 ± 0.11 
Table 4.34 J45 post-cycloplegic peripheral refractive error at each visit for the control eye 
group (mean ± SEM) 
 
 




Figure 4.29 J45 post-cycloplegic peripheral refractive error at each visit for the intervention 




Figure 4.30 J45 post-cycloplegic peripheral refractive error at each visit for the control eye 
group (mean ± SEM) 
 
 






































































 Control eye - temporal  Control eye - nasal  Control eye - superior  Control eye - inferior




• Non-cycloplegic peripheral refraction with CL correction in situ demonstrated more 
relative hyperopia in the intervention eye group than the control eye group (F (1, 10) = 
25.425, P = 0.001) and varied by location (F (3, 30) = 5.604, P = 0.004) in both groups (F 
(3, 30) = 0.592, P = 0.625). 
 
Pairwise comparisons (see Figure 4.31 and Table 4.35) for the intervention eye group showed 
that the temporal quadrant was similar to the nasal quadrant (P = 1.000) and the inferior 
quadrant (P = 0.375) but was relatively more hyperopic than the superior quadrant (P = 0.021). 
The nasal quadrant demonstrated a similar degree of relative hyperopia to the superior (P = 
0.408) and inferior quadrants (P = 0.016), while the superior and inferior quadrants were also 
similar to each other (P = 1.000). 
 
Pairwise comparisons (see Figure 4.32 and Table 4.36) for the control eye group showed that 
the temporal quadrant was similar to the nasal (P = 1.000), superior (P = 0.056) and the inferior 
quadrants (P = 0.807). The nasal quadrant demonstrated a similar degree of relative hyperopia 
to the superior (P = 0.404) and inferior quadrants (P = 1.000), while the superior and inferior 
quadrants were also similar to each other (P = 1.000). 
 




Figure 4.31 MSE non-cycloplegic relative peripheral refraction with CL correction in situ for 




 Peripheral refraction (D) 
Timepoint 
(months) Temporal 30° Nasal 30° Superior 20° Inferior 20° 
12 2.69 ± 0.40 2.25 ± 0.53 1.03 ± 0.40 1.57 ± 0.45 
Table 4.35 MSE non-cycloplegic relative peripheral refraction with CL correction in situ for the 















































Figure 4.32 MSE non-cycloplegic relative peripheral refraction with CL correction in situ for 
the control eye group (mean ± SEM) 
 
 
 Peripheral refraction (D) 
Timepoint 
(months) Temporal 30° Nasal 30° Superior 20° Inferior 20° 
12 0.98 ± 0.28 0.77 ± 0.24 0.01 ± 0.35 0.39 ± 0.37 
Table 4.36 MSE non-cycloplegic relative peripheral refraction with CL correction in situ for the 




The work outlined in this paired-eye clinical trial has explored for the first time if anisometropia 
can be reduced in anisohyperopes by imposing RPHD unilaterally in the more hyperopic eye, 
with the fellow eye serving as a control. The first of two primary outcome measures, axial 
growth, showed that despite the imposition of RPHD, AL did not increase significantly over 
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and in fact, the interocular difference in AL was greater at the point of exit from the trial than at 
baseline. The findings here are in contrast to the work outlined in Chapter 3 for isohyperopes 
where axial growth in the intervention group outperformed the control group during the 
intervention period. The outcome from the present study may be considered unsurprising given 
recently published work demonstrating that, even at a small degree, anisometropia appears to 
disrupt the regulation of eye growth (Flitcroft et al., 2020).  
 
For the second primary outcome measure, post-cycloplegic refractive error, once again results 
did not align with the original hypothesis. While mean refractive error decreased over time, this 
was by a similar amount in both the intervention and control eye group with a failure to close 
the gap between the interocular difference measured at baseline compared to the final 
outcome. As with the findings in Chapter 3, unlike AL, this outcome measure did not achieve 
statistical power. Once again, data could have been collected at each of the 7 timepoints to 
increase power but decisions such as these need to be considered alongside the burden 
placed upon young participants and potential impact upon drop out. Based upon the effect 
size, it is estimated that to achieve statistical power at 80% over 5 data collection points, a 
sample size of 49 participants would be required. 
 
For secondary outcome measures, the longitudinal changes for anisohyperopes were 
broadly in keeping with their isohyperopic counterparts (see Chapter 3). For instance, while 
unaided DV was better in the control eye than the intervention eye group, this parameter did 
not change over time. Although statistically, spectacle DVA worsened over time in both the 
control eye and intervention eye groups, this was limited to 0.03 LogMAR units from baseline 
to exit measures so is, therefore, of limited clinical relevance, particularly taking into account 
the variability seen at interim visits. DVA was better with spectacles than CLs although there 
was greater improvement with the latter form of correction over time. Interestingly, 
improvements over time in DVA with CLs were similar in both the intervention (MF) wearers 
as the control (SV) wearers suggesting that adaptation may relate more to the CL itself rather 
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than the optics of the different designs. Measures of NVA with CLs also improved over time 
in both the intervention eye and control eye groups. Stereoacuity with spectacles did not 
change over time; however, unlike the isohyperopes in Chapter 3, stereoacuity was similar 
with spectacles and CLs which may be a result of reduced image degradation with unilateral 
MF optics in the anisohyperopic cohort. In terms of CS, once again, as with isohyperopes, 
measures were similar with spectacles compared to CLs in both SV and MF designs and did 
not change over time; this offers reassurance that visual performance with both unilateral 
and bilateral MF CLs is adequate for young wearers, which is borne out in the low levels of 
drop out witnessed throughout the studies outlined in both chapters. Neither CC nor ACD 
changed over time in either group, with the latter suggesting that the longitudinal increase in 
AL seen in the control eye group was likely to be due to VCD changes. In terms of 
accommodative function, lag with spectacle correction in the intervention eye did not change 
over time although it was significantly greater when compared to CLs; this finding could be 
important given that in myopic work, impaired lag has been implicated as a driver for axial 
growth and myopia progression (Mutti et al., 2006; Chakraborty et al., 2020) although it does 
not appear to be the case here. Paradoxically, given the findings for post-cycloplegic 
spectacle refraction, central CL power reduced over time in the intervention eye group but 
not the control eye group. Nevertheless, this may be accounted for by virtue of CL power 
being assessed under non-cycloplegic conditions.  
 
All participants completed the trial, reinforcing the findings from Chapter 3 that young wearers 
can successfully transition into CL wear and also adapt well to wearing a MF design 
unilaterally. As outlined in Chapter 3, a potential limitation is the use of self-reported wearing 
times as the basis for presumed compliance. However, as with isohyperopes, the participants 
here were also, on the whole, reluctant to give up CLs at the end of the intervention period 
with the majority intending to resume wear upon exiting the study, which suggests that 
compliance was in line with reported values. 
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As with isohyperopes in Chapter 3, peripheral refraction was relatively myopic in all four 
quadrants in both the intervention eye and control eye groups and did not change over time. 
Importantly, relative peripheral refraction with CL in situ neatly demonstrated that centre-near 
MF CLs are a viable method to induce the desired defocus in anisohyperopes with a greater 
degree of RPH seen in the intervention eye group compared to the SV CL-wearing control 
eye group. However, regardless of this, as outlined in the discussion for isohyperopes, the 
role of peripheral defocus in the manipulation of axial growth remains uncertain and the 
primary outcomes here for anisohyperopes fails to add clarity. While the imposition of relative 
peripheral hyperopic defocus appears to influence growth rates in isohyperopes the same 
does not hold true for anisohyperopes using the paradigm outlined in the present work. It 
seems that, unlike isohyperopes, the unique growth patterns typically experienced by 
anisohyperopes are resistant to the influence of RPHD, at least in this age demographic and 
at the magnitude imposed here. It remains to be seen if earlier intervention and a more 
aggressive approach to defocus would yield more promising results; this provides an 
opportunity for future work with the aim to remedy the impact of near lifelong visual 
impairment these individuals would otherwise face. Instinctively, for anisohyperopes, the eye 
closer to emmetropia, in this case the control, would be considered the ‘normal’ eye. 
However, given that the mean growth rate for the more hyperopic eye is closer to the 
expected norm (Breslin et al., 2013), perhaps the control eye should be considered to be the 
‘abnormal’ one of the pair. Redefining the eye in this way could change the approach to 
refractive error modulation in anisohyperopes where the primary endeavour would be to slow 
down growth in the least hyperopic eye rather than attempting to accelerate growth in the 
more hyperopic eye. To stretch this concept further, perhaps imposing competing defocus 
models could yield the greatest result, that is to say, using myopic defocus to slow down 
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Refractive error modulation studies typically report changes to AL and post-cycloplegic 
refraction as the key outcome measures to determine the effect of a given intervention. With 
this in mind, it is important to understand the sensitivity of these measures in order to have 
confidence that any changes have arisen as a result of the intervention rather than any inherent 
variability in the clinical techniques that can occur between visits. 
 
To date, refractive modulation studies in humans have primarily focused on myopes (see 
Chapter 1). Within a hyperopic cohort, particularly in young participants, it is possible that 
fluctuations in accommodation could play a greater role in measurement variability compared 
to their myopic counterparts given that they are likely to spend time without refractive correction 
and may not have their full manifest refractive error corrected (Leat, 2011).  
 
The Zeiss IOLMaster 500 is considered ideal for the purposes of AL monitoring (see Chapter 
2) with good repeatability. Lam et al., 2002 reported a mean difference between measures 
taken on the same day of 0.0042 mm in a young, adult, myopic cohort under non-cycloplegic 
conditions with 95% limits of agreement (LoA) of ± 0.047 mm. Others concur, reporting high 
repeatability of non-cycloplegic AL measurement in adults (Santodomingo-Rubido et al., 
2002;); these measures are also repeatable for children in both mixed (Hussin et al., 2006) 
and myopic refractive cohorts under non-cycloplegic conditions (Kimura et al., 2007) and 
following cycloplegia (Carkeet et al., 2004). Interestingly, cycloplegia appears to have little 
effect on IOLMaster 500 AL measurements using tropicamide 1% (Sheng et al., 2004; 
Khambhiphant et al., 2015) or cyclopentolate HCl 1% (Cheung et al., 2009; Arici et al., 2014), 
which is also the case with the IOLMaster 700 after instillation of tropicamide 1% (Momeni-
Moghaddam et al., 2019). IOLMaster 500 ACD measurements are affected by cycloplegia with 
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shallower readings reported prior to, compared to after instillation of the drug, with mean 
differences of between 0.05 mm (SD ± 0.03) (Cheung et al., 2009) and 0.15 mm (SD ± 0.10) 
(Arici et al., 2014) using cyclopentolate HCl 1%, and 0.11 mm with tropicamide 1% 
(Khambhiphant et al., 2015). 
 
Unsurprisingly, results from non-cycloplegic autorefraction are prone to inaccuracies, 
particularly in young hyperopes due to an active accommodative response (Sankaridurg et al., 
2017). While refraction undertaken under cycloplegia will yield more accurate results, in the 
context of tracking longitudinal refractive error changes for research, it is prudent to evaluate 
both the repeatability of autorefraction and the time course of cycloplegia upon the outcome 
measure.  
 
The repeatability of autorefraction using the Grand Seiko WAM-5500, 30 minutes after the 
instillation of tropicamide 1% in a young, adult myopic cohort demonstrated a mean difference 
between visits of 0.02 D (SD ± 0.11) and LoA of ± 0.21 D (Moore and Bentsen, 2014). Similarly, 
the repeatability of autorefraction using the Shin-Nippon SRW-5000, in a mixed refractive 
cohort of children aged 4 to 8 years after the instillation of cyclopentolate HCl 1% has been 
reported as a mean difference of 0.01 D (SD ± 0.35) with LoA of ± 0.35 D (Chat and Edwards, 
2001).  
 
Measures of cycloplegic refraction are typically taken at 30 minutes after the instillation of the 
drug (Chat and Edwards, 2001; Moore and Bentsen, 2014;) as this has been shown to be the 
point at which maximum cycloplegia is reached in most children (Laojaroenwanit et al., 2016), 
although this does vary according to iris colour (Manny et al., 1993). Regardless of iris colour, 
the time course for pupil dilation is not the same as the time course for cycloplegia. Some 
report that maximal cycloplegia is not reached until 90 minutes after instillation of 
cyclopentolate HCl 1% (Kyei et al., 2017). Others suggest that in hyperopes, maximum 
refractive power is found at 50 to 70 minutes after instillation, although this can be accelerated 
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by around ten minutes by using a topical anaesthetic prior to the cycloplegic (Xiaoming et al., 
2011). Nevertheless, the difference in autorefraction taken after instillation of cyclopentolate 
HCl 1% in emmetropic and hyperopic children at 30 and 60 minutes, respectively, has been 
reported as being just 0.06 D (SD ± 0.28), with marginally more hyperopia measured at the 
latter timepoint (Mutti et al., 1994). In hyperopes with brown irides, it has been proposed that 
two drops of cyclopentolate HCl 1% instilled 10 minutes apart should be used to achieve a 
deeper level of cycloplegia than a single dose (Mohan and Sharma, 2011). In a predominantly 
hyperopic cohort, others have reported that a single drop of cyclopentolate HCl 1% appears to 
be sufficient and results in fewer side effects than a multidose approach (Bagheri et al., 2007). 
 
Within refractive error modulation studies, measures are typically taken following a specified 
time period after the instillation of a cycloplegic agent (Anstice and Phillips, 2011; Walline et 
al., 2013; Chamberlain et al., 2019a, although others use different criteria for establishing if 
adequate cycloplegia has been achieved. For instance, some use pupil diameter and absence 
of a light reflex as marker (Negrel et al., 2000), whereas others use measures of 
accommodative amplitude (Logan et al., 2011; Lam et al., 2019). 
 
While it is desirable to take measurements in strict accordance with the protocol, the reality, 
particularly with younger participants, is that there can often be minor departures from the 
intended plan. For instance, a participant may have measurements taken at precisely 30 
minutes after the instillation of the cycloplegic on the first visit, yet unexpected circumstances 
can mean that assessment takes place several minutes before or after the desired timepoint 
on a subsequent visit.  
 
Taking all of the above into account, it is useful to confirm the differences that arise in pre-
cycloplegic versus post-cycloplegic measures of AL in a mixed refractive cohort and also to 
determine if there is any short-term variability in these parameters. In addition, being able to 
elucidate the changes that occur in post-cycloplegic objective refraction across discrete time 
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intervals on the same visit, along with an assessment of repeatability across visits, provides 
helpful insight when designing refractive error modulation studies. 
 
5.2 Objective 
The purpose of this pilot study was to establish the variation in measures of post-cycloplegic 
refraction at discrete time intervals and changes to AL measures before and after cycloplegic 
refraction. The aim was to establish if there was variability in these measures taken at two 
separate visits across an interval of 1 to 2 weeks. 
 
5.3 Methods 
Sample size calculation indicated that 24 participants would be required to achieve 80% power 
for an effect size of 0.25 at a significance level of 5% using a repeated measures ANOVA 
design (G*Power 3.1, Franz Faul, Universität Kiel, Germany). The aim was to recruit 28 
participants to allow for an attrition rate of 20%. Suitable candidates were enrolled by 
displaying notices at the research venues. Potential participants were also sourced through a 
database search at the research venues to identify individuals that met the inclusion criteria.  
 
Prior to commencing the research, ethical approval was obtained from Aston University’s 
Research Ethics Committees (see Appendix 9) with the study designed to follow the tenets of 
the Declaration of Helsinki. Each participant was given detailed information regarding the 
nature of the study, both verbally and in written form; this allowed informed consent and assent 
to take place prior to participation. The participants were required to complete a short 
questionnaire to ensure they met the inclusion criteria (see Appendix 10). 
 
Inclusion criteria were as follows: 
• Aged between 8 and < 31 years-of-age 
• Parents must have read, understood and signed the informed consent form where 
appropriate (see Appendix 11) 
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• Participants must have read, understood and signed the consent or assent form as 
appropriate (see Appendix 12 and 13) 
• Be in good general health 
 
Exclusion criteria were as follows: 
• Current use of systemic medication that could affect focusing ability 
• Known ocular or systemic disease 
• Participants who were not able to provide informed consent without the aid of an interpreter 
due to lack of funding available for the provision of interpreter facilities. 
 
Participants were required to attend for two visits taking place within 1 to 2 weeks of each 
other. A summary of the procedures conducted at each visit are detailed below. 
 
Visit 1 
• Unaided DV at 6 m (LogMAR) 
• DVA at 6 m (LogMAR) 
• Slit lamp examination 
• IOPs 
• Pre-cycloplegic AL 
• Post-cycloplegic autorefraction at 25, 30, 35 and 40 minutes, following instillation of 1 drop 
of cyclopentolate HCl 1% in minim form (Bausch + Lomb, Kingston upon Thames, UK) in 
each eye  
• Post-cycloplegic AL at 30 minutes 
• Post-cycloplegic ACD at 30 minutes. 
 
Visit 2 
• Unaided DV at 6 m (LogMAR) 
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• DVA at 6 m (LogMAR) 
• Slit lamp examination 
• IOPs 
• Pre-cycloplegic AL 
• Post-cycloplegic autorefraction at 25, 30, 35 and 40 minutes, following instillation of 1 drop 
of cyclopentolate HCl 1% in minim form (Bausch + Lomb, Kingston upon Thames, UK) in 
each eye  
• Post-cycloplegic AL at 30 minutes 
• Post-cycloplegic ACD at 30 minutes. 
 
5.4 Statistical analysis 
All data were analysed using the commercially available software, SPSS, v. 25, IBM, New 
York, U.S.A. (Armstrong et al, 2011; Armstrong et al., 2002). Data were examined with t-tests 
or repeated measures ANOVA with Bonferroni correction applied, as indicated, with a 
significance level of α < 0.05 used throughout.  
 
5.5 Results 
Primary outcome measures (see 5.5.1) were changes in post-cycloplegic MSE refractive error 
over discrete time intervals at each visit and between the two visits, along with differences in 
pre- and post-cycloplegic AL measures on and between both visits. Primary outcome 
measures were the same for the right and left eyes for AL (F1,23 = 0.453, P = 0.508) and post-
cycloplegic refraction (F1,23 = 0.754, P = 0.394). As such, data presented here is for the right 
eye only (Armstrong, 2013).  
 
All 24 participants that were recruited completed the study and comprised of 18 females and 
6 males with an age range at baseline of 12.58-29.08 years (mean 19.04 SD 5.66 years); these 
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data were normally distributed (Kolmogorov-Smirnov, Z = 0.215, P = 0.05). The refractive 
range was -3.51 D to +5.91 D (mean 2.43 D SD 3.08). 
 
5.5.1 Primary outcome measures 
 
5.5.1.1 AL 
Analysis showed that AL measures were the same prior to cycloplegia compared to 30 minutes 
after instillation of cyclopentolate HCl 1% (F (1, 23) = 1.231, P = 0.279). Measures of AL did not 
change across the two visits (F (1, 23) = 0.351, P = 0.559) under pre- or post-cycloplegic 
conditions (F (1, 23) = 0.437, P = 0.515) (see Table 5.1). Observed power was 9.7% and partial η2 
was 0.019. 
 
 AL (mm) (n = 24) 
Timepoint Pre-cycloplegic Post-cycloplegic 
Visit 1 22.42 ± 0.26 22.42 ± 0.26 
Visit 2 22.42 ± 0.26 22.42 ± 0.26 
Table 5.1 AL before and 30 minutes after instillation of cyclopentolate HCl 1% at each visit 
(mean ± SEM) 
 
For pre-cycloplegic AL, the mean difference between Visit 1 and Visit 2 was 0.004 mm SD ± 
0.01 (t-test: t = 1.366, df = 23, P = 0.185) with 95% LoA of ± 0.026 mm (see Figure 5.1).  
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Figure 5.1 Difference versus the mean plot for pre-cycloplegic AL at Visits 1 and 2. 95% LoA 
enclosed by dashed lines. Mean difference indicated by solid line 
 
 
For post-cycloplegic AL, the mean difference between Visit 1 and Visit 2 was 0.000 mm SD ± 
0.013 (t-test: t = 0.000, df = 23, P = 1.000) with 95% LoA of ± 0.025 mm (see Figure 5.2). 
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Figure 5.2 Difference versus the mean plot for post-cycloplegic AL at Visits 1 and 2. 95% LoA 
enclosed by dashed lines. Mean difference indicated by solid line 
 
 
5.5.1.2 Post-cycloplegic refractive error 
Analysis for the main effects revealed that post-cycloplegic MSE refractive error did not change 
over discrete timepoints following cycloplegia (F (1, 23) = 0.392, P = 0.759). Measures did not 
change between visits (F (1, 23) = 0.121, P = 0.731) with no interaction between factors (F (1, 23) 
= 0.362, P = 0.781). Observed power was 11.8% and partial η2 was 0.016. 
 
Pairwise comparisons showed that during the first visit, post-cycloplegic MSE refractive error 
was the same at 25 (P = 1.000), 30 (P = 1.000) 35 (P = 1.000) and 40 minutes (P = 1.000) 
after instillation of cyclopentolate HCl 1%; this was also the case during the second visit at 25 
(P = 1.000), 30 (P = 1.000) 35 (P = 1.000) and 40 minutes (P = 1.000), respectively (see Figure 
5.3 and Table 5.2). 
 





Figure 5.3 Post-cycloplegic MSE refractive error at discrete timepoints after instillation of 
cyclopentolate HCl 1% at each visit (mean ± SEM) 
 
 
 Refractive error (D) (n = 24) 
Timepoint 25 mins 30 mins 35 mins 40 mins 
Visit 1 2.43 ± 0.63 2.40 ± 0.63 2.38 ± 0.63 2.42 ± 0.63 
Visit 2 2.41 ± 0.62 2.45 ± 0.62 2.38 ± 0.62 2.45 ± 0.61 
Table 5.2 Post-cycloplegic MSE refractive error at discrete timepoints after instillation of 
cyclopentolate HCl 1% at each visit (mean ± SEM) 
 
 
5.5.2 Secondary outcome measures 
 
5.5.2.1 Unaided DV 
Unaided DV did not change between Visit 1 and Visit 2 with a mean difference of -0.003 
LogMAR SD ± 0.06 (t-test: t = -0.199, df = 23, P = 0.844) (see Table 5.3) with 95% LoA of ± 
0.12 LogMAR (see Figure 5.4). Linear regression analysis indicated a level of bias between 






























 Visit 1  Visit 2
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Timepoint DV (LogMAR) (n = 24) 
Visit 1 0.25 ± 0.06 
Visit 2 0.25 ± 0.07 




Figure 5.4 Difference versus the mean plot for unaided vision at Visits 1 and 2. 95% LoA 




DVA was unchanged between Visit 1 and Visit 2 with a mean difference of 0.014 LogMAR SD 
± 0.06 (t-test: t = 1.204, df = 23, P = 0.241) (see Table 5.4) with 95% LoA of ± 0.11 LogMAR 
(see Figure 5.5). Linear regression analysis confirmed a level of agreement between visits (t 
= -1.199, P = 0.243). 
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Timepoint DVA (LogMAR) (n = 24) 
Visit 1 -0.03 ± 0.02 
Visit 2 -0.04 ± 0.02 
Table 5.4 DVA at 6 m at each visit (mean ± SEM) 
 
 
Figure 5.5 Difference versus the mean plot for DVA at Visits 1 and 2. 95% LoA enclosed by 




ACD did not change between Visit 1 and Visit 2 with a mean difference of 0.002 mm SD ± 0.05 
(t-test: t = 0.226, df = 23, P = 0.823) (see Table 5.5) with 95% LoA of ± 0.09 mm (see Figure 
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Timepoint ACD (mm) (n = 24) 
Visit 1 3.53 ± 0.06 
Visit 2 3.53 ± 0.06 
Table 5.5 ACD at each visit (mean ± SEM) 
 
 
Figure 5.6 Difference versus the mean plot for post-cycloplegic ACD at Visits 1 and 2. 95% 




This pilot study offers useful insight into the influence of cycloplegia on AL and refractive error. 
These key ocular parameters are typically the primary outcomes in refractive error modulation 
research, so it is important to understand the effect of cycloplegia on these measures. The 
study also provides data on the repeatability of the ocular parameters outlined above; this is 
valuable as it allows researchers to place any changes that have occurred over time, for 
example, to AL, in the context of variability that may arise naturally across sessions in studies 
of this type. 
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In terms of AL measures in this study, there are two important aspects to consider: firstly, the 
repeatability of AL measures under both non-cycloplegic and cycloplegic conditions; secondly, 
to understand the impact of a cycloplegic agent on AL. These insights allow researchers to 
review options when designing refractive error modulation experimental paradigms. For 
instance, in Chapters 3 and 4, participants had axial growth monitored under pre-cycloplegic 
conditions over a 3-year period at 6-monthly intervals, that is to say, on 7 visits in total. In the 
same trials, post-cycloplegic refractive error was evaluated on 5 visits over the same 3-year 
interval. In other words, a cycloplegic agent was only used on 5 out of the 7 visits. In the 
present study, measures of AL in a young, mixed refractive cohort were the same under non-
cycloplegic and cycloplegic conditions across two separate visits. The outcome here is 
reassuring as it gives researchers the confidence to design refractive error modulation studies, 
in line with the paradigm adopted for Chapters 3 and 4, without necessarily having to specify 
that a cycloplegic agent is required in order to track longitudinal axial growth. There are several 
benefits that arise from this finding: recruitment of participants may become easier, particularly 
with young children if cycloplegia is either not required, or if the requirement can be removed 
at certain data collection points; the burden of cycloplegia for participants can be removed or 
frequency reduced in study designs; researchers can take the opportunity to investigate other 
secondary outcome measures under non-cycloplegic conditions at intervals where a 
cycloplegic agent is not required, for example, peripheral refraction with CLs in situ under 
natural a refractive state (see Chapters 3 and 4).  
 
The present study also investigated both the repeatability of cycloplegic refraction in a young, 
mixed refractive cohort and the impact of duration of drug exposure at discrete time intervals. 
In terms of repeatability, as with AL measures described above, it is essential to understand 
natural variability in cycloplegic refraction that can arise between measurement sessions so 
that any reported changes are attributed confidently to a particular intervention. In addition, it 
is important to understand the effect that variability in the duration of drug exposure can have 
on the outcome measures; in the author’s experience, it is not unusual for participants to 
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unintentionally return later than specified time following instillation of the cycloplegic. For 
example, the participant or a younger sibling may request a comfort break prior to resuming 
data collection, resulting in measures being taken several minutes after the intended timepoint. 
As such, it is helpful to elucidate the potential impact of these discrete time deviations. It is 
reassuring to note that the results from the present study show that measures of refractive 
error taken at four time points across a 15-minute window do not differ significantly and are 
repeatable across two measurement sessions. 
 
In terms of secondary outcome measures, this study has shown that in line with previous work, 
measures of unaided DV and DVA (Raasch et al., 1998; Siderov and Tiu, 1999), and ACD 
(Lam et al., 2001; Sheng et al., 2004) are repeatable.  
 
In summary, the results of this study have shown that AL does not change significantly when 
comparing measures taken before and after the introduction of a cycloplegic agent in a young, 
mixed refractive cohort. The other main outcome from this study offers reassurance to 
researchers that objective measures of cycloplegic refraction are repeatable and do not vary 
significantly across discrete time intervals. Further work could look to explore objective 
measures of cycloplegic refraction at a greater spread of timepoints to establish if this key 
outcome measure can be reliably taken within a shorter window to increase the efficiency of 
data collection for the benefit of participants and investigators. It would be helpful if this pilot 
work could be expanded upon with a larger sample to achieve statistical power, and given the 
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6.0 General discussion 
The overarching conclusion from this body of work provides evidence to support the original 
hypothesis and offers a clinically accessible mechanism to reduce the lifelong impact of 
hyperopia. But there is more to do. Indeed, it is important to recognise that the clinical trials 
outlined here are a starting point in an area of research that, against the backdrop of the 
myopia epidemic, has thus far been neglected. 
 
The primary outcome measures outlined in Chapter 3 demonstrate the ability to accelerate 
axial growth in isohyperopes. Two-year axial growth rates of 0.17 mm versus 0.06 mm in the 
intervention and control groups, respectively, shows promise. In terms of the second primary 
outcome measure, post-cycloplegic error, while the decrease in hyperopia did not reach 
statistical significance, the overall trend was in the desired direction and an extension of the 
work is required with a larger sample size to achieve sufficient power. Furthermore, a larger 
sample size would permit further statistical analysis, such as multiple linear regression, to help 
identify factors that may predict potential responders to the types of intervention outlined in the 
present work. It is also worth noting the effects of ‘optical dampening’ and the reduction in the 
refraction: AL ratio seen in larger myopic eyes (Cruickshank and Logan, 2018) and how this 
may translate into a greater refractive impact for those with smaller globes, namely hyperopes. 
In other words, an increase in AL in a small, hyperopic eye would be expected to result in a 
larger refractive change than an equivalent AL change in a larger eye. Once again, this could 
be elucidated with a sufficiently large dataset. 
 
A deeper delve into the raw data clearly shows that while the majority of children respond to 
the intervention, there appears to be others that could be regarded as non-responders, where 
growth rates follow a natural time course. Interestingly, the two best responders were almost 
3 years younger and had a baseline refraction ~ +2.00 D lower than the two worst responders 
(see Appendix 14). While a trend cannot be established from this small-scale observation, it is 
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intriguing, and the relevance of age and refractive error at baseline should be explored in future 
work.   
 
Establishing proof of concept and taking into account lessons learnt throughout the 
experimental chapters has created a platform to develop the efficacy of this approach. In the 
first instance, it would be useful to assess the impact of earlier intervention. While the entry 
point for participants in the present study was 8 years of age, the mean age was > 11 years. 
Nevertheless, it is worth stressing that recruitment of hyperopes within primary care and 
research settings is challenging, particularly within a younger age group. In the absence of 
amblyopia or symptoms, low to moderate hyperopes are likely to ‘pass’ rudimentary vision 
screening at school (O’Donoghue et al., 2012) and may not present for routine assessment 
within primary care optometry. On the other hand, strabismic and / or amblyopic hyperopes 
are usually diverted to secondary care and not discharged to primary care until beyond the 
age of 7 years. Taking the above into account, two points need to be addressed, at least in the 
UK. Firstly, as with dental care, it is essential to place the visual welfare of young children on 
the healthcare checklist of parents. A timely visit to primary care optometry would allow for pre-
school detection of latent hyperopia, amblyopia and anisometropia, creating the best 
opportunity for intervention. Although, as a sidenote, it seems there is still some work to do 
within the profession itself to educate practitioners on taking an evidence-based approach to 
inform clinical decisions when using cycloplegia during paediatric examinations (Doyle et al., 
2019). Secondly, there is a pressing need for research collaboration with Hospital Eye Service 
colleagues, once again, to maximise the visual prognosis for these children at the earliest 
possible stage.  
 
Additional opportunities to expand upon refractive error modulation in children with hyperopia 
could be through nuanced optical approaches based upon the mechanism established in 
Chapter 3. In the present study, a single dose approach was taken using a 2.00 D add in an 
‘off-the-shelf’ design intended for presbyopic correction. Due to minimal axial growth typically 
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seen in hyperopes, ‘…they really need to have a good kick in the pants to reactivate their long 
dormant growth...’ (Dr Thomas Aller, California, US, personal communication, 4 September 
2020). In this context, a ‘good kick’ refers to using custom-designed MF CLs, in the smallest 
sized central zone and the highest add power that the child will tolerate; this approach is not 
unreasonable given that myopic defocus, at least in chicks, seems to have greater potency 
than hyperopic defocus (Zhu et al., 2005; Zhu, 2013). Furthermore, customising the design to 
ensure sufficient RPHD in all four quadrants on an individual basis may also yield better 
results.  
 
There remains, as with myopes, conjecture as to whether the signal for accelerated growth 
observed in this cohort was due to the imposition of RPHD, the effect of the intervention upon 
accommodative lag, or both. From a clinician’s standpoint, and certainly from the patient’s 
perspective, does it really matter? Nevertheless, from a research stance, this question requires 
answering, at the very least to satisfy curiosity, but more importantly to hone future approaches 
in this area.  
 
While the results in Chapter 3 bring optimism and a firm foundation on which to build, the 
results for anisohyperopes in Chapter 4 are an intriguing contrast to their isohyperopic 
counterparts. In view of the fact that as little as 0.50 D of anisometropia is enough to disrupt 
emmetropisation (Flitcroft et al., 2020) and given that participants in the present trial had a 
minimum baseline interocular difference in refractive error of >1.00 D, they were arguably 
faced with an uphill battle to achieve the intended outcome, particular at the age inclusion 
criteria specified in the study. Of course, the points raised previously in relation to early 
intervention are equally valid here, but perhaps also the definition of anisometropia ought to 
be softened and interocular differences of >0.50 D should be regarded as abnormal enough 
to warrant intervention. Once again, as with isohyperopes, anisohyperopes may also benefit 
from a ‘good kick.’   
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As alluded to in Chapter 4 (see Section 4.6), for anisohyperopes specifically, a more 
aggressive approach could be taken with the least hyperopic eye. The rationale for this is that 
in the present study, it was the ‘better’ eye that appeared to display a more atypical growth 
rate than its fellow. Could the ‘better’ eye actually be regarded as the abnormal one of the pair 
in the case of anisohyperopes? With this in mind, the eye closer to emmetropia could be 
treated in the same way as a progressing myope by imposing relative peripheral myopic 
defocus (RPMD) to slow down axial growth. Of course, this does not preclude the opportunity 
to simultaneously impose RPHD in the fellow eye to maximise the chances of narrowing the 
interocular difference in refractive error. Building upon this concept, even a pharmacological 
strategy could be employed in those with anisohyperopia by trying to slow down growth in the 
eye closest to emmetropia. Indeed, there is precedent for this in the context of myopic 
anisometropia where atropine has been used successfully to slow down axial growth only in 
the eye with the highest refractive error (Lixia et al., 2013).  
 
Regardless of the effect of RPHD on axial growth modulation, or lack thereof, in 
anisohyperopes, it is worth emphasising the point from Chapter 1 (see Section 1.3.3) in relation 
to the advantages of CL wear for these individuals. Certainly, practitioners should at least be 
mindful that correction of anisometropia with this form of correction instead of spectacles 
facilitates the potential for normal binocular vision (Winn et al., 1986; Romano and von 
Noorden, 1999) and can deliver improvements to VA. 
 
Outside of CL modalities, novel spectacle lens designs for both aniso- and isohyperopes 
remains an unexplored area of research. Could lessons be learnt from existing spectacle lens 
designs for myopia such as the DIMS lens? A central optic zone to provide full refractive 
correction surrounded by multiple segments to deliver constant hyperopic of defocus of -3.50 
D perhaps? 
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In addition to the experimental chapters relating to refractive error modulation, the pilot study 
summarised in Chapter 5 offers reassurance to practising clinicians and researchers that the 
typical approach to collection of key data in this field is robust. In particular, post-cycloplegic 
measures across a broad range of refractive errors are comparable at 25 minutes through to 
40 minutes, which provides scope for leeway when making assessments in the clinic or lab. In 
addition, it seems that AL measures are repeatable and comparable under both cycloplegic 
and non-cycloplegic conditions. 
 
In summary, it is hoped that by demonstrating the ability to modulate refractive error in 
isohyperopes, this will generate sufficient intrigue to build upon this work. There is much to do. 
For instance, it would be desirable to undertake a multicentre randomised control trial with 
customised MF CL designs, to explore the potential for novel spectacle lens designs, and to 
consider a different approach to the management of anisohyperopes with scope to use 
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Appendix 3  
 
Background questionnaire     Date 
 
Participant code ____________ 
 
Age _________ years _________months 
 
1. Do you wear glasses? 
☐ No (skip to Q4) 
☐ Yes  
☐ Worn previously but no longer used  
 
2. How old were you when you first started wearing glasses? 
 
_______________ years old 
 
3. When do/did you wear your glasses? 
☐ Full-time 
☐ Concentrated tasks such as TV, computer and reading 
☐ Reading only 
☐ Distance only 
☐ Never  
☐ No longer required 
 
4. Have you ever had surgery on your eyes? 
☐  No  
☐  Yes  
 





5. Have you ever been to see a specialist about any other problem with your eyes? 
☐  No  
☐  Yes 
 





6. Have you ever had to wear an eye patch? 
☐ No (skip to Q12) 
☐ Yes  
 
7. Which eye did you wear the patch on? 
☐  Right eye 
☐  Left eye 
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☐ Alternated between eyes 
 
8. How old were you when you started wearing the patch? 
 
_______________ years old 
 
9. How old were you when you stopped wearing the patch? 
 
_______________ years old 
 




11. In terms of wearing the patch did you: 
 
☐  Always use it as instructed 
☐  Mostly used it as instructed 
☐  Hardly used it as instructed 
☐  Never used it as instructed 
 
12. Do you suffer from any general health conditions? 
☐  No 
☐  Yes 
 





13. Are you taking any regular medication? 
☐  No 
☐  Yes 
 





14. Are you under the care of an eye specialist for any ongoing treatment? 
☐  No 
☐  Yes 
 





15. Do you wear or have you ever worn contact lenses? 
☐  No 
☐  Yes 
 
If yes, please detail here  







16. Are you participating in any other studies? 
☐  No 
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Appendix 4  
 




I am writing to advise you that the above-named patient is participating in a research trial 
conducted by a team from Aston University. The study will examine the effect of peripheral 
defocus on axial growth and modulation of refractive error in hyperopes. 
 
Some recent studies have shown that wearing a particular type of contact lens can slow down 
the progression of myopia. The purpose of this study is to see if a contact lens, similar to those 
used in the myopia studies, could be used to reduce hyperopia. 
 
The study will last three years with a group of participants wearing the intervention while the 
other group will have the natural progression of their hyperopia monitored. 
 
I trust that this information is useful but if you require any further information then please 







Dr Ian Beasley beasleyi@aston.ac.uk (07798 633536) 


































CONSENT FORM (Parent natural progression) 
 
 
NAME OF PARTICIPANT __________________________  Age: _______ Years 
______ Months   
 
 
Title of Project: The effect of peripheral defocus on axial growth and modulation of 
refractive error in hyperopes 
 
Project investigators: Dr Nicola Logan, Dr Ian Beasley, Dr Leon Davies   
  
Please initial the boxes: 
1. I confirm that I have read and understand the information sheet (Version 2 
09/05/16) for this study, have had the opportunity to ask questions and have 
explained the study to my child. 
 
 
2. I understand that my child’s participation is voluntary and that my child is free 
to withdraw at any time, without giving any reason, without their medical care or 
legal rights being affected. 
 
 
3. I understand that the researchers may need to review certain sections of my 
child’s eye clinic notes and give my permission for them to do so. 
 
 
4. I agree for my child to take part in the above study and I will follow the 











Name of person taking consent Date Signature 





Investigator                                      Date                                      Signature 
 
CONSENT FORM  
 
 
NAME OF PARTICIPANT __________________________  Age: _______ Years 
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Title of Project: The effect of peripheral defocus on axial growth and modulation of 
refractive error in hyperopes 
 
Project investigators: Dr Nicola Logan, Dr Ian Beasley, Dr Leon Davies   
  
Please initial the boxes: 
1. I confirm that I have read and understand the information sheet (Version 2 
07/05/16) for this study, have had the opportunity to ask questions and have 
explained the study to my child. 
 
 
2. I understand that my child’s participation is voluntary and that my child is free 
to withdraw at any time, without giving any reason, without their medical care or 
legal rights being affected. 
 
 
3. I understand that the researchers may need to review certain sections of my 
child’s eye clinic notes and give my permission for them to do so. 
 
 
4. I agree for my child’s GP to be advised about my participation in the study 
 
 
5. I agree for my child to take part in the above study and I will follow the 











Name of person taking consent Date Signature 


































CONSENT FORM (16-19 Natural progression) 
 
 
NAME OF PARTICIPANT __________________________  Age: _______  Years 
______ Months   
 
Title of Project: The effect of peripheral defocus on axial growth and modulation of refractive 
error in hyperopes 
 
Project investigators: Dr Nicola Logan Dr Ian Beasley, Dr Leon Davies   
  
Please initial boxes (not tick) 
 
1. I confirm that I have read and understood the information sheet attached (Version 
2 07/05/16) for the above study 
 
2. I have had a chance to ask questions about the research. 
 
 
3. All of my questions have been answered in a way that I understand. 
 
 
4. I understand that it is my choice on whether or not to take part in the research and 
that I can stop being part of the research at any time, without giving a reason.  The 




5. I agree to follow the investigator’s instructions regarding the dilation drops.  
 
 












Name of person taking consent Date Signature 

























ASSENT FORM  
 
Participant ID………………… Participant Initials…………. 
 
Title of Project: The effect of peripheral defocus on axial growth and modulation of refractive 
error in hyperopes 
 
Project investigators: Dr Nicola Logan, Dr Ian Beasley, Dr Leon Davies   
 
(To be completed by the child and their parent/guardian)  
 
Child (or if unable, parent on their behalf) to circle all they agree with: 
  
1. Have you read (or had read to you) the information sheet attached 
(Version 2 09/05/16) for the above study 
 
Yes No 
2. Has somebody else explained this project to you? 
 
Yes No 
3. Do you understand what this project is about?  
 
Yes No 
4. Have you asked all the questions you want?  
 
Yes No 
5. Have you had your questions answered in a way you understand? 
 
Yes No 
6. Do you understand it’s OK to stop taking part at any time?  
 
Yes No 
7. I agree to follow the investigator’s instructions regarding contact lens wear 
and the dilation drops.  
 
Yes No 
8  Are you happy to take part?  
 
Yes No 
If any answers are ‘no’ or you don’t want to take part, do not write your name below 
 
If you do want to take part, you can write your name below  
__________________________________ ________________
 ____________________ 






Name of person taking consent Date Signature 





Investigator                                      Date                                      Signature 
 
Thank you for your help. 
 
Your name (or if child is 
unable, parent/guardian to 
help) 






Follow up questionnaire     Date 
 
Participant code ____________ 
 
Age _________ years _________months 
 
1. Do you suffer from any general health conditions? 
☐  No 
☐  Yes 
 





2. Are you taking any regular medication? 
☐  No 
☐  Yes 
 





3. Are you under the care of an eye specialist for any ongoing treatment? 
☐  No 
☐  Yes 
 













6. Is the vision clear with your contact lenses? 
 
☐  No 




Follow up questionnaire     Date 
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Participant code ____________ 
 
Age _________ years _________months 
 
 
1. Do you suffer from any general health conditions? 
☐  No 
☐  Yes 
 





2. Are you taking any regular medication? 
☐  No 
☐  Yes 
 





3. Are you under the care of an eye specialist for any ongoing treatment? 
☐  No 
☐  Yes 
 

































   
                                                                                                                                                
    Aston University 
Aston Triangle  
Birmingham  
B4 7ET  
0121 204 5069 
 
Date: 12th February 2019 
Dr Ian Beasley 




Study title:   Time course and repeatability of objective refraction and axial length 
measures following cycloplegia 
REC REF:  #1331 
 
Confirmation of Ethical Opinion  
 
On behalf of the Committee, I am pleased to confirm a favourable opinion for the above research 
based on the basis described in the application form, protocol and supporting documentation listed 
below. 
 
The Committee would like to thank you for the way that your response to their letter of Provisional 
Opinion was presented. 
 
Approved documents  
 
The final list of documents reviewed and approved by the Committee is as follows:  
 
Document  Version  Date  
Parent Information Sheet 2 21/01/19 
Parent Consent Form 2 21/01/19 
Information Sheet (8-12) 2 21/01/19 
Assent form (8-12) 2 21/01/19 
Information Sheet (13+) 2 21/01/19 
Consent form (13+) 2 21/01/19 
Recruitment poster   
Background questionnaire 2 25/11/18 
 
With the Committee’s best wishes for the success of this project. 
 
Yours sincerely  
 
Professor Richard Booth 
Acting Chair of the University Research Ethics Committee  
 






Background questionnaire     Date 
 
Participant code ____________ 
 
Age _________ years  
 
1. Do you wear glasses? 
☐ No (skip to Q3) 
☐ Yes  
☐ Worn previously but no longer used  
 
2. When do/did you wear your glasses? 
☐ Full-time 
☐ Concentrated tasks such as TV, computer and reading 
☐ Reading only 
☐ Distance only 
☐ Never  
 
3. Have you ever had surgery (including laser treatment) on your eyes? 
☐  No  
☐  Yes  
 





5. Have you ever been to see a specialist about any other problem with your eyes? 
☐  No  
☐  Yes 
 





6. Do you suffer from any general health conditions? 
☐  No 
☐  Yes 
 





7. Are you taking any regular medication? 
☐  No 
☐  Yes 
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8. Are you under the care of an eye specialist for any ongoing treatment? 
☐  No 
☐  Yes 
 




















































Time course and repeatability of objective refraction and axial length measures following 
cycloplegia 
Parent consent Form 
Name of Chief Investigator: Dr Ian Beasley 
Please initial boxes 
1.  I confirm that I have read and understand the Participant Information 
Sheet (Version 3, 03/04/19) for the above study. I have had the opportunity 




2.  I understand that my child’s participation is voluntary and that I am free to 




3.  I agree to my child’s personal data and data relating to them collected 




4.  I agree to my child’s GP being informed of my participation in the study. 
 
 




6.  I agree to my child’s personal data being processed for the purposes of 
inviting them to participate in future research projects. I understand that I 
may opt out of receiving these invitations at any time.  
  
 
7.  I agree to my child taking part in this study.  
 
 
_________________________ ________________ ___________________ 
Name of parent Date Signature 
 
 
_________________________ ________________ ___________________ 






















Time course and repeatability of objective refraction and axial length measures following 
cycloplegia 
Consent Form 
Name of Chief Investigator: Dr Ian Beasley 
Please initial boxes 
1.  I confirm that I have read and understand the Participant Information 
Sheet (Version 3, 03/04/19) for the above study. I have had the opportunity 




2.  I understand that my participation is voluntary and that I am free to 




3.  I agree to my personal data and data relating to me collected during the 
study being processed as described in the Participant Information Sheet. 
 
 
4.  I agree to my GP being informed of my participation in the study. 
 
 




6.  I agree to my personal data being processed for the purposes of inviting 
me to participate in future research projects. I understand that I may opt 
out of receiving these invitations at any time.  
  
 
7.  I agree to take part in this study.  
 
 
_________________________ ________________ ___________________ 
Name of participant Date Signature 
 
 
_________________________ ________________ ___________________ 

























Name of Chief Investigator: Dr Ian Beasley  
 
(To be completed by the child and their parent/guardian)  
 
Child to circle all they agree with: 
  
2. Have you read (or had read to you) the information sheet attached 
(Version 3 03/04/19) for the above study 
 
Yes No 
2. Has somebody else explained this project to you? 
 
Yes No 
3. Do you understand what this project is about?  
 
Yes No 
4. Have you asked all the questions you want?  
 
Yes No 
5. Have you had your questions answered in a way you understand? 
 
Yes No 
6. Do you understand it’s OK to stop taking part at any time?  
 
Yes No 
7. I agree to follow the investigator’s instructions regarding the dilation drops.  
 
Yes No 
8.  Are you happy to take part?  
 
Yes No 
If any answers are ‘no’ or you don’t want to take part, do not write your name below 
 
































Change in AL 
(mm) 
1 9.58 +2.62 0.59 
2 13.50 +2.94 0.21 
3 11.83 +4.45 0.05 
4 9.25 +8.75 0.06 
5 13.33 +6.13 0.02 
6 9.67 +3.87 0.36 
7 11.08 +5.74 0.29 
8 11.83 +7.63 0.07 
9 8.42 +8.12 0.18 
10 11.17 +4.98 0.33 
11 12.75 +2.37 0.11 
 
Appendix 14 Individual participant data for intervention group showing key 
characteristics. Rows shaded in orange highlight the two best responders whereas the 
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